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Abstract
The spatial arrangement of the human genome in the nucleus is thought to be important
for regulating gene expression. Previous studies have shown that chromosomes adopt a
radial organisation, whereby gene-rich chromosomes are situated towards the centre of
the nucleus and gene-poor chromosomes are located closer to the nuclear periphery.
Centromeres, telomeres and gene clusters also have distinct nuclear localisations in
somatic cells. If nuclear organisation regulates gene expression, then it may have a role
in gene silencing as a cell commits to differentiation. It is therefore important to
determine the nuclear organisation of stem cells. Here I ask if the nuclear architecture of
human and mouse embryonic stem (ES) cells is different from that of differentiated
cells?
I have examined the position of chromosomes 18 (gene-poor) and 19 (gene-rich) and
show that their radial nuclear organisation, seen in differentiated cells, is already
established in human ES cells. However, I show that the position of centromeres is
different in ES cells and differentiated cells. I have investigated the location of two gene
dense regions, 1 lpl5 and 6p21 (which contains the pluripotent gene OCT4) and the
12pl3 region (containing NANOG), in differentiated and human ES cells. I show that
although the position of gene dense regions is maintained through differentiation,
specific genes involved in pluripotency change position either within the nucleus or
relative to their chromosome territories. In parallel I have established data on nuclear
reorganisation during differentiation of murine ES cells towards an ectodermal lineage.
I show the relocalisation of chromosome territories and genes involved in neural
development during differentiation, which is accompanied by substantial clustering of
centromeric heterochromatin. Using mutant mouse ES cells I show that clustering still
occurs in cells that lack DNA methylation, the DNA binding protein MeCP2 and the
Suv39h histone methyltransferase. I conclude that although some of the basic principles
of nuclear organisation are already established in ES cells, spatial reorganisation of the
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It is now three years since completion of the human genome project and our
understanding of the DNA code has greatly increased. However, this linear sequence
tells us nothing about how the genome is arranged into chromosomes, or which parts of
the DNA sequence are in close proximity to each other within the nucleus (Bridger and
Bickmore, 1998). The spatial arrangement of the genome is thought to be important for
regulating gene expression. Therefore, as one mapping project came to an end, others
were already underway to locate the genome and its epigenetic modifications within the
3D nucleus (Murrell et al. 2005; and references therein).
In an embryonic stem (ES) cell the genome is thought of as plastic, being poised for both
self-renewal and the generation of numerous lineages, however as a particular cell fate is
determined the need to keep parts of the genome in an open state is lost (Szutorisz and
Dillon, 2005). This is evident from studies of both histone modifications and non¬
histone proteins in ES cells (Bernstein et al., 2006a; Boyer et al., 2006). It has been
suggested that during differentiation the spatial arrangement of the genome is
reorganised, allowing active regions access to transcription factors and silent regions to
be packaged away. In this chapter, I will summarise current theories on epigenetic
regulation of the human genome and that of model organisms, with emphasis on the
relevance of these mechanisms to early development.
2
1.1 Experimenting with pluripotency
Three cell types can differentiate into all three embryonic germ layers and are therefore
pluripotent, embryonic carcinoma (EC) cells (Kleinsmith and Pierce, 1964; Martin and
Evans, 1975), embryonic stem (ES) cells (Evans and Kaufman, 1981; Martin, 1981;
Thomson et al., 1998) and embryonic germ (EG) cells (Matsui et al., 1992; Shamblott et
al., 1998). EC cell lines are derived from teratocarcinomas, which are thought to
originate from the epiblast (Hogan et al., 1994). These cells expand continuously in
culture and when reintroduced into a developing embryo they participated in
embryogenesis, contributing to various tissues of chimaeric foetuses and live born mice
(Brinster, 1974; Mintz and Illmensee, 1975). However this was soon found to be the
exception rather than the rule. EC cells are normally aneuploid, as a result of selection
pressures during tumour growth; many lines lose their potency in culture, show weak
differentiation and contribute poorly to chimeras producing embryonic tumours (Kahan
and Ephrussi, 1970; Evans, 1972; Rossant and McBurney, 1982). Although these cells
are not 'true' stem cells, because of their abnormal karyotype, this research led to the
derivation of ES cells (sections 1.1.1 and 1.1.2). The third cell type, EG cells, are
derived from primordial germ cells (Matsui et al., 1992; Shamblott et al., 1998). EG
cells have very similar developmental capacities to ES cells, but differ in the expression
of imprinted genes (reviewed by Zwaka and Thomson, 2005). However the culture of
human EG (hEG) cells is still very challenging as the cells spontaneously differentiate in
culture (Turnpenny et al., 2003), so for the puipose of this thesis I have used ES cells.
1.1.1 Mouse ES cells
In 1981, the first ES cells were derived from the inner cell mass (ICM) of mouse
blastocysts {figure 1.1; Evans and Kaufman, 1981; Martin, 1981). Mouse ES (mES)
cells can both self renew and give rise to teratocarcinomas containing mesodermal,
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Fig. 1.1 The derivation of ES cells. Cleavage stage embryos are cultured
until the blastocyst stage. The inner cell mass is then separated from the
surrounding trophectoderm and plated onto a feeder layer of irradiated mouse
embryonic fibroblasts. Following a period of attachment and expansion, the
outgrowth is dissociated and replated onto another feeder layer. Colonies are
then expanded and passaged to form cell lines. These cells can then be
differentiated in vitro, or injected back into blastocysts and implanted to make
chimeras in vivo. The chimeric embryo shown here was generated with ES
cells containing the p-galactosidase gene. Therefore when stained for p-
galactosidase (blue), the ES cell descendants are visible throughout the foetus.
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checkpoint in their cell cycle which facilitates programmed cell death, preventing cells
with damaged genomes from contributing to a developing embryo (Aladjem et al.,
1998). In female ES cells both X chromosomes are active (Rastan and Robertson, 1985).
However, even after extensive propagation in culture mES cells retain their capacity to
enter embryogenesis, making chimeras with relative consistency, although earlier
passage cells are more likely to be transmitted through the germ-line. They have been
shown to contribute to all the fetal lineages plus the yolk sac mesoderm, allantois and
amnion (Bradley et al., 1984). In keeping with their epiblast origin, mES cells contribute
poorly to the primitive endoderm and never to the trophectoderm {figure 1.2A;
Bcddington and Robertson, 1989). This is why mES cell are considered to be
pluripotent, whereas cells of the early embryo are totipotent. Unlike EC cells, mES cells
maintain their diploid karyotype, therefore, if they colonise the germ cell lineage in a
chimera, the cells are capable of proceeding through meiosis to produce mature gametes.
Thus mES cells have proven very useful for engineering the mouse genome and for
creating mutant mouse lines (reviewed by van der Weyden et al., 2002).
The first mES cells were cultured on mitotically inactivated fibroblast 'feeder' cells,
which have since been replaced by preparations of defined media. Central to this change
was the discovery that a cytokine, leukaemia inhibitory factor (LIF), produced by the
feeders could sustain mES cell self-renewal in the presence of serum (Smith et al., 1988;
Williams et al., 1988). LIF acts via the gpl30 receptor to activate STAT3 in a JAK
kinase mediated process {figure 1.2C; Yoshida et al., 1994; Niwa et al., 1998).
Following the withdrawal of LIF (or feeders) mES cells start to differentiate
spontaneously and the majority of stem cells are lost from the culture within a few days.
Interestingly the STAT3 signalling pathway is not exclusive to mES cells and has been
implicated in a number of differentiation pathways ranging from astrocyte precursors to
myeloid cells (Rajan and McKay, 1998; Minami et al., 1996). Along with feeders, the
necessity for serum in the media has also been replaced, following the discovery that
bone morphogenetic proteins (BMPs) act in combination with LIF to sustain mES cell























Fig. 1.2 Controlling early lineage selection. (A) Diagram of the late blastocyst
stage, showing expression patterns for Cdx2 (red), Gata6 (green), Oct4 and
Nanog (blue). (B) Early lineage decisions are controlled by repression of Cdx2
by Oct4 in the inner cell mass, and repression of Oct4 by Cdx2 in the
trophectoderm. Similarly within the inner cell mass, antagonism between Nanog
and Gata6 allows segregation of the epiblast and primitive endoderm (adapted
from Ralston and Rossant, 2005). (C) Activation of the STAT3 transcription
factor by LIF maintains pluripotency of mES cells in vitro and the blastocyst
during diapause in vivo. LIF binds to a LIF receptor (LIF-R) - gp130 receptor
heterodimer, which recruits the nonreceptor tyrosine kinase Janus (JAK) and
becomes phosphorylated (P). STAT3 binds to the phosphotyrosine residues on
the activated receptor where it undergoes phosphorylation and dimerization.
STAT3 dimers can then translocate to the nucleus where they function as
transcription factors (based on Boiani and Scholer, 2005).
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Transcriptional profiling of mES cells in comparison with adult neuronal and
haematopoietic stem cells, has identified between 1500 and 2300 genes enriched in the
mES cell population. Approximately 250 of these genes are common to all three cell
types, highlighting the possibility that a common genetic program exists for stem cells
(Ivanova et al., 2002; Ramalho-Santos et ah, 2002). Others, expressed only in the mES
cell population are thought to have a role in maintaining pluripotency. Two of these
genes will be analysed in this thesis. The first is the POU family transcription factor
Oct4 (Scholer et al., 1989; also known as Oct3 or Pou5fl, Okamoto et al., 1990; Rosner
et al., 1990), which is essential to establish the pluripotent identity of both nascent ICM
cells in vivo and mES cells in vitro (Nichols et al., 1998; Niwa et al., 2000). Disruption
of Oct4 expression causes these cells to differentiate into trophoblasts, implicating this
gene in the control of epiblast and trophectoderm lineages (Niwa et al., 2000). In
trophectoderm the caudal-related transcription factor, Cdx2, is one of the genes needed
to maintain cell fate and is thought to suppress the expression of ICM genes such as
Oct4 (Chawengsaksophak et al., 1997; Strumpf et al., 2005). Therefore current models
suggest that Oct4 and Cdx2 have a role in controlling ICM and trophectoderm fates,
whereby they negatively regulate each other reinforcing segregation of the two lineages
(figure 1.2B; reviewed in Ralston and Rossant, 2005). Recently, Oct4 has been shown to
bind -1000 sites across the genome, with over half of these located in gene coding
regions (Boyer et al., 2005; Loh et al., 2006).
Expressed alongside Oct4 in the ICM, is the other gene important for pluripotency to be
analysed in this thesis, the variant homeodomain protein Nanog (Chambers et al., 2003;
Mitsui et al., 2003). Both Oct4 and Nanog are downregulated during differentiation
towards the primitive endoderm (Palmieri et al., 1994; Chambers et al., 2003; Mitsui et
al., 2003), but despite being coexpressed they are thought to act on different pathways,
as loss of either gene does not affect the others expression in the blastocyst (Chambers
and Smith, 2004). In the absence of Nanog, embryos can form trophectoderm and
primitive endoderm lineages, but not ICM (Mitsui et al., 2003). Similarly, the loss of
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Nanog from mES cells causes them to take on primitive endoderm characteristics
(Mitsui et ah, 2003). The same phenotype is seen when over expressing the Gata binding
proteins, Gata4 or Gata6, which control endoderm differentiation in mES cells (Fujikura
et ah, 2002). Gata6 also has a Nanog binding site in its enhancer region and is
upregulated in Nanog null cells (Mitsui et ah, 2003). Together these observations
suggest a role for Nanog in controlling the segregation of ICM and primitive endoderm
lineages, possibly via repression of Gata genes {figure 1.2B).
Depending upon tissue culture conditions, mES cells can be differentiated into a variety
of cell types representing all three germ layers (reviewed by Smith, 2001, Chambers and
Smith, 2004). However to date, they have only been shown to generate trophoblast cells
following genetic manipulation (Niwa et ah, 2000, 2005), even when isolated from pre-
blastocyst embryos (Tesar, 2005). The principle method of differentiating ES cells
involves allowing them to aggregate in suspension leading to the formation of structures
called embryoid bodies. This differentiation is thought to occur on a similar schedule to
in vivo development (Keller et ah, 1993; Wichterle et ah, 2002), however the bodies lack
the orientation and elaborate body plan of the early embryo (Doetschman et ah, 1985).
Other protocols have been developed to differentiate mES cells in monolayers enabling
better observation, dissociation and access to the cultures (Nishikawa et ah, 1998). It is
possible to bias differentiation toward certain lineages by adding different
concentrations of retinoic acid (Rohwedel et ah, 1999; Okada et ah, 2004) or growth
factors (Okabe et ah, 1996) however the resulting culture remains a heterogeneous
mixture of cells. Various methods have been explored to achieve a more homogenous
population and are discussed elsewhere (section 4.1).
1.1.2 Human ES cells
In 1998, the first human ES (hES) cells were derived from the ICM of the early
blastocyst (Thomson et ah, 1998). Although we cannot confirm their ES cell status via
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germ line chimeras, hES lines have both the ability to self-renew and differentiate into
all three embryonic germ layers when injected into severe combined immunodeficient
(SCED) mice (figure 1.3A, Thomson et ah, 1998). The hES cells resemble their murine
counterparts in many ways, including the expression of common genes important for
pluripotency i.e. OCT4 (Reubinoff et al., 2000) and NANOG (Clark et al., 2004).
Elowever, there are many differences between mES and hES cells in their morphology,
culture, gene expression, differentiation and regulation of self-renewal (Pera and
Trounson, 2004; Ginis et al., 2004). In contrast to mES cells, hES cells can be
differentiated into all three germ layers of the epiblast plus extraembryonic lineages,
giving rise to trophectoderm spontaneously in culture and in the presence of BMP4
(figure 1.3B; Thomson et al., 1998; Xu et al., 2002). This suggests either hES cells are
derived from an earlier cell type than mES cells, or that lineage allocation between
human and mouse is different, for example, the human ICM may retain the potential to
differentiate into trophectoderm (Ralston and Rossant, 2005). There is also a third
possibility, that hES cells are more comparable to a different cell type all together, for
example germ cells (Zwaka and Thomson, 2005).
The hES cells do not respond to gpl30/LIF stimulation (Thomson et al., 1998;
Reubinoff et al., 2000). Although at present the reasons behind this are unknown, several
groups have attributed it to absence or low-level expression of components in the LIF
pathway and poor activation of the STAT3 pathway in hES cells (Ginis et al., 2004;
Richards et al., 2004; Sato et al., 2004). In mouse, there is a physiological significance
for the role of LIF as it is required during diapause, a resting state induced in the
blastocyst that allows one litter to finish suckling before a second litter can implant.
There is no equivalent stage in human development (Nichols et al., 2001). Other
pathways reported to function differently in hES cells include the BMP signalling
pathway, which promotes differentiation and the fibroblast growth factor (FGF)
pathway, which supports self-renewal (Amit et al., 2000; Xu et al., 2002). The BMP
antagonist noggin has been shown to synergize with bFGF, repressing BMP signalling













(Assady et al., 2001)
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Fig. 1.3 Differentiation of hES cells. (A) Teratoma formation following the
injection of hES cells into SCID-beige mice. (1) Gutlike structures, scale bar
400pm. (2) Rosettes of neural epithelium, scale bar 200pm (3) Bone, scale bar
100pm. (images from Thomson et al., 1998). (B) Schematic of hES cell
differentiation in vitro. In spontaneously differentiating hES cell cultures,
trophectoderm (green box) and four lineages of the inner cell mass (the
extraembryonic endoderm (red box) and the three germ layers of the epiblast
(yellow boxes)) have been identified. One of the first attempts to control each
differentiation is referenced and the main culture condition used is written along
the appropriate arrow.
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medium (Xu et al., 2005a). Furthermore, at concentrations of lOOng/ml, bFGF alone can
sustain cultures in unconditioned media with effectiveness comparable to conditioned
media (Levenstein et ah, 2006). This has enabled Ludwig et al., (2006) to derive hES
cells feeder free, under defined conditions that include only protein components derived
from recombinant sources or purified from human material. The new lines are therefore
more directly applicable to clinical use than the original lines derived in the presence of
animal products.
In comparisons between the human and mES cell transcriptomes, a group of nine genes
have been identified that are common to both species and more or less specific to
pluripotent cells (table 1.1). Unsurprisingly, as none of the pathways implemented in
pluripotency are exclusive to ES cells, a further 100 to 200 of the genes identified are
upregulated in the ES cells of both species, but are not specific to pluripotent cells (Sato
et al., 2003; Wei et al., 2005). Perhaps more significantly these studies highlight a
number of differences between the two species. In mES cells, genes involve in the LIF
signalling pathway, gpl30, and FGF4 are highly expressed, whereas in hES cells, FGF
signalling, trophectoderm differentiation and inhibition the LIF pathway are prevalent
(Ginis et al., 2004; Wei et al., 2005). The largest proportion of the hES cell
transcriptome is made up of genes involved in signal transduction and regulation, which
represent 17% of the genes enriched in pluripotent cells when compared to differentiated
cells. These genes encode receptors and secreted inhibitors of the FGF, transforming
growth factor (TGF)-p/BMP, Nodal and Wingless type (WNT) signalling pathways
(Brandenberger et al., 2004; Sato et al., 2003); all of which have been implicated in the
decision to self renew or differentiate made by hES cells and in some cases, mES cells
(Sato et al., 2004; Vallier et al., 2005; Xu et al., 2005a). There is less variation between
hES cell lines than between ES cells from different species, but there are still differences
in their expression profiles. One analysis compared three different hES cell lines and
showed that only 52% of the genes expressed were common to all three lines (Abeyta et
al., 2004). Reports of differences between the hES cell lines are not restricted to gene
expression and are also seen in growth rates and varying degrees of X-inactivation
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(Cowan et al., 2004; Hoffman et al., 2005). This may reflect not only the different
derivation and culture conditions of the cell lines, but also the different genetic
backgrounds of the blastocysts from which the lines are derived.
Class ofmolecule Name Expressed in mES Expressed in Hes











Growth Factors GDF3* + +
FGF2 - +
FGF4 + -
TDGF1 / CRIPTO* + +
Receptors FGFR1 & 2 - +
LIFR + +b
Gpl30 + +b






Table 1.1 A selective list of markers and genes expressed at high levels in
pluripotent cells. Marker expression in mouse and hES cells, (+) denotes expression, (-)
denotes the marker is not expressed; green boxes highlight differences between species,
(a) denotes variable expression between cell lines, (b) denotes the gene is expressed only
at low levels and (*) are genes expressed only in early embryos, germ cells, ES cells and
few other cell types (adapted from Pera et al., 2000, 2004; Ginis et al., 2004).
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Despite all of these differences, the main genes identified as controlling pluripotency in
mouse are also thought to be important in hES cells. Downregulation of both OCT4 and
NANOG causes the up regulation of primitive endoderm factor GATA6, caudal-related
transcription factor CDX2 and other trophectoderm markers (Hay et ah, 2004; Hyslop et
ah, 2005; Zaehres et ah, 2005). Therefore as in mouse, OCT4 and NANOG are required
to suppress extraembryonic differentiation, although in humans both genes can repress
trophectoderm and primitive endoderm lineages, perhaps indicative of being derived
from an earlier lineage. In mES cells, an octamer-Sox2 binding complex regulates Oct4,
the transcription factor Sox2 (which is important for epiblast formation, Avilion et ah,
2003) and Nanog (Catena et ah, 2004; Kuroda et al., 2004b; Okumura-Nakanishi et ah,
2005; Rodda et ah, 2005). Recently, a screen by Boyer et ah, (2005) found that OCT4,
SOX2 and NANOG co-occupy a substantial portion of their target genes in hES cells,
which are both activated and repressed. This screen confirmed that the autoregulatory
loop described for mES cells is conserved in hES cells, but more importantly, it showed
that NANOG is a component of this regulatory loop. However, as more target genes are
identified stem cell research has moved into another field, epigenetics, to investigate
modifications to the genome that enable self-renewal or differentiation to take place.
1.2 Primary chromatin structure
In eukaryotic cells, DNA is packaged along with histones and non-histone proteins as
chromatin. This serves two major purposes: first it enables the ~2m ofDNA to fit into a
single nucleus, secondly, it facilitates the regulation of cellular processes such as
transcription, DNA replication, cell division and differentiation. The basic sub-unit of
chromatin is the nucleosome, in which 146bp of DNA are wrapped 1.7 times around an
octamer of core histones (containing two molecules each of H2A, H2B, H3 and H4)
sealed with a linker histone (Luger et ah, 1997; Thomas, 1999). Each nucleosome is
separated by 10-60bp of linker DNA, resulting in a chromatin fibre ~llnm in diameter











30nm fibre of packed
nucleosomes
Chromosome region









Fig. 1.4 Organisation of DNA within the chromatin template. DNA is arranged
in nucleosomes, which consist of approximately 146bp of DNA wrapped around
a histone octamer. Nucleosomes are connected to one another by short stretches
of linker DNA. This string of nucleosomes folds into a chromatin fibre 30nm in
diameter, which is further folded to form higher-order structures (Redrawn from
Felsenfeld and Groudine, 2003).
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compacts to form a 30nm chromatin fibre. It is uncertain precisely how this chromatin
fibre condenses to form interphase chromosomes, or how changes in its conformation
contribute to the control of gene expression.
1.2.1 Histone modifications
The C-terminal region of core histones contains a 'histone fold' domain, which is shared
by many proteins and thought to be involved in histone:histone and histone:DNA
interactions. The N-terminal regions extend outside of the nucleosome, enabling
interactions with other proteins (Schroth et al., 1990). Histones are subject to post
translational modifications such as lysine and arginine methylation, lysine acetylation,
serine and threonine phosphorylation, lysine ubiquitination and sumoylation, and ADP-
ribosylation (figure 1.5; Strahl and Allis, 2000; Zhang and Reinberg, 2001). In addition,
modifications such as lysine methylation can exist in mono-, di- and tri-methylated
forms leading to a further level of complexity. The discovery of enzymes that perform
these modifications and chromatin-associated proteins that selectively bind to them,
revealed that histone modifications significantly extend the potential of the genetic code.
This led to the 'histone code' hypothesis which suggests that groups ofparticular histone
modifications provide chromatin signals to control gene expression and chromatin
condensation (Strahl and Allis, 2000; Fischle et al., 2003). However, so far there is no
evidence to back up this hypothesis, therefore histone modifications might not 'code' for
the same function every time.
1.2.1.1 Histone methylation and acetylation
Currently -60 positions across the four core histones are known to be modified by
methylation, acetylation, phosphorylation or ubiquitination. For clarity, I will
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research. In general, H3-K9 acetylation and H3-K4 methylation are associated with
active genes, whereas H3-K9 and K27 methylation are associated with gene silencing
(Lachner et ah, 2003). An example of this is the inactive X chromosome, which is
hypoacetylated and lacks methylation of H3-K4, but shows both H3-K9 and K27
methylation (Heard et ah, 2001; Plath et ah, 2003). However, recently H3-K9
methylation has also been associated with active genes, where it is important for
transcription elongation (Vakoc et ah, 2005).
The different combinations of histone modifications result from targeting histone-
modifying enzymes to specific loci. Histone acetyl-transferases (HATs) are responsible
for the acetylation of lysine residues and histone methyl-transferases (HMTs) for the
methylation of lysine and arginine residues. Within these two groups, different enzymes
recognise specific residues. For example, the HMTs group is comprised of the SET
domain family, which methylates lysine residues and the CARM1 / PRMT1 family,
which methylate arginines (Chen et al., 1999; Stallcup, 2001). The SET domain family
includes Suv39hl/2, Eset (Setdbl) and Eu-HMTase which methylate H3-K9 (Rea et al.,
2000; Yang et al., 2002; Ogawa et al., 2002), G9a which methylates H3-K9 and K27 in
vitro (Tachibana et al., 2001), SET7/9 which methylate H3-K4 (Wang et al., 2001a) and
the polycomb complex Ezh2-Eed which methylates H3-K27 (Cao et al., 2002;
Kuzmichev et al., 2002). These modifications are reversible. Histone deacetylases
(HDACs) remove acetyl groups and newly discovered groups of histone demethylases
remove methyl groups. These include PAD4, which indirectly demethylates arginine
residues by converting them to citrulline (Cuthbert et al., 2004; Wang et al., 2004a),
LSD1 which reverts mono or di-methyl H3-K4 back to an unmethylated state via an
oxidation mechanism (Shi et al., 2004); and JmjC domain proteins such as JHDM1A
which demethylates H3-K36, JHDM2A which demethylates mono or di-methyl H3-K9
(Tsukada et al., 2006; Yamane et al., 2006) and JHDM3A (also known as JMJD2A)
which demethylates tri-methyl H3-K9 and H3-K36 (Whetstine et al., 2006; Klose et al.,
2006).
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The pattern of histone modifications is thought to affect the binding of non-histone
proteins via "cross-talk" either between modifications on the same histone 'cis' or
different histones 'trans' (Jenuwein and Allis, 2001; Fischle et ah, 2003). For example,
in cis the phosphorylation of H3-S10 inhibits HP1 binding to methylated H3-K9 (Rea et
al., 2000). In trans, cross-talk is exemplified during p53 dependent transcriptional
activation whereby methylation of H4-R3 by PRMT1 stimulates acetylation of H4-K5,
K8, K12 and K16 by the HAT, CBP-p300, which in turn promotes the methylation of
H3-R2, R17 and R26 by CARM1 (Wang et al., 2001b).
The recruitment of HATs and HDACs is important for differentiation ofmany lineages
including ES cells, oligodendrocytes, astrocytes and neurons (Lee et al., 2004;
Nakashima et al., 1999; Shen et al., 2005; Sun et al., 2001). In non-neuronal lineages
HDACs associate with transcription factors such as the neuron-restrictive silencing
factor (NRSF, also known as REST) and the corepressor CoREST, recruiting HMTs,
HP1 and methyl-binding proteins to repress neuronal genes (section 1.2.3; Lunyak et al.,
2002; Hsieh and Gage, 2005). Changes in histone modifications during differentiation
have also been described for specific loci. For example, progressive modifications to the
Sox2 promoter accompany the differentiation of oligodendrocyte precursors via type 2-
astocytes to neuronal stem cells. In the starting population ofprecursor cells, where Sox2
is not expressed, the promoter is methylated at H3-K9 and unmethylated at H3-K4.
When differentiated into type 2-astrocytes, which express Sox2, H3-K4 is methylated
and H3-K9 present in both methylated and acetylated forms. Then when further
differentiated into neuronal stem cells, which display even higher levels of Sox2
expression, H3-K4 is methylated and H3-K9 acetylated but unmethylated (Kondo and
Raff, 2004). This pattern of histone modifications has also been observed during the
differentiation of astrocytes, thymocytes, muscle and haematopoietic lineages, where it
is implicated in formation of secondary chromatin structure (section 1.3; Litt et al.,
2001; Song and Ghosh, 2004; Su et al., 2004; Zhang et al., 2002).
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Recently several groups have started to analyse these chromatin modifications on a
global scale, using a combination of chromatin immunoprecipitation (ChIP), DNA
microarray and serial analysis of gene expression (SAGE) techniques. Thousands of
acetyl H3-K9, K14 and methyl H3-K4 binding sites have been located, which are highly
conserved between human and mouse (Roh et ah, 2004, 2005; Bernstein et al., 2005;
Kim et al., 2005). The vast majority show a punctate pattern, typically occurring at sites
of ~l-2kb from the promoters of active genes and regulatory elements. However, in
areas of high gene density such as Hox clusters, broad regions of H3-K4 methylation
have been found spanning multiple active genes. Recently these regions were shown to
be H3-K4 methylated in cell types such as mES cells, where the genes are repressed
(Bernstein et al., 2006a). Intriguingly, a previous study has shown that the 7,5-VpreBl
locus is marked by H3 acetylation and H3-K4 methylation at a discrete site in mES cells.
These markers spread across the rest of the locus during differentiation, so that when the
genes are fully active in pre-B cells an active chromatin domain is already established.
This suggests that genes expressed at later stages in development might be set up for
transcription, as early as the pluripotent cell stage (Szutorisz et al., 2005).
On a genome-wide scale patterns of active histone modifications (di-methyl H3-K4,
K36, K79) generally correlate closely with each other and areas of hyperacetylation,
whereas markers of gene silencing (di-methyl H3-K27, H4-K20 and tri-methyl H3-K9)
associate with each other and areas of hypoacetylation (Miao and Natarajan, 2005).
However, recently H3-K27 methylation has been associated with the active markers of
H3-K4 methylation and H3-K9 acetylation in ES cells, where it prevents the early
expression of lineage specific genes in areas of open chromatin, via polycomb protein
mediated repression (section 1.3.3). This allows pluripotency to continue whilst
chromatin is remodelled, enabling lineage specific genes to become poised for
differentiation (Azuara et al., 2006; Bernstein et al., 2006a; Boyer et al., 2006; Lee et al.,
2006). Approximately 50% of genes found to contain this H3-K27, -K4 methylation
bivalent mark are binding sites of at least one of the transcription factors Oct4, Nanog or
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Sox2. It has been suggested that this creates a chromatin state in which key lineage
markers are repressed but yet transcriptionally poised.
1.2.2 DNA methylation
One of the mechanisms responsible for silencing chromatin is DNA methylation, where
predominantly CpG dinucleotides are modified at cytosine bases by the addition of
methyl groups. This cytosine methylation can be copied after replication, resulting in
heritable alterations to the chromatin fibre. It is associated with X-inactivation (Panning
and Jaenisch, 1996), genomic imprinting (Ng and Bird, 1999), cancer (Jones and Baylin,
2002; Esteller and Herman, 2002) and several mental retardation disorders including
immunodeficiency centromeric instability facial anomalies syndrome (ICF), fragile X,
Alpha-Thalassemia Retardation X-linked (ATRX) and Rett syndromes (Robertson and
Wolffe, 2000). DNA methylation is thought to affect gene expression by either blocking
the binding of transcription factors (Watt and Molloy, 1988) or attracting proteins that
modify nucleosomes (Boyes and Bird, 1991; Hendrich and Bird, 1998). However,
recently a further two ways it might regulate transcription have been suggested. First, the
DNA methyltransferase (DNMT) enzymes themselves may be involved in gene
repression in addition to their catalytic activities; and second, DNA methylation might
affect transcriptional elongation as well as inhibiting transcriptional activation (reviewed
by Klose and Bird, 2006).
DNA methylation of the mouse genome changes throughout development. During
cleavage, a wave of demethylation strips the paternal genome of methylation within
hours of fertilization; this is in contrast to the maternal genome, which is only passively
demethylated during subsequent cleavage divisions (reviewed in Fi, 2002). This process
is conserved between mouse, pig and cow but not sheep or rabbit (Dean et ah, 2001;
Beaujean et ah, 2004). However, studies analysing the DNA methylation pattern of
human zygotes have provided opposing views on whether the paternal genome is ever
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completely demethylated (Beaujean et al., 2004; Fulka et al., 2004; Xu et al., 2005b).
Following implantation there is genome wide de novo methylation (Jaenisch, 1997),
which accounts for the high levels of methylation seen in developing mouse embryos.
These levels decrease in developing tissues (Ehrlich et al., 1982) and de novo
methylation rarely occurs postgastrulation, although it is frequently seen in the
development of cell lines in vitro (Jones et al., 1990; Kawai et al., 1994) and cancer cells
(Rhee et al., 2002). Because hES cell lines are derived from the blastocyst stage, which
is characterized by global epigenetic remodelling, it was thought that their DNA
methylation status could be subject to variation. However, so far analysis of imprinted
genes in hES cell lines has not revealed any aberrant changes in DNA methylation
(Rugg-Gunn et al., 2005). In differentiated cells, -80% of CpGs are methylated. The
remaining CpGs are mainly present as CpG islands, which locate to the promoter
regions of genes predominantly in early replicating R-bands; although, how these islands
remain unmethylated is still not fully understood (Larsen et al., 1992; Craig and
Bickmore, 1994).
1.2.2.1 DNA methyltransferases
Our current understanding of DNA methylation is mainly based on knockout mice for
the DNMTs and the various DNA binding proteins (section 1.2.2.2). DNMTs are a
family of enzymes responsible for catalysing the addition of methyl groups onto
cytosine bases. The first of these genes to be studied, Dnmtl, is responsible for the
methylation of hemi-methylated CpGs during DNA replication and therefore
maintaining the pattern of DNA methylation (Bestor et al., 1988; Yoder et al., 1997).
Deletion of this gene in mouse resulted in global demethylation and embryonic lethality,
but had no effect on the viability of ES cells homozygous for the mutation (Li et al.,
1992; Lei et al., 1996). The next two genes in the family, Dnmt3a and Dnmt3b, are also
expressed in the developing mouse embryo and are responsible for the global de novo
methylation of the genome after implantation (Okano et al., 1998, 1999). However, the
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ability of Dnmt3a and 3b to maintain this methylation pattern has also been
demonstrated, as in culture Dnmt3a/3b~ ~ cell lose their methylation (Chen et al., 2003a).
Together with Dnmt3L, a protein that on its own has no methyltransferase activity, these
proteins establish the methylation imprints in the female germ line (Bourc'his et al.,
2001; Hata et al., 2002). Dnmt3b is ofparticular interest to nuclear organisation because
mutations in this gene cause ICF syndrome, with patients showing destabilisation of
centromeric heterochromatin (Xu et al., 1999). The last known protein in this family is
Dnmt2, also has no detectable methyltransferase activity in mammals, and gives no
apparent phenotype when knocked out in mice (Okano et al., 1998). However, in
Drosophila this gene is expressed during oogenesis, where it may be responsible for the
small amount of non-CpG methylation seen in the fly embryo (Lyko et al., 2000;
Gowher et al., 2000).
When induced to differentiate Dnmtl " cells, which lack DNA methylation, apoptose
(Panning and Jaenisch, 1996). Similarly, at very low levels of DNA methylation,
Dnmt3a/3b~ ~ ES cells are unable to differentiate into myeloid, erythroid or
cardiomyocyte colonies (Jackson et al., 2004). Even after 20 days of differentiation
without LIF, Dnmt3a/3b*" cells are not able to downregulated Oct4 and large numbers of
ES cell colonies can be recovered. Interesting, during the same differentiation with
Dnmtr7" ES cells Oct4 is downregulated as normal, but is re-expressed at day 20 post-
LIF withdrawal (Jackson et al., 2004). This re-expression can also be induced by treating
differentiated ES cells with the inhibitor of DNA methylation 5-aza-2'deoxycytidine
(Tsuji-Takayama et al., 2004).
Recently, attention has focused on the role ofDNMTs during ectodermal differentiation.
This work is based on experiments carried out by Teter et al., (1994) showing that
several CpG sites in the astrocyte marker gene GFAP undergo a demethylation and
remethylation process during embryonic development. It was later shown that one of
these CpG sites, within the binding element of the signal transducer and activator of
transcription (STAT) transcriptional activator, needed to be demethylated to allow
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binding of STAT3 to the GFAP promoter, and subsequent GFAP expression (Takizawa
et al., 2001). Even when strong glial inducing factors are present, the CNS progenitors
are not capable of differentiating into glia with these binding sites methylated (Takizawa
et ah, 2001; Sauvagoet and Stiles, 2002). Most of the factors shown to influence glia are
present in what is essential an astrogliogenic JAK-STAT pathway (Nakashima et ah,
1999; Song and Ghosh, 2004; Sun et ah, 2001; He et ah, 2005), the activity of which, is
suppressed during neuronal development and elevated upon a glial switch (He et ah,
2005). In the CNS of Dnrntl"7" mice, the absence of methylation triggers precocious
astrocyte differentiation (Fan et ah, 2001). This confirms not only a role for DNA
methylation in regulating the timing of astrocyte differentiation, but more importantly
that for neuronal differentiation to occur the JAK-STAT pathway must be inhibited by
DNA methylation (Fan et ah, 2005). Further support for this theory comes from the
Dnmt3a~'~ knockout, which survives embryonic development but dies within a month of
birth, coincident with a defect in terminal neuronal maturation (Okano et ah, 1999). In
contrast to the demethylation of genes involved in terminal differentiation, there is also
the methylation of genes expressed earlier in development such as Oct4, which will be
discussed later (section 1.2.3).
1.2.2.2 Methyl-CpG binding proteins
Methyl-CpG binding proteins (MBPs) are recruited to sites of DNA methylation along
the chromatin fibre. Six MBPs have so far been identified, MeCP2, the methyl-CpG
binding domain proteins MBD1-4, and the unrelated protein Kaiso. These proteins share
a conserved MBD domain (with the exception ofMBD3 and Kaiso) thought to mediate
the effects ofDNA methylation in mammalian cells (Hendrich and Bird, 1998). The first
to be identified was MeCP2 (Lewis et ah, 1992; Nan et ah, 1997). This protein is
ubiquitously expressed, although particularly high levels are seen in the brain. Mutations
in MeCP2 are responsible for a neurological disorder in humans (Rett syndrome, Amir
et ah, 1999) and mice (Chen et ah, 2001; Guy et ah, 2001; Shahbazian et ah, 2002), but
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do not affect other cell types, therefore suggesting a structural role for MeCP2 in
neurons (Brero et al., 2005). However, microarray analysis has identified only a few
subtle differences in gene expression between the knockout and wild type mice (Tudor
et ah, 2002). This is due to the selectivity of the MeCP2 binding site, which means that
MeCP2 does not compete with other MBPs for access to methyl-CpG nucleotides, but is
restricted in its binding sites (Klose et al., 2005). So far only two known targets of
MeCP2 have been associated with changes in chromatin organisation, the brain derived
neurotrophic factor (BDNF) and the imprinted gene Dlx5. The depolarization of primary
neurons induces expression of BDNF, which correlates with the dissociation of the
MeCP2 histone deacetylase mSin3A repression complex from the BDNF promoter and a
decrease in DNA methylation within the regulatory region of this gene (Chen et al.,
2003b; Martinowich et al., 2003). Whereas the imprinted Dlx5 locus and its adjacent
non-imprinted Dlx6 gene on chromosome 6, associate with MeCP2 to form a loop of
silent chromatin characterised by methylated H3-K9 in wild types cells. This structure is
absent in MeCP2 null mice, where Dlx5 interacts with a more distant sequence to form
an active chromatin loop, characterised by acetylated H3-K9 and K14 (Horike et al.,
2005). Since a global de-repression of genes does not occur in MeCP2 null mice, the
absence of MeCP2 may cause incomplete silencing of its target genes, rather than their
full expression (Caballero and Hendrich, 2005). However, when coupled with changes
in other MBPs or histone modifications the role of MeCP2 in regulating target genes
will become more apparent.
Three of the other MBD proteins, (MBD1-3) also function as transcriptional repressors.
MBD1 and MeCP2 are concentrated at centromeric heterochromatin where the DNA is
highly methylated (Lewis et al., 1992; Ng et al., 2000). MBD1 knockout mice are viable,
although their neuronal stem cells show reduced differentiation and genomic instability,
which leads to decreased neurogenesis, impaired spatial learning and a reduction in long
term potentiation in the brain (Zhao et al., 2003). MBD2 null mice show mild maternal
behaviour deficits and lack the MeCPl protein complex, comprising ofMBD2 plus the
nucleosome remodelling and histone deacetylation complex NuRD, which explains the
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abnormal expression of some genes in MBD2_/" mice (Ng et al., 1999; Zhang et al.,
1999; Hendrich et al., 2001). MBD3 is also a member of the NuRD complex, however
the knockout for this gene was embryonic lethal with no normal embryos recovered after
implantation (Zhang et al., 1999; Hendrich et al., 2001). Recently generation ofMbd3"/_
ES cells, have shown that the cells are viable and can initiate differentiation but fail to
commit to lineages, due to an inability to silence genes needed pre-implantation (Kaji et
al., 2006).
1.2.3 Interactions between transcriptional repressors
Both MBPs and DNMTs can recruit or interact with HDACs and can therefore bind,
remodel and deacetylate nucleosomes, thus connecting the processes of DNA
methylation and histone modification (Nan et al., 1998; Feng and Zhang, 2001; Fuks et
al., 2001). In both Neurospora and Arabidopsis HMT proteins are involved in the
maintenance of DNA methylation (Tamaru and Selker, 2001; Jackson et al., 2002).
However, in mammals the story is more complicated. It is known that heterochromatin-
associated protein 1 (HP1), which binds to methylated H3-K9, interacts with MBPs,
DNMTs and HMTs (Fujita et al., 2003; Fuks et al., 2003b; Lehnertz et al., 2003). This
would suggest that as in Neurospora and Arabidopsis DNA methylation might depend
on the methylation ofH3-K9. However, the reverse can also occur, as MeCP2 associates
with a HMT to increase the level of H3-K9 methylation at sites of DNA methylation
(Fuks et al., 2003a). Therefore, MeCP2 can mediate a positive feedback loop to maintain
H3-K9 methylation at silenced loci. In addition, Sarraf and Stancheva (2004) have
shown that MBD1 also recruits a H3-K9 HMT, SETDB1, to form a complex that
facilitates H3-K9 methylation during replication.
The inactivation of Oct4 is thought to be mediated via trans-acting repressors, such as
ARP-1, COUP-TF1 and GCNF, induced by the onset of differentiation {figure 1.6; Ben-
Shushan et al., 1995; Gu et al., 2005). In undifferentiated cells the Oct4 promoter is H3-
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Fig. 1.6 Model for the transcriptional repression of Oct4. In ES cells, where
the gene is expressed, the Oct4 promoter region is acetylated at H3-K9 and
K14. At the onset of differentiation transcriptional repressors (such as GCNF)
bind to the RA receptor element (RARE). This brings about the binding of the
histone methyltransferase (HMT) G9a, which recruits histone deacetylases
(HDAC). Once deacetylated, H3-K9 can be methylated either by G9a or by
another HMT. Methylated H3-K9 can then bind the chromodomain protein HP1.
Together with G9a, HP1 recruits the DNA methyltransferases 3a and 3b
(DNMT3a/b), which catalyse DNA methylation. Prior to DNA methylation Oct4
can be reactivated (double arrows), however following de novo methylation
repression seems to be irreversible (adapted from Feldman et al., 2006).
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K9, K14 acetylated and H3-K4 methylated. During differentiation, these markers of
active chromatin are removed in parallel with a reduction in chromatin accessibility, as
detected by DNasel sensitivity (Feldman et ah, 2006). Repression of Oct4 is followed by
increased H3-K9 methylation mediated by the SET-containing protein G9a or another
HMT. HP1 can then bind the promoter, where it is required for subsequent de novo
methylation by Dnmt3a/3b (Ben-Shushan et ah, 1995; Gidekel and Bergman, 2002).
Without this second layer of repression Oct4 can switch back on (section 1.2.2.1.). In
Dnmt3a/3b " ES cells, Oct4 undergoes methylation of E13-K9, as well as the formation
of heterochromatin through the binding of HP1 but without DNA methylation, the gene
is not repressed. The process of H3-K9 methylation followed by HP1 binding also
occurs at Rexl but not Nanog, Sox2 or Stella, which suggests that only some of the
embryonic genes use this silencing mechanism (Feldman et ah, 2006).
1.3 Heterochromatin
1.3.1 Constitutive heterochromatin
Constitutive heterochromatin is generally comprised of tandem satellite repeats, and
does not normally contain protein coding genes. These regions are marked by histone
hypoacetylation, tri-methylation of H3-K9 and H4-K20, and DNA methylation (section
1.2.2; Kourmouli et ah, 2004; Schotta et ah, 2004). Facultative heterochromatin
describes a previously permissive chromatin environment that is subject to
transcriptional silencing, such as the inactive X chromosome. Although hallmarks of this
chromatin state are not as well defined, they include hypoacetylation of H3 and H4
lysine residues, di-methylation of H3-K9 and tri-methylation of H3-K27. In contrast,
euchromatin is associated with actively transcribed genes or regions of the genome that
have the potential to become active, and is characterized by histone hyperacetylation,
H3-K4 methylation and a lack ofDNA methylation (Arney and Fisher, 2004).
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In the current model of constitutive heterochromatin formation, Suv39h enzymes are
first targeted to satellite repeats through interaction with the RNA interference (RNAi)
machinery (Hall et ah, 2002; Volpe et ah, 2002; Maison et ah, 2002). Tri-methylation of
H3-K9 by Suv39h, then allows the binding of chromodomain containing proteins such
as HP1 (Bannister et ah, 2001; Lachner et ah, 2001), which recruits more Suv39h and
Suv4-20h enzymes, enabling the tri-methylation of neighbouring H3-K9 and H4-K20
residues (figure 1.7; Schotta et ah, 2004). In mammals, the Suv39h-HPl histone
methylation system is necessary for both DNA methylation of pericentric
heterochromatin by Dnmt3a and Dnmt3b (Lehnertz et ah, 2003) and repression of
euchromatic genes by the retinoblastoma protein (Nielsen et ah, 2001). However in
chicken erythrocytes, heterochromatin is formed in the absence ofHP1 proteins (Gilbert
et ah, 2003), which suggests that this is not a universal mechanism.
1.3.2 The role of heterochromatin in gene silencing
Position effect variegation (PEV) is caused by the transcriptional repression of genes
inserted within, or brought in close proximity to, heterochromatin. In Drosophila, this is
illustrated by the insertion of a large (>lMb) heterochromatic block into the coding
region of the brown gene, known as the brown dominant (bwD) allele. The bwD allele
associates in trans with similar repeat sequences in heterochromatin; however, through
homologous pairing the normal allele is also recruited to these regions, where it to is
silenced. Analysis of several rearrangements has shown that the amount of
transcriptional silencing observed, correlates with the distance of the bwD allele from the
centromere, with both alleles localized close to centromeric heterochromatin in
interphase nuclei (Csink and Henikoff, 1996; Dernburg et ah, 1996). Relocalisation to
regions of heterochromatin also occurs in mammals. For example in B-lymphocytes,
some transcriptionally inactive genes associate with the DNA-binding protein, Ikaros, at
centromeric heterochromatin (Brown et ah, 1997, 1999). Furthermore, studies on
immunoglobulin genes in B cells have found that one allele is often recruited to Ikaros
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Inactive chromatin Active chromatin
H3-K9me me me me me ac
Insulator
Fig. 1.7 The propagation of inactive and active chromatin states.
Nucleosomes marked by H3-K9 methylation can bind HP1, which recruits HMTs
such as Suv39h to methylate neighbouring nucleosomes at H3-K9. This way
methylation is propagated along the chromatin fibre until it reaches an insulator
element, which serves as a barrier to HMTs. HATs are also shown to acetylate
nucleosomes by a similar mechanism. Nucleosomes bound by HP1 can
associate with DNMTs, enabling DNA methylation and compaction of the
chromatin fibre. The insulator therefore defines a boundary between areas of
heterochromatin and euchromatin (adapted from Felsenfeld and Groudine,
2003).
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containing heterochromatin domains, which has implications for the mono-allelic
expression of these genes (Skok et ah, 2001; Goldmit et ah, 2005). However, analysis of
a promoter mutation that interferes with Ikaros mediated silencing, has shown that
silencing is not rescued by integration into heterochromatin. Therefore, it is Ikaros
binding rather than centromere recruitment per se, which is responsible for influencing
gene activity (Sabbattini et ah, 2001).
Studies on the (3-globin locus and derivative transgenes in erythroid cells have provided
further evidence for an association between centromeric heterochromatin and gene
expression. Francastel el ah, (1999) showed that at genomic integration sites where
stable expression does not require the presence of an enhancer, (1-globin transgenes are
located away from centromeric heterochromatin regardless of their transcriptional
activity. However, at sites where an intact enhancer is required for stable expression, the
active transgene is localised away from centromeric heterochromatin only when linked
to a functional enhancer. Mutations in the enhancer not only affected its ability to
suppress silencing but also result in the transgene locating to centromeric
heterochromatin, even before the gene was silenced. Therefore, functional enhancers are
required for both maintenance of transgene expression and localisation away from
heterochromatin. A further study in erythroid cells showed that the (3-globin locus is
located away from pericentric heterochromatin when it displays an open chromatin
structure, as assayed by nuclease sensitivity and histone hyperacetylation. In contrast,
the same locus with a naturally occurring deletion in its LCR is recruited to
heterochromatin, where it displays an inactive chromatin structure as revealed by
nuclease insensitivity and histone hypoacetylation (Schubeler et al., 2000). Together
these studies demonstrate the importance of enhancer elements or LCRs in preventing
the relocalisation of active genes (or genes with a potential to become active) to
centromeric heterochromatin.
The sequestering of genes into regions of heterochromatin is also important for
differentiation, as recently shown by a study investigating the murine terminal
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transferase gene, Dntt, during thymocyte maturation. Silencing of Dntt starts 2-6 hours
into the differentiation programme with deacetylation of the promoter at H3-K9, which
coincided with pericentromeric repositioning. H3-K4 methylation is lost within 4-12
hours, followed by H3-K9 methylation and bidirectional spreading of each event at a
rate of 2kb/hour. Later on in the differentiation, when the thymocytes migrate into the
spleen, CpG methylation is detected at the locus ensuring a more permanent state of
repression. In transformed thymocytes, the inactivation ofDntt is reversible and occurs
without repositioning or spreading of histone modifications (Su et ah, 2004). This would
suggest that for specific genes, relocation to heterochromatin is necessary to maintain
transcriptional repression. A previous study into the silencing of a pre-B-cell specific X5
transgene has shown that transcription factor dosage may be involved in relocalisation
(Lundgren et ah, 2000). Despite integration into pericentromeric heterochromatin and
localisation next to centromeric heterochromatin, the X5 transgene is expressed in pre-B-
cells. The locus contains a DNasel hypersensitive (HS) site located 3' of the gene, which
when present excludes the transgene from centromeric heterochromatin. However when
the HS site is deleted, the gene is embedded within centromeric heterochromatin. This
affect is sensitive to the dosage of early B-cell factor (EBF), which binds to the X5
promoter and is able to relocate the transgene outside of the heterochromatin complex in
the absence of a HS site. Therefore, transcription factors, such as EBF can disrupt
regions of heterochromatin to enable the expression of specific genes in a lineage
dependent manner.
1.3.3 Polycomb proteins
The Polycomb group (PcG) proteins are negative regulators of transcription that were
originally discovered in Drosophila (reviewed in Orlando, 2003; Valk-Lingbeek et al.,
2004). In conjunction with their positively acting counterparts, the Trithorax group
(TrxG), they maintain the transcription memory of several hundred genes during fly
development, including the homeotic (Hox) genes. There are two distinct PcG proteins
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complexes, polycomb repressive complex 2 (PRC2), is involved in the initiation of gene
silencing and contains the H3-K27 HMTase Ezh2, and polycomb repressive complex 1
(PRC1), which is involved in the maintenance of gene repression. Similar to HP1
proteins the PCR1 protein Polycomb (Pc) contains a chromodomain capable of binding
methylated H3-K27. It also contains H2A ubiquitination activity. PRC2 proteins bring
about H3-K27 methylation on the inactive X chromosome, where they are thought to
maintain gene silencing via the recruitment of PRC1 (Plath et ah, 2003; Silva et ah,
2003). However, it has been shown that the PRC2 protein Eed is not necessary for X
chromosome inactivation in undifferentiated trophoblast stem (TS) cells, but is required
to prevent reactivation upon differentiation (Kalantry et ah, 2006).
PcG proteins have been implicated in the self-renewal of ES, neuronal, hematopoietic
and cancer stem cells (reviewed in Valk-Lingbeek et ah, 2004). For example, Ezh2
enhances the self renewal of hematopoietic stem cells (Kamminga et ah, 2006; Iwama
et ah, 2004). The very early (gastrulation) phenotypes ofmice mutant in components of
the PRC2 complex points to the critical role of PRC2 in early development and
differentiation. Until recently binding sites of PcG protein and their target genes in
mammals were largely unknown. However, several recent large scale ChIP studies have
identified numerous sites throughout the genome (Boyer et ah, 2006; Lee et ah, 2006).
Different homologs of the Drosophila Polycomb protein can bind either tri-methyl H3-
K27, tri-methyl H3-K9 or both modifications in associations that are at least partially
dependent upon the chromodomain binding to RNA (Bernstein et ah, 2006b). Both of
these histone modifications were previously associated with condensed heterochromatic
regions of the genome. However, at genes not expressed by ES cells, tri-methyl H3-K27
has recently been found in areas of decondensed chromatin along with the active
markers ofH3-K4 methylation and H3-K9 acetylation (Azuara et ah, 2006; Bernstein et
ah, 2006a). In both human and mES cells, PcG proteins have been shown to associate
with over 200 repressed genes occupied by H3-K27 methylation, preventing the early
expression of lineage specific genes (Boyer et ah, 2006; Lee et ah, 2006). This allows
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pluripotency to continue whilst chromatin is remodelled, enabling genes expressed at
later stages to become poised for differentiation. Interestingly, approximately 50% of
genes containing this H3-K27, -K4 methylation domain are binding sites of at least one
of the transcription factors Oct4, Nanog or Sox2. Therefore, suggesting that these
domains in association with other non-histone proteins may prevent gene expression by
blocking transcription factor binding in pluripotent stem cells (Boyer et ah, 2005;
Bernstein et ah, 2006a). In another study Bracken et ah, (2006), expanded on this theory
by showing that for genes activated during neuronal differentiation, PcG proteins were
displaced. However, for genes repressed during the differentiation, they found that these
proteins were already associated, despite the genes being activity transcribed.
This model of lineage specific genes kept silent in region of open chromatin is supported
by evidence from two other sources. The first is the global analysis of open and closed
regions across the human genome, which revealed that regions of high gene density are
present in an open state. This structure is not correlated with gene expression, since
inactive genes are also found within the domains of open chromatin (Gilbert et al.,
2004). Secondly, the genome-wide identification of DNasel hypersensitive sites has
identified a strong representation of both expressed and non-expressed genes, implying
that a majority of genes reside within open chromatin domains, regardless of their
transcriptional status (Sabo et al., 2004). In the future approaches such as DNasel
digestion linked with high-resolution microarrays will lead to a better understanding of
the relationship between chromatin accessibility and gene expression profiles (Crawford
et al., 2004; Weil et al., 2004).
1.4 Nuclear organisation
A cell nucleus is functionally compartmentalized {figure 1.8), and some areas, such as
the nuclear periphery and regions surrounding centromeric heterochromatin, are



























Fig. 1.8 Nuclear domains. Specialised domains or subnuclear organelles
within the interphase nucleus, that can be observed by light microscopy (taken
from Spector, 2001).
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areas surrounding nuclear bodies or regions of high gene density (reviewed by van Driel
et al., 2003; Kosak and Groudine, 2004). Therefore, it is not surprising that the spatial
arrangement of a genome within this structure is thought to be important for gene
expression. Chromosomes, centromeres and genes all have distinct localisations both in
respect to the nucleus and each other, suggesting a functional relationship between the
DNA sequence and its environment. Here I will outline current theories on how this
relationship aids both the transcriptional plasticity of a stem cell and its progression
through differentiation.
1.4.1 Chromosome territories
In the 1880s, Rabl and Boveri proposed that chromosomes retained their distribution
throughout the cell cycle (Cremer et al., 1982). The 'RabT configuration suggests that
nuclei are polarised and maintain their anaphase-telophase chromosome orientation
during interphase. This gives rise to a nucleus with centromeres clustered towards one
pole and telomeres located at the other. The Rabl configuration has been observed in
numerous organisms, from plants (Abranches et al., 1998) to insects (Marshall et al.,
1996), but it is not present in mammals. In Drosophila, the arrangement is particularly
interesting, because it is seen in the embryo but not in the imaginal disks, suggesting that
chromosome position can change during development (Csink and Henikoff, 1996).
The DNA from individual chromosomes is located in distinct regions of the nucleus,
referred to as 'chromosome territories' (CTs), which can be visualised by fluorescent in
situ hybridisation (FISH; Manuelidis, 1985). In humans, the first evidence that CTs have
a preferred localisation came from work on the inactive X chromosome, which is
positioned against the nuclear membrane, and the rDNA containing chromosomes 13,
14, 15, 21 and 22, which are clustered around the nucleolus (Manuelidis, 1990). Later
analysis of Homo sapiens chromosomes 18 and 19 (HSA18 and 19) showed that CTs
display a radial distribution related to gene density (Croft et al., 1999). HSA18 and 19
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are similar sized chromosomes being 76 and 63 Mbp respectively, but HSA18 is gene
poor with -449 genes whereas HSA19 is gene-rich at -1528 genes
(http://www.ensembl.org/Homo_sapiens/). When visualised by FISH in a variety of
differentiated cells, HSA18 is located towards the nuclear periphery and HSA19 is
situated closer to the nuclear centre (Croft et al., 1999; Cremer et al., 2003). This radial
organisation is applicable to all human chromosomes (Cremer et al., 2001; Boyle et al.,
2001) conserved in higher primates (Tanabe et al., 2002) and chickens (Habermann et
al., 2001; Stadler et al., 2004). Similarly, within a CT there is also evidence to suggest
that gene-rich (R-bands, early replicating) are located towards the centre of the nucleus
and gene-poor (G/C bands, late replicating) are towards the periphery (Sadoni et al.,
1999). The evolutionary conservation of this chromosome distribution, would suggest
that it has a functional relevance, but to date the precise nature of that function is still
unknown. There are two main hypotheses: first, that it facilitates gene expression, and
second, that it protects the genome by using gene-poor chromatin at the nuclear
periphery as a sink for mutagens (Hsu, 1975), referred to as the 'bodyguard' hypothesis.
However, a recent study into the affects of oxidation on radial organisation suggests that
the nuclear periphery is unable to protect the interior from damage (Gazave et al., 2005).
The radial organisation of CTs is not without exceptions. In the flat nuclei of amniocytes
and fibroblasts, gene-poor HSA18 is located nearer to the centre of the nucleus, rather
than at the periphery as is characteristic of cells with more spherical nuclei (Cremer et
al., 2001, 2003; Bolzer et al., 2005). Furthermore, in contrast to previous findings
(Bridger et al., 2000), the Cremer lab has shown that in fibroblasts CTs are not arranged
according to gene density. Instead, they propose a radial distribution dependent on
chromosome size for these cells, whereby smaller chromosomes are positioned more
centrally than larger ones (Sun et al., 2000; Cremer et al., 2001; Bolzer et al., 2005).
HSA18 is also more centrally located in the nuclei of quiescent fibroblasts when
compared to proliferating fibroblasts; although at present, it is unknown whether this
change is due to cell cycle affects and/or further changes in the shape of the nucleus
(Bridger et al., 2000; Bolzer et al., 2005).
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Differences in chromosome position between various tissues and during differentiation
were recently reported in the mouse, (Kim et al., 2004; Parada et al., 2004; Mayer et al.,
2005) and the chicken (Stadler et al., 2004). In the mouse, chromosomes do not vary in
terms of gene density or size as much as in humans, although in cell types such as
lymphocytes, chromosome distribution has been related to gene density. However, in
mES cells CT distribution showed a similar correlation with either gene density or
chromosome size (Mayer et al., 2005). Significant changes in distribution were reported
for the most gene dense chromosome in mouse, MMU11 (15.9 genes/Mbp), for example
in mES cells this chromosome was more peripheral than in lymphocytes; although in
both cell types it was still the most internal CT. In human cells, prior to this thesis, there
were no reports of significant changes in the radial organisation of chromosomes during
differentiation, only differences in chromosome associations (Kuroda et al., 2004a). The
positions of HSA18 and 19 were shown to be already established in haematopoietic
progenitor cells (Cremer et al., 2003) and similar findings were reported for HSA8 and 9
during myeloid differentiation of leukaemic promyelocytic cell lines (Skalnikova et al.,
2000), suggesting that the radial distribution of CTs is established very early in
development.
1.4.2 Centromere position
In addition to CTs, centromeres also display an organised distribution within the
mammalian nucleus. This arrangement is cell-type specific, although it changes in
response to cell cycle, physiological and differentiation state (Haaf and Schmid, 1991;
Alcobia et al., 2000). In most differentiated cell types, the centromeres are located
towards the nuclear periphery or around nucleoli (Carvalho et al., 2001; Weierich et al.,
2003; Ochs and Press, 1992). It is currently unknown what determines this organisation,
although the composition of chromosome arms is likely be an influencing factor.
Carvalho et al., (2001) showed that centromeres surrounded by G-dark bands (gene-rich
areas) were located at the nuclear periphery and centromeres with a lower content of G-
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bands (gene-poor areas) tended to associate with the nucleolus, along with the rDNA
containing chromosomes. This is consistent with the radial distribution of CTs (Boyle et
al., 2001; Cremer et ah, 2001; 2003), suggesting that centromere position is determined
by the 'chromosome environment' as well as other currently unknown factors (Carvalho
et ah, 2001). However, recently another study has shown that even rDNA containing
chromosomes associate with the nuclear periphery (Weierich et al., 2003).
Centromeres have a significantly different localisation in mES cells, when compared to
fibroblasts, myoblasts, macrophages and lymphocytes (Mayer et al., 2005). Whereas
lymphocytes display a more peripheral nuclear distribution of centromeres than mES
cells the other cell types all showed a more internal localisation. This is surprising, as
previous studies in mouse, rat and human, have shown that centromeres associate with
the nuclear periphery following neuronal, muscle and haematopoietic differentiations
(Manuelidis, 1985; Martou and de Boni, 2000; Chaly and Munro, 1996; Kim et al.,
2004; Skalnikova et al., 2000). During differentiation, centromeres are also known to
cluster forming heterochromatic structures called chromocentres. These gene-poor
regions of the nucleus are associated with markers of repression and have been
implicated in gene silencing (Brown et al., 1997; Merkenschlager et al., 2004; Bartova et
al., 2002). The combination of centromeres involved in the chromocentres is
characteristic of each cell type and is therefore subject to change during differentiation
(Alcobia et al., 2000; Alcobia et al., 2003).
In human and mouse, chromocentre clustering increases during neuronal, muscle,
lymphoid and myeloid differentiation (Manuelidis, 1984; Brero et al., 2005; Terranova
et al., 2005; Beil et al., 2002; Alcobia et al., 2003). However, in contrast to these studies,
others have reported a decrease in the amount of clustering during mouse neuronal
differentiation (Martou and de Boni, 2000; Meshorer et al., 2006). One explanation for
these differences may be the differentiation status of the cell type. For example, Mayer
at al., (2005) has shown that during differentiation of mES cells towards postmitotic
macrophages the number of chromocentres decreases significantly. However, when they
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compared mES cells to a precursor cell, such as a myoblast, the number of
chromocentres is increased. Therefore, in specific lineages the number of chromocentres
may first increase to facilitate the process of differentiation, before it decreases upon
terminal differentiation to maintain a particular transcriptome. Another explanation
could be the cell cycle, as clustering is less pronounced in the nuclei of cycling cells than
terminally differentiated cells (Weierich et ah, 2003). The distribution of centromeres
has not been studied in hES cells. However, recently a study following the formation of
chromocentres in relation to the establishment of transcriptional activity during early
mouse development, has shown that chromocentres are established during zygotic
genome activation. The process was reported to be complete by the blastocyst stage,
with only subtle movements of pericentric heterochromatin associated with switches in
replication timing and epigenetic markers that correlate with the onset of differential
gene expression (Martin et ah, 2006).
The nuclear periphery is enriched in hypoacetylated chromatin (Sadoni et ah, 1999),
although it is unclear whether histone acetylation has a direct role in nuclear
organisation. In support of this theory Taddei et ah, (2001) report that the histone
deacetylase inhibitor Trichostatin A (TSA) reversibly disrupts HP1 binding at
pericentric heterochromatin, which results in the relocalisation of centromeres towards
the nuclear periphery. However, Gilchrist et ah, (2004) have shown that TSA treatment
does not alter centromere position and consistent with many other studies, that the
majority of centromeres in differentiated cells are located at the nuclear periphery
without drug treatment. In mouse, hypoacetylation occurs upon the induction of
differentiation (Keohane et ah, 1996), and therefore may have a role in enabling
chromocentre formation. This theory has been tested by adding various HDAC
inhibitors (TSA, Sodium butyrate and Valproic acid) to a muscle differentiation system
(Terranova et ah, 2005). However, adding these drugs within the first 24 hours, blocks
the differentiation. Therefore, the inhibitors were added after 24 hours, when the
changes in gene expression that allow myoblasts to differentiate into a myocytes have
already occurred. The HDAC inhibitors interfere with tri-methylation of H3-K9 and
39
block centromere clustering, but no affect on gene expression is shown except for the
delayed transcription of a myogenic regulatory factor. This differentiation was stopped
after only 6 days. It would therefore be interesting to see if these cells could differentiate
from myocytes to myotubes, or if centromere clustering and HDACs are required for
terminal differentiation.
Terranova et ah, (2005) also show that Cycloheximide (which inhibits transcription
elongation) and 5-Azacytidine (which inhibits DNA methylation) has no affect on
centromere clustering. This last result is interesting in light of another study, which
reports that over expression of the MBP, MeCP2 induces centromere clustering (Brero et
ah, 2005). If cells that lack DNA methylation can still form chromocentres, then it
would be unlikely that a MBP alone is responsible for their formation. In neurons, both
HI and the polycomb protein Eed are associated with chromocentres at the nucleolus
(Akhmanova et al., 2000). The authors suggest that DNA replication and/or cell division
might disrupt this association in progenitor cells, while it can proceed to completeness in
terminally differentiated neurons, where neither of these processes takes place.
However, the role of polycomb proteins in maintaining nuclear organisation has yet to
be described.
1.4.3 Telomere position
Telomeres are the protein-DNA structures at the ends of eukaryotic chromosomes,
essential for maintaining chromosome stability, positioning and complete replication
(reviewed in Zalenskaya and Zalensky, 2002). Unlike centromeres, human telomeres are
distributed throughout the nuclear interior (Molenaar et al., 2003; Weierich et al., 2003),
whereas in mouse, half of the telomeres are associated with heterochromatic
chromocentres at the periphery and the rest are distributed throughout the nucleus, as
expected for telocentric chromosomes (Cerda et al., 1999; Weierich et al., 2003).
Furthermore, the order of these domains, q-telomere, p-telomere and then centromere,
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from the nuclear interior to the periphery, contributes to the polar organisation of human
CTs (Ferguson and Ward, 1992; Amrichova et ah, 2003) and to a lesser extent mouse
CTs (Vourc'h et al., 1993). Telomere position has not been studied in other immortal
cells, although Nagele et al., (2000) reported that telomeres cluster less frequently in
cycling and immortal HeLa cells, then in non-cycling cells such as quiescent fibroblasts.
They suggested that clustering might be important for stabilising chromosome positions
in the interphase nucleus, however more recently these telomere associations have been
shown to be transient in nature (Molenaar et al., 2003).
1.4.4 The nuclear periphery and gene expression
The position of a gene within the nucleus is thought to affect its transcription. For
example in yeast, Andrulis et al., (1998) silenced a gene by tethering it to the nuclear
periphery. Flowever, the transcriptional activation of specific genes in yeast has also
been shown to result in their relocation to the nuclear periphery, demonstrating that this
change in position is not controlled by transcription alone (Casolari et al., 2004). In
mammals, a direct link between nuclear position and transcription has yet to be
demonstrated. However, some silent genes associated with the nuclear periphery have
been shown to relocate to the nuclear interior when expressed (Kosak et al., 2002; Zink
et al., 2004). This spatial arrangement is also consistent with the localisation of late
replicating and gene-poor genomic regions at the nuclear periphery (Ferreira et al., 1997;
Sadoni et al., 1999; Croft et al., 1999; Boyle et al., 2001). During differentiation of mES
cells, both the Hox genes and the transcription factor Mashl (Ascll) move towards the
nuclear interior when activated (Chambeyron and Bickmore, 2004; Williams et al.,
2006). In the case ofMashl, this relocalisation was shown to accompany a change in
replication timing. Mashl is one of three genes found to be late replicating in mES cells
by Perry et al., (2004). It is currently not known whether transcription of the other genes
(Neurod and Myf5) is accompanied by relocation within the nucleus. Interestingly,
Williams et al., (2006) showed that the position of Mashl is conserved in
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undifferentiated mES cells lacking the Ezh2-Eed HMTase complex and several other
chromatin silencing candidates (Suv39hl, Dnmtl, Dnmt3a and Dnmt3b). However, the
position of a gene has yet to be followed during the differentiation of these cell types.
Not all genes change location in response to transcription. Some genes, such as the
proteolipid protein (PLP) gene, are constantly located at the periphery, whereas others
such as the immunoglobulin (Ig) genes show a conserved distribution throughout the
nucleus, independent of both cell type and transcriptional activity (Nielsen et al., 2002;
Bartova et al., 2002; Parreira et al., 1997). This is consistent with reports that sites of
transcription are present throughout the nucleus (Verschure et al., 1999; Szentirmay and
Sawadogo, 2000). Other loci such as CD4 only relocate to the nuclear interior in cells,
which expressed the gene at high levels and not their precursors (Kim et al., 2004). This
would suggest that although movement of a locus is not necessary for gene expression,
the centre of the nucleus might confer some transcriptional advantage on gene-dense
regions that require high levels of transcription.
1.4.5 Nuclear organisation and transcription
Instead of directly recruiting the transcriptional machinery, it has been suggested that
genes move into preassembled transcription sites in the nucleus (Osborne et al., 2004).
This would provide evidence for the model originally proposed by Cook, (2002), that the
physical properties of chromatin and the sum of interacting proteins, such as
polymerases, might determine the distribution of chromosomes and genes in a self-
organizing manner. For example, whereas inactive genes on different chromosomes can
colocalise in association with polycomb proteins (Bantignies et al., 2003) or centromeric
heterochromatin (Brown et al., 1997, 1999; Su et al., 2004), active genes colocalise at
sites of concentrated transcriptional components, such as RNA polymerase (Osborne et
al., 2004), providing anchor points, which might determine the spatial organisation of
the genome (Cook, 2002). A recent study has even documented colocalization of the
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interferon (IFN)y locus on mouse chromosome 10, with the Th2 cytokine gene cluster on
chromosome 11, in the absence of transcription (Spilianakis et al., 2005). Interestingly,
this association is only seen in cell types that have the potential to express the genes, and
not in cells that will never express the genes. The interaction between chromosomes is
also lost in favour of intrachromosomal associations upon gene activation. Therefore,
physical associations between chromosomes may have implications for coordinating
gene expression (Spilianakis et al., 2005). Unlike the cytokine genes, human a- and (3-
globin genes are frequently in spatial proximity when active (Brown et al., 2006). The
human ot-globin genes can extend outside of their CTs, irrespective of transcriptional
status, but associate with each other and nuclear speckles in a transcription dependent
manner. The same degree of proximity does not occur between human (3-globin genes or
between mouse globin genes, which are more constrained to their CTs (Brown et al.,
2006). This suggests that spatial organisation of globin genes within the nucleus is
controlled by both their expression and the genomic environment.
In a review, Gasser (2002) suggested a functional role for chromosome tethering in
controlling the genetic plasticity of stem cells (figure 1.9). If anchorage in the cell
nucleus controls gene expression, she perceived chromatin mobility as an indication of
the active (or inactive) state of the nucleus. For example in large pluripotent nuclei, the
chromatin may be fully dynamic. Integration of the lac operator at different positions in
the human genome has shown that in general, chromatin associated with the nucleolus or
the nuclear periphery is more restricted in its movement than that of chromatin
associated with nucleoplasmic regions (Chubb et al., 2002). This motility may reflect the
ability of the chromatin to either be transcribed or silenced, reminiscent of genes in an
ES cell. As the cell differentiates and the transcription pattern of the nucleus is defined,
the nuclei become smaller with less mobile chromatin. Recently this change in
chromatin dynamics was reported to accompany the differentiation ofmES cells towards
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Fig. 1.9 Model for nuclear organisation during differentiation. This model
predicts that progressive differentiation restricts both gene expression and
chromatin mobility. For example in large pluripotent nuclei, the chromatin may
be fully dynamic. This motility reflects the ability of the chromatin to either be
transcribed or silenced, reminiscent of the genes in an ES cell. As the cell
differentiates and the transcription pattern of the nucleus is defined, the nuclei
become smaller with less mobile chromatin (adapted from Gasser, 2002).
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1.4.6 Transcription and the chromosome territory
It was originally proposed that genes clustered together on chromosomes according to
tissue specific expression or high transcription rates (Caron et al., 2001; Versteeg et al.,
2003). However, more recently it has been shown that the most gene-dense regions of
the genome contain genes, which are expressed in a wide range of tissues and cell types
(Hurst et ah, 2004; Lercher et ah, 2002). Therefore, it is genes that are broadly
expressed, rather than those that are highly expressed, which cluster together across the
genome.
Early studies suggesting that transcription and RNA processing occurred in a
compartment between the CTs, led to the interchromosome domain (ICD) model of
nuclear organisation (figure 1.10; reviewed in Cremer and Cremer, 2001). Support for
this model came from experiments showing that genes, but not non-coding regions, were
positioned on the surface of CTs (Kurz et ah, 1996). Furthermore, active genes on the X
chromosomes were found to locate at the periphery of their CT, whereas a silent gene
was located within the inactive X CTs interior (Dietzel et ah, 1999). However, studies
contradicting the ICD model have shown that transcription sites are found deep within
CTs (Abranches et ah, 1998; Verschure et ah, 1999) and that both early and later
replicating DNA, as well as C-G rich sequences are found throughout the CTs (Visser et
ah, 1998; Tajbakhsh et ah, 2000). Together these observations led to the revised
interchromatin compartment (IC) model figure 1.10), which predicted that genes might
also be transcribed from within CTs. Later, evidence confirming this prediction came
from studying the WAGR locus at llpl3, which is active from within the chromosome
11 territory (Mahy et ah, 2002a). Therefore, genes do not need to be at the surface of
their CT or in the nuclear interior to be transcribed.
In addition to being on the surface or in the interior of a CT, some genes can also extend
out from their CTs into the nucleus. Examples of this include the major

















Fig. 1.10 A comparison of the interchromosome domain (ICD) model and
the interchromatin compartment (IC) model. The ICD model, originally
proposed that active genes would be located on the surface of CTs, where they
could access transcription factors in the ICD, and inactive genes would be
situated within the CT. However, evidence has now shown that transcription
is not confined to the ICD, and takes place throughout the CT, leading to the
proposed IC model.
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(EDC) located at lq21 (Volpi et al., 2000; Williams et al., 2002), which both loop out
from their CTs in response to transcriptional activation. The genes within these clusters
are not all structurally related, although they can be co-ordinately regulated. Therefore, it
was unknown whether these gene-dense regions looped out of their CTs because of this
specialized regulation, or if other regions of the genome also located outside of their
CTs. This was addressed by analyses of 1 lpl5.5, which is a gene-dense region that
consists of functionally unrelated genes with different expression patterns (Mahy et al.,
2002b). 1 lpl5.5 was found outside of its CT in both lymphoblasts and fibroblasts,
suggesting that local gene density and transcription, rather than the expression of
individual genes are responsible for the nuclear organisation of these looped out regions.
The destination of these looped out regions is still unclear. It has been shown that
proteins involved in transcription and RNA processing are present predominantly in the
interchromatin space, inside and between CTs, and are largely excluded from domains
of condensed chromatin (Verschure et al., 2002). Interestingly, the chromosome band
6p21 (which contains the MHC genes) was found to associate with the transcriptionally
active OPT (Octl/PTF/transcription) domains in nuclei of HeLa cells (Pombo et al.,
1998). Therefore, even though fluorescence recovery after photobleaching (FRAP)
experiments show that transcription factors are highly dynamic and are not excluded
from CTs (Phair et al., 2004), perhaps these gene-dense regions need to decondense
away from their CTs to gain access to large protein complexes or nuclear organelles that
are restricted in their location, or to associate with regions of other CTs. Electron
microscopy of BrdU labelled chromosomes has shown that chromatin from adjacent
chromosomes may be in contact in limited regions (Visser et al., 2000). Recent evidence
from Branco and Pombo (2006) has suggested that this overlap between CTs might be
more significant than previously described. This would enable genes on adjacent
chromosomes to associate with the same transcription site (section 1.4.5; Osborne et al.,
2004; Brown et al., 2006). Although so far the distances measured between these genes
(>400nm) imply that they are not sharing the same 'transcription factories', which are
only 50nm in diameter, as detected by bromouridine triphosphate incorporation (Iborra,
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2002). Gene-dense region have also been shown to colocalise with Promyelocytic
leukemia (PML) bodies (Shiels et ah, 2001; Wang et ah, 2004b) and SC-35 domains
(Shopland et ah, 2003; Moen et ah, 2004). However, disruption ofPML bodies by RNAi
does not have any significant consequences on the expression of genes associated with
them, suggesting that although PML bodies are formed in transcriptionally activity
regions, they are not necessary for transcription (Wang et ah, 2004b).
It is also currently unclear if transcription happens prior to nuclear relocalisation or vice
versa. The mammalian P-globin locus, for example, was reported to loop out of its CT
prior to transcriptional activation (Ragoczy et ah, 2003). However, during the
differentiation of mES cells in vitro and mouse embryonic development in vivo, Hox
genes are located outside their CT, accompanying their collinear pattern of expression
(Chambeyron and Bickmore, 2004; Chambeyron et ah, 2005). Prior to this movement,
locus wide changes in chromatin structure (histone modifications and chromatin
decondensation) may establish a transcriptionally poised state, but this alone is not
enough for gene expression. Therefore, the nuclear reorganisation of Hox genes
represents a transcriptionally active state and not a poised state. In light of recent
advances in the stem cell field, it may also be important to note that polycomb group
proteins are localised at the periphery of chromatin domains, and throughout the
interchromatin space (Cmarko et ah, 2003). This would provide a way in which
neighbouring genes might be kept poised in amongst looped out regions of open
chromatin.
1.4.7 PML bodies
First described by Szostecki et ah, (1990) PML bodies (also known as nuclear domain
10 (ND10), PML oncogenic domains (PODs) and Kremer (Kr) bodies) are multi-protein
domains. A mammalian nucleus contains 5-30 of these bodies, which vary in size from
0.3pm to 1.0pm in diameter (Melnick and Licht, 1999). They have been implicated in
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many cellular processes including cell-cycle regulation, apoptosis, proteolysis, tumour
suppression, DNA repair and transcription (reviewed by Dellaire and Bazett-Jones,
2004; Ching et al., 2005). There are currently three proposed models for PML body
function. First, they may be aggregates of excess nuclear proteins, which can regulate
nucleoplasmic levels by releasing proteins when they are needed. Second, these bodies
might be sites of post-translational modification and protein degradation; and third, PML
bodies may be sites of specific nuclear activities, for example transcriptional regulation
(Ching et al., 2005). This last model is supported by the detection of nascent RNA
around PML bodies (Boisvert et al., 2000) and their association with regions of high
transcriptional activity (Shiels et al., 2001; Wang et al., 2004b). Prior to this thesis, their
localisation within the nuclei of ES cells had not been described.
1.5 Proposed research
This thesis expands on previous work carried out in the Bickmore lab, which analysed
the location of CTs and gene-dense regions of the genome in differentiated cells. It was
thought that if nuclear organisation regulates gene expression, it would have a role in
gene silencing as a cell commits to differentiation. Therefore, it is important to
determine the nuclear organisation of a pluripotent stem cell. The initial aim was to
locate CTs, centromeres and genes known to be important for pluripotency, within a hES
cell nucleus. Prior to starting the project, no previous research had been published on
this subject. Therefore, it was to provide the first description of nuclear organisation in a
hES cell. In parallel, work on mES cells differentiated towards a neuroepithelial cell
type, would allow any differences in nuclear organisation to be analysed throughout the
early development of a lineage. This would enable questions about the role of chromatin
modifying proteins in genome localisation to be addressed in knockout mES cells.
Together both the human and the mES cell projects aim to identify whether spatial
reorganisation is evident during differentiation, or if nuclear organisation is established
prior the to ES cell stage.
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Chapter 2: Materials and Methods
All the reagents were analytical grade and obtained from Sigma or Roche, unless stated
otherwise. General solutions were prepared by technical staff of the Human Genetics
Unit (HGU), autoclaved and stored at the required temperature. Most nucleic acid
manipulations were performed in 0.5ml or 1.5ml Eppendorf tubes. All centrifugations
were carried out at room temperature, unless stated otherwise.
2.1 Mammalian cell culture
2.1.1 Cell counting
After harvesting, cells were resuspended in phosphate buffered saline (PBS) and counted
using a haemocytometer (Weber Scientific International Ltd.). 10pl of cell suspension
were pipetted onto the haemocytometer, which had a chamber 0.1mm in height with 4
etched grids of 1mm2. Therefore, the total volume defined by each grid was lxlO"4 ml,
and the concentration of cells per ml was obtained by averaging the number of cells
counted over 4 grids and multiplying by 104.
2.1.2 Freezing and thawing cells
Cell suspensions were frozen in cryotubes containing 0.5ml of freezing medium (10%
DMSO (v/v) in foetal calf serum (FCS) (Globalpharm)), at a concentration of
approximately 106 cells/ml and placed in -70°C for short term storage, or liquid N2 for
long term storage. To retrieve cells from liquid N2, vials were thawed at 37°C in a water
bath, after expelling excess nitrogen gas from the tube by loosening the cap. Cells were
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diluted in 7ml culture medium and the medium changed after 24 hours incubation at
37°C.
2.1.3 Culture of transformed mammalian cell lines
All cells were incubated at 37°C with 5% CO2 in tissue culture medium containing
penicillin (10,000units/ml) and streptomycin (650pg/ml). Tissue culture solutions were
pre-warmed to 37°C before use.
2.1.3.1 Suspension cells:
The FATO (46XY) human lymphoblast cell line (LCL) was grown as a suspension
culture in Roswell Park Memorial Institute 1640 medium (RPMI, Invitrogen)
supplemented with 10% FCS and 2mM glutamine (Invitrogen). Cells were split 1:3 -
1:5 in fresh medium every 2-3 days.
2.1.3.2 Monolayer cells:
Human HT1080 (male fibrosarcoma-derived; Chen et al., 1983) and RITVA (human
primary fibroblasts carrying an aniridia-associated translocation, transformed with
hTERT by C. Griffiths) cell lines were grown in high glucose Dulbecco's Modified
Eagle Medium (DMEM, Invitrogen) supplemented with 10% FCS. Cells were grown to
near confluence before splitting into fresh culture flasks (Costar). To passage cells, the
medium was removed from flasks and monolayers rinsed once in PBS. Cells were then
covered in a small volume of 10% Trypsin-EDTA/versene and incubated at 37°C for 5
minutes. Gentle agitation dislodged the cells, fresh medium was added and the cells
pelleted at 400g for 5 minutes before being re-plated or fixed.
For immunofluorescence and 3D FISH (sections 2.6 and 2.8.4) cells were seeded
directly onto sterile coverslips (processed through washes of 2M HC1, 100% ethanol,
52
(IH2O, 100% methanol and air dried in a sterile culture hood) in a 6-well plate (Greiner,
Bio-one) or slides (washed in detergent, soaked for at least 1 hour in 100% ethanol with
~2 drops 8M HC1, stored in 100% methanol and flamed before use) in Quadriperm slide
chambers (Vivascience, Satorius).
2.1.4 Primary human fibroblast culture
A 46XY primary fibroblast cell line (1HD), derived from foreskin tissue was obtained
from J. Bridger, Brunei University. The cells were cultured in high glucose DMEM
supplemented with 10% FCS. Cultures were grown to almost confluence and passaged
using trypsin-EDTA/versene, as described above. Cells were seeded at concentrations of
1.5x10s cells per slide and 5xl05 cells per 75cm2 tissue culture flask. Primary cell lines
can be maintained in culture for a limited number of passages before they senesce.
2.1.5 Human embryonic stem cell culture
All hES cell culture was carried out under licence by W. Cui at the Roslin Institute.
Human ES cell lines HI (46XY), H7 and H9 (46XX) (Thomson et ah, 1998) were
grown as previously described (Xu et al., 2001), with minor modification. Briefly, the
cells were cultured on Matrigel coated culture dishes with mouse embryonic fibroblast
conditioned medium, supplemented with 8ng/ml basic fibroblast growth factor (bFGF).
Cells were routinely split 1:3 with collagenase.
2.1.6 Mouse embryonic stem cell culture
The mES cell lines (table 2.1) were maintained in Glasgow Modified Eagle Medium
(GMEM/BHK21, Invitrogen) supplemented with 10% FCS (v/v), lOOmM sodium
pyruvate, 1% non-essential amino acids (NEAA) (v/v), 2mM glutamine, 50pM P-
mercaptoethanol (P-me), lOOU/ml Leukaemia inhibitory factor (LIF) as described by
Smith et al., (1988). The LIF was obtained from conditioned medium derived from
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Cos-7 cells, transfected with a LIF expression construct. Mouse ES cells were
maintained on gelatinised (0.1% gelatin/PBS) flasks. The flasks were coated 10 minutes
before plating, excess gelatin was then removed and the cells seeded. The media was
changed 24 hours later, and the cells passaged every 48 hours at 1:6.





A gift ofA. Smith
(Billon et al., 2002)
Suv39h double null
Suv39hl and Suv39h2
targeted with LacZ and
neomycin
A gift ofT. Jenuwein
(Peters et al., 2001)
Suv39h wt
WT ES cells from a
C57BL6/129 background
A gift of T. Jenuwein
Dnmt3abv"
Targeted disruption of
Dnmt3a and 3b with ERES-
figeo in J1 ES cells
A gift of E. Li
(Okano et al., 1999)
J1
WT ES cells from a
129S4/SvJae background
A gift of E. Li
MeCP2
MeCP2 targeted with Pgeo in
CGR8 cells
A gift ofA. Bird
(Tate et al., 1996)
CGR8
WT ES cells from a 129/ola
background
A gift ofA. Bird
(Mountford et al., 1994)
Table 2.1 - mES cell lines used in this thesis.
2.1.7 Culture and disaggregation of embryoid bodies
To form embryoid bodies (EBs), OS25 cells at a density of 3xl04 cells/ml (in ES cell
media -LIF) were cultured in lOpl hanging drops by pipetting onto 120 x 120mm square
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dishes (greiner). After two days the EBs were resuspended in 15ml ES cell media -LIF
on bacterial petri dishes and cultured further in suspension depending on the
differentiation conditions (section 4.2). Every 48 hours, EBs were collected by
sedimentation at the bottom of a 50ml falcon tube, the media changed and EBs moved to
a fresh petri dish. To disaggregate EBs, they were first allowed to settle in 50ml falcon
tubes, then the media was removed and the EBs washed once with PBS. The EBs were
then incubated in a mixture of 1ml PBS, 1ml Dispase (2.4U/ml) and 20pl DNase I
(7mg/ml) for 30 minutes at 37°C with gentle shaking, before being dissociated by gentle
pipetting with a 5ml stripette. The dissociated cells were washed with 38ml of PBS and
centrifuged at 300g for 4 minutes. The supernatant was removed and the pellet washed
again in 20ml PBS, centrifuged at 300g for 4 minutes and resuspended in 10ml neuronal
differentiation media (50/50 neurobasal media/DMEM-F12, B27 and N2 supplements).
Cells were then plated onto gelatin coated coverslips or petri dishes as needed.
2.1.8 Cell culture drugs
Drugs were added to cell culture media at the specified concentrations for the
appropriated time (table 2.2). Every 48 hours media was decanted from flasks and fresh
media and drugs added.
2.1.9 Bromodeoxyuridine (BrdU) incorporation
BrdU is a thymidine analogue incorporated into DNA during S-phase, used to establish
the percentage of cells in cell cycle. It was added to culture media at 10p,M for 1 hour
before slides were fixed in 4% paraformaldehyde (pFa). Slides were then processed with
a 1 hour incubation using an anti-BrdU antibody as described in section 2.6.1.
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Drug Application Concentration Time
Colcemid




An aminocyclitol antibiotic used to inhibit







An aminoglycoside antibiotic that blocks







The drug is phosphorylated by viral
thymidine kinase, and incorporated into
the DNA of replicating cells where it
inhibits DNA polymerase. These cells are






Table 2.2 - Drugs used in tissue culture.
2.2 Microbiology
2.2.1 Growth of E. coli bacterial strains
Competent DH5-a (Library Efficiency, Invitrogen) were used for all cloning procedures.
Cultures were grown in Luria-Bertani (LB) medium with shaking or on L-agar plates at
37°C. Plasmids were stored in glycerol (15% glycerol/LB) at -70°C.
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2.2.2 Bacterial transformations
Competent cells were incubated on ice with plasmid DNA for 30 minutes, then heat
shocked at 42°C for 45 seconds. After addition of 400pl SOC medium (2% tryptone,
0.5% yeast extract, lOmM NaCl, 2.5mM KC1, lOmM MgCB, lOmM MgSCL, 20mM
glucose, Invitrogen), reactions were incubated at 37°C for 30 minutes before being
plated on L-agar plates containing the appropriate antibiotic for selection (ampicillin at
50ug/ml or chloramphenicol at 170ug/ml). Transformation plates were then grown
overnight at 37°C.
2.3 Preparation and analysis of nucleic acids
2.3.1 Isolation of plasmid DNA
Single bacterial colonies were picked and grown overnight in 3ml of LB medium at
37°C with shaking. Plasmid preparations were then harvested from these cultures using a
miniprep kit (Qiagen). Briefly, bacteria were lysed under alkaline conditions. The lysate
was then neutralised and passed through a silica-gel membrane that selectively absorbs
DNA. The membrane was then washed before the plasmid DNA was eluted with dH20.
2.3.2 Isolation of bacterial artificial chromosome (BAC) clones
BAC stocks stored at -70°C in 15% glycerol were grown overnight in 3ml cultures
containing chloramphenicol (170pg/ml), with shaking at 37°C. These were streaked out
onto L-agar plates containing chloramphenicol to obtain single colonies; which were
used to inoculate 3ml and then 200ml LB cultures, all grown overnight at 37°C. BAC
DNA was isolated either by Qiagen prep (see section 2.3.1) for PCR or by maxi prep
(without the Qiagen column step) to prepare FISH probes. Briefly, the colonies were
pelleted and the bacteria lysed under alkaline conditions. The lysate was then neutralised
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and the supernatant filtered through muslin. DNA was precipitated in cold isopropanol.
This was centrifuged, and the pellet washed twice with 70% ethanol, air dried and
resuspended in an appropriate amount ofTE.
2.3.3 Purification ofDNA
2.3.3.1 Phenol/chloroform extraction
An equal volume of buffered phenol/chloroform (50% buffered phenol pH>7.8/48%
chloroform v/v, 2% isoamylalcohol v/v) was added to the DNA preparation and
vortexed. This was centrifuged at ~12,000g for 15 minutes. The top aqueous layer was
decanted into a fresh tube, avoiding any white precipitate present at the boundary
between the two layers and an equal volume of chloroform added. Vortexing and
centrifugation was repeated. Again, the top layer was decanted. Ethanol precipitation
was then performed to concentrate the DNA (section 2.3.2.2).
2.3.3.2 Ethanol precipitation
DNA was precipitated by adding 0.1 volumes 3M sodium acetate, pH5.2 and 2 volumes
100% ice cold ethanol to the DNA sample. After vortexing, the sample was incubated at
-20°C for 30 minutes and then centrifuged at 12,000g for 15 minutes at 4°C. The
supernatant was discarded and the pellet washed in 70% ethanol (v/v with dH20).
Centrifugation was repeated and the supernatant discarded. Once the pellet had dried at
room temperature, it was resuspended in an appropriate volume of dlEO.
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2.3.4 DNA digestion and preparation
DNA was digested with restriction enzymes (New England Biolabs) in reaction buffer
according to the manufacturers' instructions. Digestion products were then analysed by
agarose gel electrophoresis.
2.3.5 Agarose gel electrophoresis
0.5-2% horizontal agarose ('HiPure' Low EEO agarose, BioGene UK) gels (w/v) in lx
Tris-borate-EDTA (TBE, 45Mm Tris-borate, ImM EDTA pH8.3) were used with lx
TBE electrophoresis buffer to resolve DNA samples, PCR products and plasmid
digestion products. 0.5-1% gels were used to resolve DNA molecules of 0.2 to 50Kb, to
resolve smaller fragments of 0.05 to 5Kb 1.5-2% gels were used. Ethidium bromide
(EtBr; 2,7-diamino-10-ethly-9-phenyl-phenathridium bromide), a DNA intercalating
stain, was added to molten agarose to a final concentration of 0.2pg/ml before pouring
the gel. One volume of 6x gel-loading buffer (15% Ficoll™ 400 (Amersham
Biosciences), 0.25% bromophenol blue, 0.25% xylene cyanol, all w/v in dE^O) was
added to five volumes of sample. DNA size markers c))Xl74 DNA Haelll digest
(Promega) and X DNA Hindlll digest (Invitrogen) were diluted to 50ng/pl, with 500ng
loaded on the gel to enable size determination and quantification of DNA fragments.
Stained DNA was then visualised using UV light and photographed using Quantity One
4.4.1 (Bio-Rad) and a thermal printer (Mitsubishi).
2.3.6 Measuring quality and quantity ofDNA
Quantification ofDNA was either by comparison with a known quantity ofDNA on an
agarose gel (see section 2.3.4), or by measuring its absorbance in a spectrophotometer
(Ultrospec 3000pro, Amersham Biosciences). For this DNA was diluted 1:100 in Tris
EDTA (TE, lOmM Tris-HCl, ImM EDTA, pE17) and transferred to a quartz cuvette. The
optical density (OD) at 260nm (A260) was then measured. An OD of one corresponds to
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~50pg/ml ofDNA. To determine the purity of nucleic acid, the A28o was also measured.
Pure DNA has an A260/A280 of 1.8 and values lower than this indicates contamination
with proteins, RNA or phenol.
2.3.7 Polymerase chain reaction (PCR)
2.3.7.1 PCR reagents
dNTPs (Abgene) were purchased as lOOmM stocks of each dNTP. Working stock
concentrations of lOmM were prepared and used at a final concentration of 0.2mM.
Primer3 (http://frodo.wi.mit.edu/) was used to design PCR primers between 17 and 25
nucleotides in length for which the [G+C]:[A+T] ratio was approximately equal, and
which would not self anneal. Primers were purchased from Invitrogen as lyophilised
desalted compounds and diluted to a stock concentration of lOOpM with dE^O.
Working stock concentrations were prepared at 25pM and oligonucleotides were used at
final concentrations of 0.5pM. Template DNA was at a concentration of lOOng/pl.
AmpliTag® DNA polymerase (5U/pl) was used at 0.5 pi per 25pl reaction. lOx PCR
buffer and 2.5mM MgCl2, supplied with the polymerase, were used at 1:10 and O.lmM
respectively. Reaction mixes were made up to 25 or 50pl total volume with dH20.
2.3.7.2 PCR programs
PCRs were performed in 0.5ml centrifuge tubes or 96 well PCR plates in a DNA Engine
Tetrad (MJ Research). The general PCR amplification program was as follows: -
1. An initial 10 minute DNA denaturation step at 95°C
2. 30 second denaturation step at 94°C





30 second elongation step at 72°C
Steps 2 to 4 were cycled 30 times
A final elongation step for 5 minutes at 72°C to complete the program
Primer sequences, product sizes and annealing temperatures used in PCRs are shown in
table 2.3.

























































Table 2.3 - Primer sequences, product sizes and annealing temperatures used in
PCR. These primers were used to check the genomic sequences in BACs.
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2.3.8 Real time PCR
Real time PCR was carried out using a QuantiTect1M SYBR® Green PCR kit (Qiagen)
according to the manufactures' instructions. For each reaction 5pi of 2x QuantiTect
SYBR Green PCR master mix were used together with 0.5pM of each primer in a final
reaction volume of lOpl. The PCR amplification program was as follows: -
1. An initial 15 minute DNA denaturation step at 95°C
2. 15 second denaturation step at 95°C
3. 20 second annealing step at 60°C
4. 20 second elongation step at 72°C
5. Steps 2 to 4 were cycled 40 times
6. A melting curve was then taken from 55°C to 95°C
7. A final elongation step for 10 minutes at 72°C to complete the program
Primer sequences used in real time PCRs and their product sizes are shown in table 2.4.




Oct4 Exon 1 GGATGGCATACTGTGGACCT
AGTTGCTTTCCACTCGTGCT
105
Olig2 Exon 1 CTGCCTCCACCCAGCTATAA
GAGGAGAACCTGGCTCTGG
98
Olig2 Exon 2 ATCTTCCTCCAGCACCTCCT
GGGCTCAGTCATCTGCTTCT
82
Table 2.4 - Primer sequences used in real time PCRs and their product sizes.
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Each reaction was performed in duplicate, on a PTC-200 Peltier Thermal Cycler coupled
to a Chromo4 continuous fluorescence detector. Analysis was carried out using MJ
OpticonMonitor™ software version 3.1 (BIO-RAD).
2.3.9 RNA isolation and purification
Cells at 5xl06 cells/ml were lysed in 1ml TRI Reagent by repeat pipetting and then
passed though a 21-gauge needle. After standing at room temperature for 5 minutes, 0.2
volumes of chloroform were added and mixed vigorously for 15 seconds before
incubation at room temperature for a further 10 minutes. The homogenate was then
centrifuged at 12,000g for 15 minutes at 4°C. The RNA in the upper aqueous phase was
transferred to a fresh tube and mixed with 0.5ml isopropanol, per ml of TRI Reagent
used. After 10 minutes at room temperature the RNA was pelleted by centrifuging at
12,000g for 10 minutes at 4°C, the supernatant removed and the pellet washed with 75%
ethanol. The sample was vortexed and centrifuged at 7,500g for 5 minutes at 4°C before
being allowed to air-dry for ~10 minutes and resuspended in an appropriate volume of
dH20.
RNA was DNase treated (20pg RNA, 20U RNA inhibitor, 2U DNase I, IX buffer) for
one hour at 37°C. The RNA was then purified by adding one volume of
phenol/chloroform, mixing and centrifuging for 10 minutes at 12,000g. The top aqueous
layer was taken and one volume of chloroform added before centrifugation at 12,000g
for 10 minutes. The upper aqueous layer was added to one volume of 5M ammonium
acetate, two volumes of 100% ethanol and put at -20°C for ~30 minutes before
centrifuging for a further 20 minutes at 12,000g. The pellet was then resuspended in an
appropriate amount ofDEPC treated H2O and the RNA was quantified by measuring the
A26o in a spectrophotometer. At A26o an OD of 1 corresponds to ~38pg/ml RNA. To
determine the purity of the RNA the A2go was also measured. Pure RNA has an A26o /
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A280 of approximately 1.8-2.0 and values lower then this indicate contamination. The
RNA was then stored at -70°C.
2.3.10 cDNA synthesis
2pg RNA in 19pl dH^O were added to 8pM of random hexamers (Amersham
Biosciences) incubated at 70°C for 5 minutes, and then placed on ice. Added to this was
8pi of 5x first-strand buffer (250mM Tris-HCl, pH8.3, 375mM KC1, 15mM MgCfi),
lOmM dithiothreitol (DTT), 40U RNA inhibitor, 0.5mM dNTPs and 400U Superscript II
reverse transcriptase (RT, Invitrogen "). RT was omitted from the negative RT control.
Reactions were then incubated at 42°C for 1 hour in a total volume of 40pi, followed by
5 minutes at 80°C to inactivate the RT and complete first strand synthesis.
2.3.11 Reverse transcription polymerase chain reaction (RT PCR)
In each reaction lpl RT was added to 2pl lOx PCR buffer II, 2.5mM MgCl2, 0.2mM
dNTPs, 1,25pM of each forward and reverse primer, and 1U Taq Gold polymerase in a
total 20pl. Sequences for primers, sizes of the fragments generated, annealing
temperatures and the numbers of cycles used are recorded in table 2.5. For RT PCR the
program shown in section 2.3.6.2 was used with the exception of the GAPDH PCR,
which requires an elongation step time of 20 seconds. The number of cycles used also
varied between 25 and 35, depending on the abundance of the transcript. All PCR
products were resolved on 1.5% agarose gels (section 2.3.5).
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Table 2.5 - RT-PCR conditions. Mouse primer sequences, product size and PCR
conditions used in RT-PCR.
2.4 Preparation and analysis of cellular proteins
2.4.1 Harvesting cellular proteins
Cells grown on flasks were washed twice with PBS, and lysed in equal volumes of PBS
and 2x SDS (Sodium dodecylsulphate) protein loading buffer (125mM Tris pH6.8, 4%
SDS w/v, 10% P-me v/v, 20% glycerol v/v, 0.1% bromophenol blue). Samples were
scraped from the surface of flasks and boiled at 100°C for 5 minutes, before being stored
at -20°C.
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2.4.2 Resolution ofproteins by SDS PAGE
Protein extracts were resolved by SDS polyacrylamide gel electrophoresis (SDS-PAGE).
Samples were thawed on ice and sonicated at 5pA for 10 seconds (Soniprep 150) before
loading 10 to 15pl onto the gel. Polyacrylamide minigels (12% acrylamide v/v, 0.39M
Tris-HCl pH8.8, 0.1% SDS w/v, 0.1% ammonium persulphate w/v, 0.04% N,N,N',N'-
tetramethylethylenediamine (TEMED) v/v in dH20) with stacking gels (5% acrylamide
v/v, 0.13M Tris-HCl pH6.8, 0.1% SDS w/v, 0.1% ammonium persulphate w/v, 1%
TEMED v/v in dH20) were poured using 30% acrylamide (29:1 acrylamide :bis-
acrylamide v/v, Severn Biotech). Gels were resolved in electrophoresis tanks (Mighty
Small, Hoefer) in Tris-glycine running buffer (25mM Tris base, 250mM glycine pH8.3,
0.1% SDS w/v) at 110V for 2 hours. 10pl of BenchMark™ pre-stained protein ladder
(Invitrogen) were loaded to aid with analysis.
Following SDS-PAGE, the stacking gel was removed and the resolving gel was rinsed in
transfer buffer (24mM Tris, 192mM glycine, 20% methanol v/v). The gel was then
submerged in Coomassie Stain (0.25% Coomassie Brilliant Blue R-250 w/v, 45%
methanol v/v, 45% dH20 v/v, 10% glacial acetic acid v/v) for 1 hour with gentle
agitation. The stain was discarded and gel was incubated overnight in destain (30%
methanol v/v, 10% glacial acetic acid v/v in dH20) with gentle agitation.
2.4.3 Western blotting
After SDS-PAGE (section 2.4.2) protein samples were transferred to polyvinylidene
difluoride (PVDF) membrane (Hybond-P, Amersham Pharmacia Biotech) by semi-dry
transfer. Briefly, the stacking gels were removed and gels were washed in transfer
buffer. The PVDF membrane was soaked in methanol for 10 seconds, rinsed twice in
dH20 and then equilibrated in transfer buffer. Transfer apparatus (WEB Company,
Washington) was assembled in accordance with the manufacturers' instructions with the
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gel and membrane sandwiched on each side by 3 pieces of 3MM filter paper (Whatman)
equilibrated in transfer buffer. The apparatus was run at 20mA for 1 hour.
Membranes were blocked for 1 hour with agitation in lx TBS (150mM NaCl, lOmM
Tris-HCl pH7.5) with 4% milk protein (Marvel). Primary antibodies were diluted in 4%
milk, lx TBS and incubated with membranes overnight at 4°C with shaking (antibody
dilutions are shown in table 2.6). Membranes were washed six times in lx TBST (lx
TBS, 0.05% Tween-20 v/v) and incubated with secondary antibodies (table 2.6) for at
least 1 hour. After a further six washes membranes were detected by enhanced
• -t • ®
chemiluminescence (ECL) according to the manufacturer instructions (SuperSignal
West Pico Chemiluminescent Substrate, Pierce) and signals were exposed on
Hyperfilm™ ECL (Amersham Biosciences).
Antibody Species Source Concentration
GAPDH Rabbit polyclonal Abeam 1:2,000
Pan H3 Rabbit polyclonal A. Verreault 1:30,000
H3-K9 di-methylated Rabbit immunoaffmity purified Upstate 1:2,000
H3-K9 tri-methylated Rabbit polyclonal T. Jenuwein 1:1,000
H3-K9 acetylated Rabbit polyclonal Upstate 1:1,000
H3-K4 methylated Rabbit antiserum Abeam 1:5,000
Serine 10
phosphorylation
Rabbit polyclonal Upstate 1:1,000
Cyclin B1 Mouse monoclonal Santa Cruz 1:1,000
Secondary Rabbit Goat whole molecule Sigma 1:10,000
Secondary Mouse Goat FAB specific Sigma 1:8,000
Table 2.6 - Antibody dilutions used for western blotting
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2.5 Chromatin analysis
2.5.1 Chromatin immunoprecipitation (ChlP)
1% formaldehyde in culture medium was added to a confluent T75 cm flask of cells, for
10 minutes at room temperature. The cells were rinsed in cold PBS and 5ml NBA
(85mM KCL, 5.5% sucrose v/v, lOmM Tris pH7.5, 0.2mM EDTA, 0.5mM spermidine,
250pM PMSF) were added with 0.5% NP40 and lpl protease inhibitor (lU/ml). Cells
were harvested by scraping and placed on ice for 5 minutes. The flask was rinsed in 5ml
NBA and this was added to the cells on ice. The nuclei were centrifuged at 250g for 3
minutes at 4°C. The supernatant was aspirated off and the nuclei resuspended in 100pi of
NBA; this was then transferred into a centrifuge tube and placed on ice. 400pi of ChlP
sonication buffer (1% SDS, lOmM EDTA, 50mM Tris-HCL pH8, 250uM PMSF) were
added and the nuclei sonicated for 3x 15 seconds at lOu on ice. The sample was
centrifuged for 3 minutes max speed at 4°C and the OD measured. A 150pg aliquot was
frozen at -20°C to use as input chromatin. 30pg was purified through phenol/chloroform,
chloroform and ethanol precipitation and run on a gel, and the remaining sample added
to lOOpl protein G agarose (previously washed twice with NBA) and lOpg Salmon
sperm DNA. This was then incubated for 1 hour at 4°C with end-over-end rotation. The
sample was centrifuged for 2 minutes at 3400g 4°C, and the supernatant diluted in TBS
plus 0.5% TX-100 to give 150pg in 250pl for each IP. To each 250pl, the appropriate
amount of antibody was added (table 2.7) and incubated at 4°C overnight with end-over-
end rotation. One sample was incubated without antibody as a negative control.
Antibody Species Source Concentration
Pan H3 Rabbit polyclonal A. Verreault 12:1,000
H3-K4me2 Rabbit antiserum Abeam 20:1,000
H3-K9ac Rabbit polyclonal Upstate 20:1,000
Table 2.7 - Concentrations of antibodies used in ChlP.
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100pi 50% protein G agarose and lOOpg salmon sperm DNA were added to each tube
and incubated at 4°C for 2 hours. Samples were then centrifuged at 3400g for 2 minutes,
the supernatant removed and stored at -20°C. The pellet was taken though a series of
washes: lx TBS (lOOmM Tris pH8, 150mM NaCl, 0.5% TX-100), lx TBS high salt
(lOOmM Tris pH8, 500mM NaCl, 0.5% TX-100), lx ChIP wash buffer (lOmM Tris
pH8, 500mM LiCl, 1% NP40, 1% deoxycholate (free acid)) and finally lx TE pH8, all
in 500pl for 5 minutes at room temperature with end-to-end rotation, centrifuging
between washes for 2 minutes at 4700g. The pellet was resuspended in lOOpl TE plus
5pi RNase A (lOmg/ml) and incubated for 30 minutes at 37°C. The sample was then
centrifuged for 2 minutes at 4700g, and eluted in 250pl freshly prepared ChIP elution
buffer (1% SDS, 0.1M NaHCCE), which was then incubated for 15 minutes at 37°C. The
sample was centrifuged for a further 2 minutes, the supernatant stored, and 250pl of
fresh ChIP elution buffer added to the pellet. This was incubated with end-to-end
rotation at room temperature for 15 minutes, centrifuged again, and the supernatants
pooled. NaCl was added to a final concentration of 200mM (to all samples including the
input) and the samples incubated at 65°C for six hours to reverse the cross-links. The
samples were incubated for 1 hour at 55°C with 20pg/ml Proteinase K (PK), then
extracted with phenol/chloroform, and then chloroform, followed by ethanol
precipitation overnight at -20°C. The pellet was resuspended in 20pi of dH20. This
protocol was based on Christenson et ah, (2001).
2.6 Immunohistochemistry
2.6.1 Immunofluorescence
For immunofluorescence, slides were prepared as in section 2.1.3.2. Cells grown in
adherent monolayers were seeded directly onto slides, and cultured until the required
confluency was reached. The media was removed, and the slides were washed twice
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with PBS and fixed in 4% pFa/PBS (Boehringer) for 10 minutes. The fix was then
quenched in 50mM NH4C1 for 12 minutes, the slides washed twice in PBS and
permeabilised in 0.1% Triton/PBS for 10 minutes. After a further two washes in PBS the
slides were blocked for 20 minutes in 5% serum/PBS v/v under parafilm (the serum used
to dilute antibodies should be from the same species in which secondary antibodies were
raised). Primary antibodies diluted in 5% serum/PBS were then added to the slide and
incubated under parafilm for a period of 1 hour to overnight in a moist chamber at room
temperature. Concentrations ofprimary antibodies used are shown in table 2.8.
Antibody Species Source Dilution Factor
CENP-C Rabbit Gift ofW. Earnshaw 1:1,000
CREST (Cummings) Human anti-sera Gift ofB. Sullivan 1:1,000
CREST (Campbell) Human anti-sera Gift ofB. Sullivan 1:1,000
BrdU Rat monoclonal Harlan Seralab 1:100
5E10 Mouse monoclonal Gift of P. De Jong 1:10
Ki67 Rabbit DAKO 1:100
Fibrillarin Mouse monoclonal Gift of J. Aris 1:1,000
Nucleolin Rabbit Gift ofB. McStay 1:250
SSEA-1 Mouse polyclonal DSHB 1:200
p-gal Rabbit polyclonal Europa 1:2,000
Nestin Mouse DSHB 1:250
Oct4 Mouse BD Bioscience 1:250
Soxl Rabbit Gift ofR. Lovell-Badge 1:500
01ig2 Rabbit Gift of T. Jessell 1:1,000
H3-K4me2 Rabbit antiserum Abeam 1:500
H3-K9me2 Rabbit Upstate 1:500
H3-K9ac Rabbit polyclonal Upstate 1:500
Table 2.8 - Primary antibodies used in immunofluorescence.
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Slides were then washed three times in PBS. Species-specific fluorescein isothiocyanate
(FITC) or Texas Red (TxRd) conjugated secondary antibodies (Jackson Labs, table 2.9)
were diluted in 5% serum/PBS and applied in the same manner and incubated for at least
one hour in moist chambers at 37°C. The slides were washed a further three times and
mounted with 4,6-diamidino-2-phenylindole (DAPI) in Vectashield (Vector), at a
concentration of 0.5pg/ml. Coverslips were sealed with rubber solution (Pang) and
slides were stored in the dark at 4°C.
Antibody Species Dilution Factor
FITC anti-rabbit Donkey 1:200
FITC anti-mouse Donkey 1:150
FITC anti-human Donkey/Goat 1:150
TxRd anti-human Goat 1:100
TxRd anti-mouse Donkey 1:100
Table 2.9 - Secondary antibodies used in immunofluorescence.
For suspension cultures and cells non-adherent to glass surfaces, the cells were first
trypsinised and/or pelleted. The pellet was washed twice in PBS, and resuspended in 4%
pFa for 10 minutes. The fix was then quenched in 50mM NH4C1 for 12 minutes and the
pellet washed a further two times with PBS. The cell suspension was diluted in PBS to a
final concentration of 1x10s cells/ml, and cytospun (Shandon, Cytospin3) in 500pl
aliquots onto poly-L-lysine coated slides (BDH) at 1 lg for 5 minutes. The slides were
then treated as for adherent cells.
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2.7 Histochemical staining
2.7.1 Alkaline phosphatase staining
An alkaline phosphatase staining kit (Sigma, 86-R) was used to detect the differentiation
state ofmouse ES cells. The cells were grown on glass coverslips in 6-well plates. After
rinsing the cells with PBS, 1ml of fix (for 98ml: 25ml citrate solution, 65ml acetone and
8ml of 37% formaldehyde) was added to each well for 30 seconds. The fix was replaced
with dH20 and the cells rinsed gently for 45 seconds. The dH20 was then removed and
~400pl of freshly prepared stain was added to each well. Cells were incubated in the
dark for 30 minutes at room temperature. Those cells that express alkaline phosphatase
stain intensely pink. The stain was removed, the cells washed with dH20 and mounted in
an aqueous mountant (lOg gelatin, 70g glycerine in 60ml dH20). The cells were then
photographed under brightfield using xlO and x20 objectives.
2.7.2 X-Gal staining
The X-Gal staining solution was prepared by dissolving 250mg of 5-Bromo-4-chloro-3-
indolyl-P-D-galactoside (X-Gal, Melford) in 5ml dimethylformamide (DMF) before
adding the remainder of the buffer (5mM potassium ferricyanide (K3Fe(CN)6), 5mM
potassium ferrocyanide (K4Fe(CN)6), 0.25mg/ml spermidine, 2mM MgCl2 made up to
500ml with wash buffer (0.1M phosphate buffer (23:77 v/v 1M NaFfjPCCTM
Na2HP04), 2mM MgCl2, 0.05% Bovine serum albumin (BSA)). The solution was stored
at -20°C and filtered before use. Cells were rinsed twice in PBS before fixing for 15
minutes at 4°C in 0.5% glutaraldehyde, 2mM MgCl2, 5mM EGTA made up in 0.1M
phosphate buffer pH7.3. After washing twice in wash buffer, cells were stained in the
dark at 37°C overnight for a maximum of 15 hours in X-Gal staining solution. The
staining solution was then removed and the cells washed once with PBS before
mounting in an aqueous mountant (lOg gelatin, 70g glycerine in 60ml dH20). The cells
were then photographed under brightfield using xl 0 and x20 objectives.
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2.8 Fluorescence in situ hybridisation (FISH)
2.8.1 Preparation of nuclei for FISH
2.8.1.1 Harvesting and fixing cells in 3:1 methanol:acetic acid (MAA)
For 2D analysis, the cells were swollen after harvesting by suspension in 10ml
hypotonic solution (75mM KC1), added drop-wise whilst continually agitating the tube
(the concentration of cells in the hypotonic should be <2xl07cells /ml). The cell
suspension was left at room temperature for 10 minutes before centrifuging at 400g for 5
minutes. Cells were then fixed with 2ml of fresh 3:1 methanol:glacial acetic acid added
drop-wise to the cells whilst the tube was agitated. A further 8ml of fix were added and
the tube placed on ice for a minimum of 15 minutes or stored at -20°C overnight. Cells
were fixed twice more and stored indefinitely at -20°C.
2.8.1.2 Preparation of three-dimensionally preserved nuclei
For 3D analysis, cells were grown on Superfrost plus microscope slides (BHD) prepared
as in section 2.1.3.2 at a density of 1.5xl03 cells/slide in 5ml of media, to result in
approximately 70% confluency after a further 16 hours in culture. Slides were washed
three times for 5 minutes each in PBS and then permeabilised in CSK buffer (lOOmM
NaCl, 300mM sucrose, 3mM MgCl2, 10mM PIPES pH6.8, 0.5% Triton XI00) for 5
minutes on ice. After washing in PBS, cells were fixed with 4% pFa/PBS for 10
minutes. Cells grown in suspension cultures or non-adherent to glass were fixed and
cytospun onto slides as described in section 2.6.1. The slides were washed a further three
times for 5 minutes in PBS before incubation in 20% glycerol (v/v, high grade)/PBS,
either for 30 minutes at room temperature or at 4°C overnight.
Slides were dipped into liquid nitrogen until completely frozen, allowed to thaw at room
temperature, then returned to 20% glycerol for -three minutes before being frozen again.
74
This freeze thaw procedure was repeated four times, and on the fifth freezing the slides
were either taken directly through the 3D FISH protocol (section 2.8.4) or stored
indefinitely at -70°C.
2.8.2 Preparation ofFISH probes
Probes were labelled using biotin-16-dUTP (biotin), digoxigenin-11-dUTP (dig-dUTP)
or Alexa 488 incorporated into the DNA by PCR or nick translation. Following either
method, unincorporated nucleotides were removed and efficiency of biotin or dig-dUTP
labelling was assessed.
2.8.2.1 Preparation of labelled human chromosome paints by PCR
Human micro-dissected chromosome arms (gifts ofMichael Bittner; Guan et al., 1996)
were amplified on PTC-225 Peltier Thermal Cycler (MJ Research). Biotin or dig-dUTP
was incorporated directly by PCR into chromosome paints by adding these analogues to
the PCR reaction mix (used for HSA18p, 18q, lip and 6p). For direct labelling of
chromosome paints, lpl of PCR template (from a second round of amplification of an
original template stock) was added to a mixture of: 5pi each of 2mM dATP, dCTP,
dGTP and 3pi of 0.5mM dTTP, 3pl of lmM biotin or dig-dUTP, 400ng primer
fCCGACTCGAGNNNNNNATGTGG3'), 3U Taq polymerase, 5pi MgCl2 (25mM),
5pi PCR buffer (lOx) and the volume made up to 50pl with dH>0. Amplification
conditions were four minutes at 94°C then 30 cycles of: 94°C for 30 seconds, 56°C for
30 seconds and 72°C initially for two minutes extending by three seconds per cycle. All
chromosome PCR fragments were resolved on 2% agarose gels in TBE (section 2.3.4).
Alternatively, when the PCR products were too large (> ~500bp), cold PCR products
were precipitated using ethanol and sodium acetate pH5.5 (section 2.3.2.2), then biotin




1-1 -5jo.g of DNA were added to 4jj.1 lOx nick translation salts (0.5M Tris-HCl pH7.5,
0.1M MgS04, lmM DTT, 500|ag/ml BSA), 4pl each of 2mM dATP, dGTP and dCTP,
2pl of 0.5mM dTTP and 4li! lmM biotin or dig-dUTP. DNase I was freshly diluted to a
concentration of 20U/ml in dH20 at 4°C and 2pi added to the reaction mixture to give a
final concentration of lU/ml. After the addition of 1 ul DNA polymerase I (Invitrogen,
10units/pl), dH20 was added to make the total volume of reaction mixture 40pl The
reaction was mixed thoroughly and allowed to proceed at 16°C for 90 minutes. The
reaction was stopped by placing at -20°C or immediately processed for removal of
unincorporated label (section 2.8.2.3).
2.8.2.3 Removal of unincorporated label
Quick spin columns containing G50 Sephadex beads were used to remove any biotin or
dig-dUTP that remained free in solution as per the manufacturer's instructions. Cleaned
probes were eluted in ~60pl TE pH7.5.
2.8.2.4 Quantifying label incorporation
Gridded nitrocellulose membranes were prepared by soaking briefly in dH20 followed
by 20x SSC (3M NaCl, 0.3M tri-sodium citrate, pH7.4) for 10 minutes then allowing to
air dry. Labelled DNA probes were diluted to lxlO"3 and lxlO"4 in TE (pH7.5) and lpl
of each was spotted twice onto a gridded membrane. After the spots had dried, a further
lpl was added to one of each dilution. On the same membrane 20, 10, 2 and lpg of
appropriately labelled lambda DNA standards were spotted. DNA was cross-linked onto
the membrane by exposure to 30mJ ofUV irradiation.
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The membrane was immersed in buffer 1 (0.1M Tris-HCl pH7.5, 0.15M NaCl) for 5
minutes at room temperature, then in 3% BSA in buffer 1 for 45 minutes at 60°C. 10pl
streptavidin-alkaline phosphatase (Boehringer) and/or anti-digoxigenin-alkaline
phosphatase (Boehringer) were added to 10ml of buffer 1 and placed in a 50ml falcon
tube with the membrane for 30 minutes with continuous agitation at room temperature.
The membrane was washed twice for 15 minutes in buffer 1 then for 5 minutes in 0.1M
Tris-HCl, pH9.5. The colour reaction was developed by incubation of the membrane, in
a sealed polythene bag, with 5ml of 0.1M Tris-HCl pH9.5 and 2 drops from bottles 1-3
of the alkaline phosphatase substrate kit IV (Vector). The substrates in this colour
reaction are 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium, which
produce a blue reaction product. A complete colour reaction was observed within two
hours and an estimate of the concentration of DNA labelled probe was made by
comparison with the lambda standards.
2.8.3 FISH on two-dimensional MAA-fixed nuclei
2.8.3.1 Slide preparation
Glass slides were stored in a dilute solution of HC1 in ethanol. Immediately prior to slide
making, slides were dried and polished with muslin. Methanol:acetic acid (MAA) fixed
cells (section 2.8.1.1) were removed from storage at -20°C, left to warm to room
temperature for 30 minutes and centrifuged at 400g for 5 minutes. Fresh MAA fix was
added until the cell suspension reached a 'milky' appearance. A single drop of cell
suspension from a fine-tipped pastette was dropped onto a horizontal microscope slide
from a height of ~30cm. The spread of cells on the slide was improved by coating the
slide with a thin layer of moisture, usually by breathing. An air humidity of -50% also
aided spreading. Spreading was monitored by phase contrast microscopy. Slides were
stored for two to six days prior to hybridisation. When fixed material had a high level of




MAA nucleus preparations may not hybridise with a high efficiency after the 2D FISH
protocol if they still have cytoplasm attached. To increase the efficiency of
hybridisation, these slides were treated with pepsin. Slides were dehydrated in acetone
for 5 minutes then air dried. RNase treatment was then carried out as in section 2.8.3.3.
43pl of 11M HC1 were added to 50ml of dH20 and pre-heated to 37°C, then 125pi of
2% pepsin were added and the slides incubated for three minutes before washing in PBS
with 50mM MgCh. Slides were subsequently dehydrated through an ethanol series and
hybridisation was carried out as described in section 2.8.3.3.
2.8.3.3 Hybridisation
Slides were mounted vertically in a metal rack and subsequent incubations carried out in
200ml glass troughs. Slides were first treated with lOOpg/ml RNase A in 2x SSC for one
hour at 37°C, washed briefly in 2x SSC and dehydrated through an ethanol series (two
minutes each in 70%, 90% and 100% ethanol). The slides were left to air dry for 10
minutes before being heated in a 70°C oven for 5 minutes and immediately denatured in
70% formamide, 2x SSC pH7.5 at 70°C for 90 seconds, or 75 seconds for hES cells.
After passing through 70% ethanol at 4°C and an ethanol series (as above), the slides
were again air dried.
Probes were prepared at the same time as slides. Labelled DNA (section 2.8.2) (200ng
human chromosome paint, 70ng BAC or plasmid per slide) suspended in TE, was
precipitated with 5 pg salmon sperm DNA and mouse or human Cot 1 DNA (Invitrogen)
as a competitor (the amount of which varied from 5 to 50pg, depending on the potential
repeat content of the probe). After the addition of 2 volumes of ethanol, probes were
spun down under vacuum until they had precipitated, and re-suspended in lOpl
hybridisation mix (50% deionised formamide v/v, 10% dextran sulphate v/v, and 1%
Tween 20 v/v in 2x SSC). Commercial probes (Cambio) were usually provided in or
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with hybridisation buffer and did not require addition of salmon sperm DNA or Cot 1
DNA. All probes were denatured at 70°C for 5 minutes and reannealed at 37°C for 15
minutes before spotting onto pre-cleaned coverslips. The denatured slides were carefully
laid onto the appropriate coverslip and sealed with rubber solution (Tip Top) before
placing in a metal tray in a 37°C water bath overnight.
2.8.3.4 Washing and detection
Slides were washed in glass racks in 200ml troughs. After removal of the rubber
solution, they were immersed in 2x SSC at 45°C for three minutes, with gentle agitation
to facilitate detachment of the coverslips. Slides were washed a further three times in the
same buffer then four times for three minutes in 0.1 x SSC at 60°C before transferring to
4x SSC/0.1% Tween 20. Detection was carried out in a moist chamber preheated to
37°C. Biotin was detected with sequential layers of fluorochrome-conjugated avidin
(FITC or TxRd, Vector Laboratories), biotinylated anti-avidin (Vector Laboratories),
and a further layer of fluorochrome-conjugated avidin. Digoxigenin labelled probes were
detected with sequential layers of FITC- (BCL) or Rhodamine-conjugated anti-
digoxigenin and FITC- or TR-conjugated anti-sheep antibodies (Vector Laboratories).
Detection reagents were diluted in SSCM (4x SSC, 5% marvel dried skimmed milk w/v)
to the appropriate concentration (table 2.10). After incubation with 40pl SSCM for 5
minutes at room temperature, 40pl of the appropriate detection layer were applied to the
slide on a 22mm by 40mm coverslip. Slides were incubated in the moist chamber at
37°C for 45 minutes, followed by 3 washes of 2 minutes in 4x SSC/0.1% Tween 20 at
37°C.
All slides were mounted with 0.5pg/ml DAPI, in Vectashield (Vector). Coverslips were








Avidin-FITC Goat Vector 2.0 1:500
Avidin-TxRd Goat Vector 2.0 1:500
Biotinylated anti-avidin Goat Vector 0.5 1:100
Rhodamine-anti-digoxigenin Sheep Roche 0.2 1:20
TxRd-anti-sheep Rabbit Vector 0.5 1:100
Table 2.10 Antibodies and fluorochrome-conjugates used for FISH.
2.8.4 FISH on three-dimensionally preserved nuclei
This method was used to maintain the three-dimensional architecture of nuclei (Kurz et
al., 1996; Croft et al., 1999) through the process of FISH. Cells were grown and fixed on
slides as described in section 2.8.1.2. Slides were washed for 30 minutes at least twice
with PBS then incubated in 2x SSC (300mM NaCl, 30mM tri-sodium citrate, pH7.4)
containing 1 OOug/ml RNase A for 1 hour at 37°C. Following this, slides were returned
briefly to PBS and then placed in 0.1M HC1 in dH20 for 7 minutes before being returned
to PBS again. Slides were then denatured in 70% formamide, 2x SSC (pH7.0) for 3
minutes then 50% formamide, 2x SSC (pH7.0) for 1 minute, both at 78°C. Probes were
applied immediately after the second formamide incubation. The probes were prepared,
hybridised and detected as described in 2.8.3.3 and 2.8.3.4. When chromosome paints
were used in conjunction with BAC probes, chromosome domains were always detected
using FITC-conjugated secondary antibodies and BAC probes using TR-conjugated
secondary antibodies (table 2.10).
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2.8.5 ImmunoFISH
Cells were fixed as for 3D FISH (section 2.8.1.2) the slides were incubated in block (5%
serum/PBS) for 20 minutes at room temperature and the primary antibody was added
overnight as for immunofluorescence (section 2.6.1). Then the 3D FISH protocol was
carried out (section2.8.4), the slides washed once in PBS and the secondary antibody for
the immunofluorescence was added for one hour at room temperature. Slides were
washes three times in PBS and mounted with DAPI in Vectashield (Vector), at a
concentration of lpg/ml for human and O.Spg/ml for mouse. Coverslips were sealed
with rubber solution (Pang) and slides were stored in the dark at 4UC.
2.8.6 PNA FISH
3D telomere FISH was carried out to the manufacturers' instructions using a PNA FISH
kit (DAKO) on cells fixed in 3.7% formaldehyde.
2.9 Image capture and analysis
2.9.1 Capture and analysis of 2D images
Brightfield images of cells were taken using differential interface contrast (DIC) optics
with a Photometries CoolSnap HQ monochrome CCD camera (Roper Scientific,
Arizona). EPLab Spectrum (Scanalytics Inc., VA) wrote the image capture scripts that
controlled camera capture. After FISH or immunofluorescence, 2D slides were
examined using a Zeiss Axioplan fluorescence microscope with a 100 Watt mercury
bulb and triple band-pass filter (Chroma #83000), using xlO, x20 and x40 objectives.
Grey scale images for each fluorochrome were captured with a cooled CCD camera
(Princeton Instruments Pentamax) and analysed using custom IPLab v3.6 scripts.
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For 2D analysis 50 bin 2 images were collected of consecutive nuclei that fulfilled the
following criteria: nuclei had to be intact and, when involving chromosome territories
(CTs), contain two chromosome domains in which locus signals (if present) were
visible; in addition, some analysis scripts required images of single nuclei not touching
any other nuclei.
The radial distribution of CTs was determined using an erosion script, adapted from that
previously described by Croft et al., (1999). Nuclei were segmented using a histogram of
the image data. The valley between background and foreground peaks represented the
nuclear periphery and the value at the bottom of this valley was set as the threshold
value for segmenting nuclei. Mouse nuclei and human ES cell nuclei are particularly
difficult to segment because of the wide variations in DAPI staining across the nucleus.
The script then removed the background fluorescence by calculating the most frequent
pixel value in the area outside the nucleus and subtracting this value across the whole
image. The area and the sum of all pixels were measured for the segmented area. This
was then eroded into five shells of equal area and the overlay transferred to both FITC
and TxRd images. The fluorescence in each of the five shells was calculated for both
FITC and TxRd images and normalised to the DAPI intensity.
Analysis of probe position relative to the surface of CTs was as previously described
(Mahy et al., 2002a; Chambeyron and Bickmore, 2004). Briefly, the background was
removed from the image, and the outline of the CT and the probe segmented. The
distance between the centre of the CT and the probe was then calculated. A two tailed t-
test was used to test the significance of this data.
2.9.2 Capture and analysis of 3D images
For 3D analysis, z-stacks of up to three colour images (DAPI, FITC and TxRd) were
captured using an Axioplan microscope fitted with a 100 Watt mercury bulb, Ludl filter
wheel, Chroma filter set #81000 and motorised stage, attached to a cooled CCD (Xillig
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CCD camera) Kodak KAF 1401e sensor camera (Princeton Instruments). A script was
devised (P. Perry) using IPLab software to capture bin 2 resolution images, the DAPI
excitation filter was selected, as was a region of interest for capture. The number of
optical slices to be collected, the z distance between each optical slice and the exposure
times for each fluorochrome signal (from an automatic test capture in the plane of best
focus) were also determined. The microscope focus motor then moves the stage
downward for half the total depth of the focus series to the starting point for capture. To
compensate for backlash in the focus mechanism, the stage was moved downwards a
further 200pm, followed by an upward movement of the same distance. Image capture
started, collecting the specified DAPI, FITC or TxRd images at each focal plane and
placing each into a stack file, then moving the stage upwards the specified z distance
before repeating the same capture sequence. After the final plane was captured, the stage
returned to the original "best focus" focal plane. The stack files were then merged to
provide a colour stack file that can be animated or projected. For each nucleus, 25-30 bin
2 image planes were captured at 0.25-0.5pm intervals in the z-plane, so as to include the
whole nucleus in the image stack. The image stack was then deconvolved to remove
excessive background fluorescence using Flazebuster (Vaytek, Inc) and analysed in
IPLab.
CT positions in 3D were determined as previously described by Bridger et al., (2000).
The distances between the centre of the CT and the nuclear periphery were measured in
x, y and z-planes and expressed as proportions of the radius. The 3D analysis of
centromeres, telomeres and PML bodies in the z-plane was performed using a custom
IPLab script. Briefly, the script defines the outline of the DAPI nucleus in each frame of
the z-stack, calculates the highest level of intensity for each fluorescent spot and locates
which frame the spot is positioned in the z-plane. This was carried out for n=25 nuclei.
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2.10 Statistical analysis
Differences in the radial position of CTs, the distances between BAC probes and
centromere analysis were tested for statistical significance using a Mann-Whitney U test
in Minitab 13 (Minitab Inc.). This is the nonparametric equivalent of a t-test, as it tests
the hypothesis that two groups come from the same distribution without assuming that
the data are normally distributed.
A two tailed T-test was used for BAC to CT analysis. This is a parametric test to
determine whether the distributions of two normally distributed populations are
significantly different. The other parametric test used in this thesis is one-way analysis
of variance (ANOVA), which again tests whether two or more normally distributed data
sets have the same mean.
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Chapter 3: Nuclear Organisation in
Human Embryonic Stem Cells
Chapter 3
Nuclear Organisation in Human Embryonic Stem Cells
3.1 Introduction
Within the nucleus of a differentiated cell, the human genome has a defined spatial
organisation. In many differentiated cells, chromosome territories (CTs) adopt a radial
organisation according to gene-density, with gene-rich chromosomes situated towards
the centre of the nucleus and gene-poor chromosomes located closer to the nuclear
periphery (Croft et al., 1999; Boyle et al., 2001; Cremer et al., 2001; Cremer et al.,
2003). Alternatively, Bolzer et al., (2005) reported a size-related chromosome
organisation, in the nuclei of fibroblasts and amniotic fluid cells. Individual genes and
chromosome domains also occupy distinct locations, both within the nucleus and with
respect to their CTs (Zink et al., 2004; Volpi et al., 2000; Williams et al., 2002; Mahy et
al., 2002a). Non-coding regions such as centromeres are located near to the nuclear
periphery or, for the acrocentric chromosomes containing rDNA genes (chromosomes
13, 14, 15, 21 and 22), cluster around the nucleolus (Manuelidis 1990; Carvalho et al.,
2001; Weierich et al., 2003; Gilchrist et al., 2004), whereas telomeres have a more
internal localisation (Weierich et al., 2003).
If spatial organisation of the genome reflects gene expression, as is believed for model
organisms (Spector 2003), you would expect to see differences amongst cell types. In
humans, there is a conserved radial organisation for all chromosomes with one noted
exception. The gene-poor HSA18 is located nearer to the centre of the nucleus in the flat
86
ellipsoidal nuclei of amniocytes and fibroblast, rather than at the periphery as is
characteristic of cells with spherical nuclei (Cremer et ah, 2001, Cremer et ah, 2003;
Bolzer et ah, 2005). The Misteli lab recently reported differences in chromosome
positioning in the mouse, both between various tissues (Parada et ah, 2004) and during T
cell differentiation (Kim et ah, 2004). However, there are no reports of significant
changes in the radial organisation of chromosomes during differentiation of human cells,
to date only differences in chromosome associations have been described (Kuroda et ah,
2004a). Previous studies have focused on the spatial arrangement of chromosomes and
centromeres in haemopoietic progenitor cells (Cremer et ah, 2003) and CD34+ stem cells
from cord blood (Alcobia et ah, 2003). It is therefore important to determine the nuclear
organisation of uncommitted stem cells (Fisher and Merkenschlager, 2002).
In this chapter, I describe the nuclear organisation of hES cells in comparison to that of
differentiated cell types. I show that already established in the nuclei of hES cells is the
radial organisation of chromosomes related to gene density. However, I report
differences in the location of chromosomes and genes with known roles in pluripotency
and describe a more centralised distribution of centromeres within hES cell nuclei.
3.2 The radial organisation of HSA18 and 19 in hES cells
I started investigating the nuclear organisation of hES cells with FISH for HSA18 and
19. These were the first chromosomes used by Croft et al., (1999) to describe the radial
organisation of CTs. HSA18 and 19 are a similar physical size being 76 and 63 Mbp
respectively, although they have different gene densities and functional characteristics.
HSA18 is gene-poor with -449 genes while HSA19 is gene-rich at -1528 genes
(http://www.ensembl.org/Homo_sapiens/). When visualised by FISH in a variety of
differentiated cells, HSA18 is located towards the nuclear periphery and HSA19 situated
closer to the nuclear centre (Croft et al., 1999; Cremer 2003). This radial organisation is
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applicable to all human chromosomes (Cremer et ah, 2001; Boyle et ah, 2001),
conserved in higher primates (Tanabe et ah, 2002) and chickens (Stadler et ah, 2004).
I investigated the position of HSA18 and 19 first in 2D, on 3:1 methanol:acetic acid
fixed nuclei from the Wisconsin hES cell lines, HI (XY) and H9 (XX) (Thomson et ah,
1998). Fixing the nuclei in this way flattens the nuclear morphology, but does not alter
the organisation of the CTs and allows for large numbers of nuclei to be analysed (Croft
et ah, 1999). W. Cui of the Roslin Institute cultured the cells on matrigel coated culture
dishes and described the cell populations using flow cytometry with the cell surface
antigens SSEA4 and Tra-1-60 (figure 3.1). The HI hES cells were 70% SSEA4 positive,
55% Tra-1-60 positive, confirming that the majority of the cells were undifferentiated
(Draper et ah, 2002; Carpenter et ah, 2004). I prepared chromosome paints for HSA18
and 19, and carried out 2D FISH on both HI and H9 hES cells. Fifty images of nuclei
taken from each cell line were analysed through a 2D erosion script, previously
described in Croft et ah, (1999). Briefly, the script divides each nucleus into five shells
of equal area and measures the amount of fluorescence in each of the segments. This
was normalised to the amount of total DNA present in each shell (figure 3.2). In both
hES cell lines, HSA19 was centrally localised in comparison to HSA18 (p<0.001).
In many circumstances, 2D analysis is representative of the 3D nuclear organisation.
However, when CTs are located in the centre of the nucleus by the erosion script this
could be due to a peripheral localisation of the CT at the top of the nucleus flatted by the
2D fixation. Therefore, I carried out FISH on HI hES cells fixed in 4%
paraformaldehyde for 3D analysis. The nuclei were photographed at 0.25pm intervals
through the z-plane and the distance measured from the centre of the CT to the edge of
the nucleus in x, y and z-planes. 3D analysis confirmed the result previously described in
2D, showing that HSA19 was located near to the centre of the nucleus and HSA18 was
towards the nuclear periphery (figure 3.3). HSA19 was significantly more central than




Fig. 3.1 Markers of pluripotency in hES cells. H9 hES cells with an OCT4-
GFP transgene stained for cell surface antigens SSEA4 and Tra-1-60. Taken
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Fig. 3.2 The radial distribution of HSA18 and 19 in hES cells. (A) hES cell
nuclei, counterstained with DAPI (blue) and hybridised with chromosome paints
for HSA18, 19 or both. The bottom right hand image shows the nucleus divided
into five shells of equal area by the erosion script. Green, biotin labelled paint
detected with avidin-FITC. Red, dig-labelled paint detected with a TxRd anti-
sheep. (B) Distribution of HSA18 and 19 hybridisation signals within the nucleus
of H9 and H1 hES cells analysed by erosion of 2D images into five concentric
shells from the edge (1) to the centre (5) of the nucleus. The mean (±s.e.m.)
proportion of hybridisation signal, normalised to the amount of DAPI signal, is
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Fig. 3.3 The 3D localisation of HSA18 and 19 in hES cells. 3D FISH with
biotin labelled paints for (A) HSA18 and (B) HSA19, detected with avidin-FITC
(green). Images show single frames taken at 0.5pm intervals through the z-
axis of H1 hES cell nuclei, counterstained with DAPI (blue). (C) Orientation of
a cell nucleus within a z-stack. (D) Graph showing the distribution of the centres
of HSA18 (black) and 19 (red) CTs, along the x, y and z-axis of 3D preserved
H1 hES cell nuclei. The axis show the fractional distance between the nuclear
periphery (0) and the centre of the nucleus (1) (n=20). (E) Analysis of HSA18
and 19 hybridisation signals within 3D-preserved H1 hES cell nuclei. Graphs
are the distributions of the centres of HSA18 and 19 territories, along the
fractional radius of each nucleus, in x, y and z-planes (n=20). Scale bar, 10pm.
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distributions in the z-plane (p=0.68). I therefore conclude that a gene density related
radial distribution ofHSA18 and 19 CTs is present in hES cells.
3.3 Distribution of chromosomes 12p and 6p in hES cells
To investigate if there was a change in the position of CTs specific to hES cells, I
analysed two CTs that contain genes important for pluripotency. OCT4 (Pou5Fl), a
transcription factor essential for maintaining the undifferentiated state of hES cells
(Matin et ah, 2004), is located on IISA6p21.33 within the non-class I genes of the MHC
class I region {figure 3.4A). NANOG, another transcription factor required to maintain
the undifferentiated phenotype of ES cells (Zaehres et al., 2005) is located on
HSA12p 13.31, in a cluster of genes containing GDF3 and STELLA, which are also down
regulated upon differentiation {figure 3.4B; Clark et al., 2004). I carried out 2D FISH
with chromosome paints for 6p or 12p together with BACs containing OCT4 or
NANOG, on hES cells and an LCL {figure 3.5A). Using the erosion script used in the
analysis of HSA18 and 19 {figure 3.2), the radial positions of these CTs were
established. In the LCL, 6p and 12p have distributions intermediate to those of HSA18
and 19, i.e. not at the nuclear periphery, or the nuclear centre, which is consistent with
their gene density. A result confirmed by previous analysis in LCLs and fibroblasts
(Boyle et al., 2001). In hES cells the localisation of HSA6p was analysed and found to
be the same as in the LCL. However, HSA12p had a different localisation in the nuclei
of hES cells and LCLs {figure 3.5B). In hES cells 12p occupied a significantly more
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Fig. 3.4 The genomic regions surrounding OCT4 and NANOG in humans.
Green boxes show the positions of (A) FLOT1, OCT4 (POU5f1) and MICB on
HSA6, and (B) NANOG on HSA12. Red boxes show the positions of the BACs
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Fig. 3.5 Radial distribution of 6p, 12p, OCT4 and NANOG in LCLs and hES
cells. (A) 2D FISH with BAC probes containing either OCT4 or NANOG (red),
and chromosome paints for 6p or 12p (green), within interphase nuclei of hES
counterstained with DAPI (blue). (B) Distribution of HSA6p or 12p hybridisation
signals within the nucleus of LCLs and hES cells, by erosion of 2D images into
five shells of equal area from the edge (1) to the centre (5) of the nucleus. The
mean hybridisation signal normalised to the DAPI signal (± s.e.m.) is shown
for each shell (n=50). (C) Distribution of signals from OCT4 or NANOG containing
BACs within the nucleus of LCLs and hES cells, by erosion of 2D images into
five shells of equal area. The number of probe signals in each shell was counted
and the proportion of probe normalised to the amount of DAPI signal, is shown
for each shell (/?=50). Scale bar, 5pm.
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3.4 Gene position in the hES cell nucleus
If the position of a CT differs between undifferentiated and differentiated cells, then it is
possible that the genes on these chromosomes will also change radial positions to follow
their host chromosome. I investigated the position of both OCT4 and NANOG, using the
erosion script to segment the nuclei and manually counting the number of BAC signals
in each shell (figure 3.5). Consistent with the CT HSA6p result, the position of OCT4 in
the nucleus did not change between the two differentiation states. However, the position
ofNANOG was more peripheral in the differentiated LCL compared to the hES cells.
This result agrees with the findings of Zink et al., (2004), who show that within the
nucleus, the location of genes varies among cell types in a transcription dependent
manner and that some genes move away from the nuclear periphery when they are
active. In the mouse, Hox genes that are induced upon the differentiation of ES cells are
also shown to move towards the nuclear interior (Chambeyron and Bickmore, 2004).
However, in this case it was not accompanied by any change in radial position of their
host chromosome (Bickmore et al., 2004). Instead, this relocalisation accompanied the
movement of a gene out of its CT.
Similarly, alterations in the position of gene-dense regions of the genome, relative to
their CTs occur in different somatic cell types (Volpi et al., 2000; Williams et al., 2002).
This change in gene position relative to CT occurs during the differentiation of mES
cells with RA (Chambeyron and Bickmore, 2004), but there is no previous study of the
nuclear localisation of genes in hES cells. With this in mind, I began to look at the
relationship between gene rich regions of the human genome and their host CTs. The
telomeric end ofHSAllp is one of the most gene-dense regions of the human genome.
The genes are functionally unrelated and not co-ordinately expressed. However, this
region loops out of its CT in lymphoblasts and fibroblasts (Mahy et al., 2002a). 1 lp 13
contains genes such as RCN, a housekeeping gene, which is active from within the CT.
In contrast, genes such as IFITM3 (involved in early germ cell development) located at
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the distal region of lip (1 lpl5.5) loop out of their CT. To investigate if this looping
occurs in hES cells, I carried out 2D FISH with three cosmids containing the genes RCN,
INS and IFITM3 labelled in dig-dUTP, alongside a biotin labelled HSA1 lp chromosome
paint {figure 3.6A). The script described previously by Mahy et ah, (2002a) measured
the distance between each cosmid and the edge of the lip CT. The nuclear organisation
of this region previously observed for somatic cells was also present in hES cells {figure
3.6B). The centromeric RCN loci, expressed in both LCLs (Mahy et ah, 2002b) and hES
cells (Ramalho-Santos et ah, 2002) but located within the low gene density region 1 lpl3
(32Mb), was within the 1 lp CT. In contrast the INS and IFITM3 genes at the gene-dense
telomeric end, 1 lpl 5.5 (positions 0.25-2.1 Mb, NCB1 build 35,
http://www.ensembl.org/Homo_sapiens), looped out of the CT in hES cells, even though
this region does not contain genes with a known role in pluripotent cells. Distances
relative to the edge of the CT are shown in table 3.1 on page 99.
I then investigated CT organisation for loci expressed specifically in pluripotent cells.
Two regions significant to stem cell function were used, the MHC class I region on
HSA6p which contains the non-class I gene OCT4, and the cluster of pluripotency genes
on HSA12p containing the transcription factor NANOG. In the LCL, the class I genes of
the MHC are constitutively expressed. Similarly, hES cells also express the MHC class I
genes along with OCT4 (Drukker et ah, 2002; Draper et al., 2002; Carpenter et ah,
2004). Chromosome paints for HSA6p and HSA12p labelled with biotin, and their
corresponding BACs labelled with dig-dUTP, were hybridised to LCL and hES cell
nuclei. Previous reports have shown the class I and class III regions of the MHC outside
the HSA6p CT in lymphocytes (Volpi et ah, 2000). I confirmed this using the two alleles
either side of OCT4, FLOT1 on the class I side and MICE on the centromeric side
nearest the class III genes {figure 3.7A). These two genes located on average, outside the
CT in hES cells and an LCL {table 3.1). However, in the LCL, OCT4 relocated with
respect to its CT in comparison to hES cells {table 3.1 and figure 3.7). When expressed
in hES cells, OCT4 was located on average outside of the 6p CT. In the LCL that does
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Fig. 3.6 Intrachromosome territory organisation of HSA11p in hES cells.
(A) Interphase hybridisation of cosmid probes containing IFITM3, INS or RCN
(red), and chromosome paint for HSA11 p (green), within the nuclei of hES cells
counterstained with DAPI (blue). (B) Histogram of the distribution of FISH signals
from cosmids containing IFITM3 (black), INS (white) or RCN (hatched), relative
to the edge of the chromosome 11 p CT, in the nuclei of hES cells. Negative
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Fig. 3.7 Intrachromosome territory organisation of NANOG and OCT4. (A)
Position relative to their CT, of OCT4 and two flanking loci on HSA6p and
NANOG on HSA12p, in the nuclei of hES and LCLs (r?=100). Negative values
indicate localisation outside the CT. Map of genomic regions around OCT4 and
NANOG (NCBI build 35) is shown below, with genes present in the BACs used,
highlighted in bold. (B) Distribution of a BAC containing OCT4 relative to the
HSA6p CT, in nuclei from hES cells and LCLs. Negative distances indicate
localisation outside of the CT (n=100).
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statically significant (p=0.041). Closer inspection of the data (figure 3.7B) showed that
the movement of OCT4 into the 6p CT was not due to a change in the proportion of loci
found far outside the CT (>0.2pm) which remained at 36% for both LCLs and hES cells.
The change was in the number of loci found deep within the CT (>0.6pm), and in
consequence the increased number of loci found at the edge of the CT. In contrast to
OCT4, NANOG occupied a location just within the HSA12p territory in both hES cells
and LCLs (p=0.12, figure 3.7A).
Locus Cytogenetic Genomic Probe name Position relative to CT
position position (Mb) edge
LCL (pm) hES (pm)
IFITM3 1 lpl5.5 0.2 D11S483 -1.4±0.3 -0.70±1.13
INS 1 lpl5.5 2.1 CINS/IGF2 -0.6±0.2 -0.55±0.15
RCN 1 lpl3 32.0 cHl1148 0.6±0.2 0.26±0.04
NANOG 12p 13.31 7.8 RP11-358117 0.23±0.06 0.32±0.04
FLOT1 6p21.33 30.8 RP11-324F19 -0.07±0.07 -0.11±0.08
OCT4 6p21.33 31.2 RP11-1058J10 0.03±0.06 -0.15±0.09
MICE 6p21.33 31.6 RP11-184F16 -0.25±0.09 -0.31±0.16
Table 3.1 Intra-CT position of loci in hES cells and LCLs. Cytogenetic and genomic
positions (from NCBI build 35, http://www.ensembl.org/Homo_sapiens) of each locus,
together with the name of the cosmid or BAC used in FISH. Mean (±s.e.m.) position, in
pm, of loci relative to the edge of the CTs in hES and LCL nuclei. Negative values
indicate the positions outside the visible limits of the CT. LCL data for 1 lpl 5.5 loci is
taken from Mahy et al., (2002a).
The movement of loci with respect to their CTs has previously been associated with
changes in condensation of the chromatin fibre (Chambeyron and Bickmore, 2004). To
investigate this in the OCT4 region, I carried out FISH with OCT4 and the two flanking
BAC clones in hES cells and the LCL figure 3.8A). The interphase distance (d) was
measure between OCT4 and the FLOT1 or MICE BACs. These distances always
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Fig. 3.8 Chromatin decondensation of the OCT4 region in hES and
differentiated cells. (A) 2D FISH with BAC probes containing OCT4 (green)
and FLOT1 (red), within the interphase nuclei of H9 hES cells and a LCL,
counterstained with DAPI (blue). (B) The distribution of squared interphase
distances (d2) in pm2 measured between probes for OCT4 and FLOT1 or MICB,
in the nuclei of hES cells and a LCL (n=100). Numbers show the mean d2 value
(±s.e.m). Scale bar, 10pm.
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structure (s.d. = 0.52-0.6; median/mean -1.0) (Sachs et al., 1995; Chambeyron and
Bickmore, 2004). The mean-squared interphase distance (<d >) between OCT4 and
MICB BACs (genomic distance, 350kb) was not significantly different between hES
cells and the LCL (<d2>=0.5±0.06 and 0.41±0.04pm2 respectively, p=0.41 \ figure 3.8B).
However, there was a significant increase in the distance between OCT4 and FLOT1
(genomic distance, 400kb) in the LCL compared to hES cells (<d2>=0.33±0.04 and
0.24±0.03pm2 respectively, p=0.04). The large d2 values measured around OCT4 in both
cell types is consistent with the gene being in an area of open chromatin, as apposed to a
compact chromatin fibre (Gilbert et al., 2004). These results suggest a difference not
only in the localisation of OCT4 in respect to its CT but in the chromatin configuration
of the OCT4 region between undifferentiated and differentiated cell types.
3.5 Position of centromeres and PML bodies during differentiation
I have shown specific organisation of chromosomes and genes involved in maintaining
pluripotency in hES cells. To investigate whether this defined organisation extends to
the non-coding regions of the genome, I analysed the number and position of centromere
clusters in hES cells. The position of centromeric heterochromatin in somatic cells has
been associated with gene silencing in mouse (Brown et al., 1997). In both mouse and
human cells, centromeres are generally located at the nuclear periphery or the nucleolus
(Carvalho et al., 2001; Weierich et al., 2003). However, centromere position is specific
to cell type and changes during the cell cycle, through differentiation or with cellular
transformations (Beil et al., 2002, Shelby et al., 1996, Vourc'h et al., 1993, Manuelidis
1984). Centromeres also associate in lineage specific clusters known as chromocentres,
which accompany transcriptional silencing. This centromere clustering increases during
differentiation down lymphoid and myeloid lineages, accompanying the commitment of
a cell to a lineage (Beil et al., 2002; Alcobia et al., 2003).
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To study this clustering in human cells, I first visualised centromeres in primary
fibroblasts by FISH with an alpha satellite repeat probe p82h (Mitchell et ah, 1985), and
by immunofluorescence with CREST anti serum (Cummings; Moroi et ah, 1980) and an
antibody to the centromeric protein CENP-C (Earnshaw and Rothfield, 1985). The
CENP-C and CREST antisera detected the same number of centromeres, although the
CREST serum identified more than one signal at the centromere of some chromosomes.
This was due to the serum detecting the presence of other centromeric proteins, such as
CENP-A (Gilbert personal communication). The FISH with p82h did not detect as many
centromeres. Therefore, I continued the analysis with the CENP-C antibody {figure
3.9A). I compared the number of centromeres visualised in H7 hES cells (mean=34),
with the number detected in proliferating primary fibroblasts (mean=38), ritva (hTERT
transformed fibroblasts, mean=37), quiescent fibroblasts (serum starved for 7 days,
mean=40) and a LCL (mean=36) (n-20). There was no significant difference in the
extent of centromere clustering observed between the hES cells and any of the
differentiated cell lines. Therefore, centromere clustering may be restricted to
haematopoietic lineages in human cells.
I also investigated the number ofpromyelocytic leukaemia (PML) bodies in the nuclei of
human cells by immunofluorescence with a 5E10 antibody, which recognises the PML
protein (Stuurman et al., 1992; figure 3.9B). PML bodies have been implicated in many
cell processes, from transcription regulation to apoptosis, DNA damage response and
stress sensing (Dellaire and Bazett-Jones, 2004). The number of PML bodies changed
significantly between cell types, with the average number in hES cells (11) lower than in
LCLs (15), ritva (15), fibroblasts (27) or quiescent fibroblasts (27). A trend, which may
indicate an increase in the presence of PML bodies towards the later stages of
differentiation.
The position of PML bodies in the nucleus is not extensively studied, but
transcriptionally active parts of the genome including the MHC on HSA6p, have been
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Fig. 3.9 Clustering of centromeres and PML bodies in human cells. (A)
The number of chromocentres counted in proliferating primary fibroblasts,
quiescent fibroblasts, ritva, a LCL and the H7 hES cell line, after
immunofluorescence with a CENP-C antibody. (B) The number of PML bodies
counted in proliferating primary fibroblasts, quiescent fibroblasts, ritva, a LCL
and the H7 hES cell line, after immunofluorescence with a 5E10 antibody
(n=20).
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of the genome suggests that PML bodies would be present towards the centre of the
nucleus, in contrast to the transcriptionally silent centromeric regions, which are known
be located at the nuclear periphery. To confirm this, I localised the 3D position of
centromeres (CENP-C) and PML bodies (5E10) by immunofluorescence in the nuclei of
fibroblasts and H7 hES cells, relative to the nearest nuclear periphery {figure 3.10). This
provided two obstacles in terms of analysis. Firstly, the nuclear periphery was difficult
to define accurately. I visualise the nucleus with DAPI using a conventional
fluorescence microscope, which gives a blurred edge to the nucleus as it comes in and
out of focus. I could eliminate this to some extent by using a confocal microscope, and
outlining the nucleus with an antibody to one of the nuclear membrane proteins, such as
lamin A/C. However, in hES cells there is no expression of lamin A/C (Constantinescu
et al., 2006). Lamins B1 and B2 are only dimly expressed and little known about the
other nuclear membrane proteins. The second obstacle was that within a population of
cells the nuclei are all different sizes, and here the two cell types for comparison are
different morphologies. I attempted to overcome this problem by comparing each
nucleus to a sphere of the same volume, and then plotting the distance between the
object and the edge of the nucleus as a proportion of the volume (i.e. the cube root of (3
x volumeAfrr)).
Images taken at 0.25pm intervals throughout the z-axis of the nucleus (figure 3.3C) had
the outline of the DAPI nucleus segmented from the background. Centromere and PML
body positions were then calculated using the coordinates of the highest fluorescence
intensity for each fluorescent spot in the x, y and z planes and the distance to the nearest
nuclear edge was measured. This was then normalised to a sphere of the same volume as
the nucleus and the distance between the fluorescent spot and the nearest nuclear edge
plotted as a fraction of the radius. In fibroblasts, PML bodies and centromeres were
localised to different parts of the nucleus. PML bodies were localised towards the centre
of the nucleus, whereas centromeres had a more peripheral localisation. This showed the
central localisation of the PML bodies in comparison to the centromeres relative to the
























Fig. 3.10 Centromere and PML body distribution from the nearest edge of
the nucleus. The mean distance (±s.e.m.) from centromeres (CENP-C) and
PML bodies (5E10) to the nearest nuclear periphery, normalised to the volume
of the nucleus in (A) fibroblasts and (B) H7 hES cells. (C) A comparison of the
distribution of centromeres to the nearest nuclear edge, normalised to nuclear
volume, in nuclei from fibroblasts and H7 hES cells {n=20).
105
p<0.006; figure 3.1 OA). In hES cells PML bodies were also distributed towards the
nuclear centre {figure 3.1OB), but in these cells the distribution of centromeres and PML
bodies was the same as each other (0.5, p=0.994). A significantly more central
localisation was observed for centromeres in hES cells than in fibroblasts (0.5, p<0.001;
figure 3.10C). However, this method of normalising the data to nuclear volume,
assumed that nuclear morphology was not important for spatial organisation.
The above analysis suggested that the location of centromeres in the nucleus is different
in hES cells and fibroblasts. To investigate this further in a way that does not need a
defined nuclear periphery, or that does not make any assumptions about the shape of the
nucleus, the position of centromeres and PML bodies were analysed throughout the z-
axis of nuclei. Images taken at 0.25 pm intervals along the z-axis, had the DAPI nucleus
segmented. The positions of centromeres and PML bodies were then calculated in the z-
plane, using the coordinates of the highest fluorescence intensity for each fluorescent
spot. I calculated the average distribution by dividing each nucleus into ten equal
distances in the z-plane (n=20, figure 3.11). The position of PML bodies was
investigated in proliferating fibroblasts, Ritva telomerase immortalised fibroblasts,
quiescent fibroblasts, a LCL and H7 hES cell nuclei. Despite differences in abundance,
in all these cell-lines PML bodies displayed a centralised localisation in the z-plane
(figure 3.11).
Centromeres however, display a bi-modal distribution toward the nuclear periphery in
primary fibroblasts and Ritva. So due to the flat nuclei of these cells, the graphs depict a
peak of centromeres at the top surface of the nucleus, less centromeres in the middle and
another peak at the bottom of the nucleus. Quiescent fibroblasts have a disrupted
distribution, with less centromeres present towards the top of the nucleus, suggesting
that centromere arrangement relates to cell cycle as was previously shown by Weimer et
ah, (1992). In hES cells and LCLs, centromeres have a normal distribution along the z-
axis, which may reflect the position of the nucleolus and therefore the position of the
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Fig. 3.11 Centromere and PML body localisation in human cells. (A)
Localisation of centromeres (CENP-C, green), and PML bodies (5E10, red) in
H7 hES, LCL, fibroblast, quiescent fibroblast and ritva cell nuclei counterstained
with DAPI (blue). The mean (±s.e.m.) distribution of (B) centromeres and (C)
PML bodies through the z-plane from top (0) to bottom (1) of nuclei from H7
hES, LCL, fibroblasts, quiescent fibroblasts and ritva cells (n=20). Scale bar,
5pm.
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effects that cytospinning may have on these cell types, this experiment was repeated on
proliferating fibroblasts that had been cytospun onto slides. In comparison to the
proliferating fibroblasts grown on slides, no difference was observed in the position of
centromeres relative to the nuclear periphery in the cytospun nuclei.
To investigate whether the increase of centromeres in the centre of the z-axis in hES cell
nuclei was due to an increase of centromeres at the nucleolus, I stained fibroblast, LCL
and hES cell nuclei with an antibody to the Ki67 antigen (pKi67) to detect the nucleoli
(Verheijen et al., 1989), and CREST serum to identify the centromeres (figure 3.12A).
The number of centromeres present at the nucleolus, nuclear periphery and not
associated with either were counted (figure 3.12B). The number of centromeres present
at the nucleolus of fibroblasts, a LCL and hES cells was similar (p>0.39). However, in
fibroblasts (p<0.001) and LCLs (p<0.04) significantly more centromeres were present at
the periphery of the nucleus than in hES cells. In comparison significantly more
centromeres were found to be not associated with either the nucleolus or the nuclear
periphery in hES cells (p<0.004). The normal distribution of centromeres observed in
the z-plane of hES cells was not due to a change in number of centromeres at the
nucleolus, but an increase in the numbers present in the nucleoplasm. A re-distribution
of centromeres to the nuclear periphery during differentiation would be consistent with
the nuclear periphery being associated with gene silencing as cells differentiate (Gasser,
2002; Kosak et al., 2002).
Lastly, I looked at the position of telomeres in human nuclei. In differentiated cells,
telomeres are found distributed throughout the nucleoplasm (Weierich et al., 2003).
Unlike somatic cells, hES cells and germ cells express telomerase, which stops telomere
shortening and allows the cell to self-renew in culture (Thomson et al., 1998). I
investigated the position of telomeres using a pan telomeric probe (Lansdorp et al.,
1996), in the nuclei of primary fibroblasts, Ritva, hES cells, LCLs, HT1080 and HTC75-
T19 cells with induced telomere fusions (van Steensel et al., 1998). These last cells had
been transfected with a truncated form of the human telomeric binding protein TRE2
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Nucleolus Nuclear Periphery None Associated
Fig. 3.12 Centromere localisation relative to the nucleolus. (A) Localisation
of centromeres (CREST, red), and nucleoli (Ki67, green) in single frames, taken
at 0.75pm intervals through the z-axis of H1 hES cell nuclei counterstained with
DAPI (blue). (B) Mean proportion of centromeres per cell that are associated
with the nucleolus (left), the nuclear periphery (middle), or neither of these
nuclear compartments (right), in H1 hES cells (white), a LCL (black) and
fibroblasts (hatched) (r?=20). Scale bar, 10pm.
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under G418 selection, which lacked both the N-terminal basic domain and the C-
terminal Myb domain (AbasicAmybTRF2), as well as tetracycline-controlled trans-
activator under hygromycin selection. Therefore, the cells grow normally in the presence
of doxycyclin and G418, but in the absence of doxycyclin, the expression of this
dominant negative TRF2 protein induces telomere fusions within 4-5 days (van Steensel
et al., 1998). There was a conserved telomere distribution across cell types grown on
slides, with telomeres located in a skewed distribution towards the bottom of the nucleus
(figure 3.13). Even in the transformed HTC75-T19 cells following induced telomere-
telomere fusions, this distribution pattern was unchanged. The hES and LCLs that were
cytospun onto slides show a near-normal distribution of telomeres, which may reflect the
different nuclear morphology of these cells or the cytospinning.
3.6 Discussion
I have shown that some aspects of the radial organisation of CTs previously seen in
differentiated cells are already established in hES cells. The gene-rich HSA19 is more
centrally localised than gene-poor HSA18 in both 2D and 3D FISE1 (figures 3.2 and 3.3).
E1SA18 localises to the periphery in most cell types, including lymphocytes (Croft et al.,
1999), keratinocytes and cancer cell lines (Cremer et al., 2003). However, HSA18
displays a more central localisation within the flat nuclei of amniotic fluid cells and
quiescent fibroblasts (Bridger et al., 2000; Cremer et al., 2001). The nucleus of a hES
(average height: length ratio=l ,02±0.1) however, more closely resembles the shape of a
spherical lymphocyte nucleus (ratio=1.00±0.1), than the shape of a flat fibroblast
nucleus (ratio=0.25±0.4). Granulocyte-macrophage colony forming cells (GM-CFC)
also display a radial organisation of CTs, and it has been suggested that haematopoietic
stem cells have this arrangement as well (Cremer et al., 2003). I think that since this
distribution of chromosomes is present in hES cells, it is likely that most cell types will
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Fig. 3.13 Telomere localisation in human cells. (A) Localisation of telomeres
(PNA probe, green) in single image frames, taken at 0.75pm intervals, through
the z-axis of fibroblast cell nuclei counterstained with DAPI (blue). (B) Mean
(±s.e.m.) distribution of telomeres through the z-plane from the top (0) to the
bottom (1) of nuclei from H1 hES, LCL, fibroblast, Ritva, HT1080 and HTC75-
T19 cell lines (n=20). Scale bar, 5pm.
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Differences in the distribution of mouse chromosomes have been reported previously,
both between different tissue types and during T cells differentiation (Parada et al.,
2004; Kim et al., 2004), but only changes in chromosome associations have so far been
identified in human cells (Kuroda et al., 2004a). I detected a more central localisation for
HSA12p in hES cells. One of the chromosome abnormalities that occurs in hES cells is
the recurrent gain of chromosome 12, including isol2p (Draper et al., 2004). It has been
suggested that HSA12p is transcriptionally advantageous to pluripotent stem cells and
increasing the number of chromosomes, therefore increases the amount of gene
expression, which may help maintain the propagation of undifferentiated hES cells
(Draper et al., 2004). In this experiment, not only HSA12p located towards the centre of
the nucleus in hES cells, but also a BAC covering NANOG {figure 3.5). Although the
significance of being located in the centre of the nucleus, is as yet unknown, the fact that
the most gene dense chromosomes locate there (Boyle et al., 2001) suggests that it
confers some transcriptional advantage.
In contrast, silenced genes are associated with the nuclear periphery in some
differentiated cell types (Kosak et al., 2002; Zink et al., 2004). However, neither
NANOG nor OCT4 relocated to the nuclear periphery upon differentiation. It would be
interesting to know if these pluripotent genes located to centromeric heterochromatin
upon their silencing, or if genes involved in pluripotency are required to stay away from
heterochromatin, either because of active genes in the surrounding region, or because
their expression is required again at a later time point.
Alongside their organisation within the nucleus, I also explored the intra-CT
organisation of these regions. The telomeric end of HSAllp has been shown to locate
outside of its CT in differentiated cell types (Mahy et al., 2002a). This organisation was
seen in hES cells, even though the region does not contain any genes with a known role
in pluripotent cells (figure 3.6). Therefore, in both hES cells and differentiated cells
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gene-dense regions may be organised in a similar manner, irrespective of gene
expression.
There was no difference in the nuclear position of HSA6p and OCT4 between hES cells
and a differentiated cell type, with both the gene and the CT locating to an intermediate
position in the nucleus (figure 3.5). However, OCT4 was located just outside the 6p CT
in hES cells, but inside the 6p CT in a LCL (figure 3.7). The flanking genes of the
expressed class I regions were located outside 6p CT in both cell types consistent with
previous results (Volpi et al., 2000). The local chromatin structure of the OCT4 region is
unknown in hES cells, but in mouse, there is increased DNA methylation and histone
deacetylation of the Oct4 promoter/enhancer in trophoblast cells compared to ES cells
(Hattori et al., 2004). The data I present here would be consistent with a similar
chromatin remodelling of the region around OCT4 in hES cells, possibly contributing to
its transcriptional regulation. Therefore, both NANOG and OCT4 possess a distinctive
nuclear organisation in hES cells, in comparison to LCLs. With NANOG, there is a
movement of the whole CT out of the centre of the nucleus between hES cells and
LCLs. Whereas OCT4, surrounded by active genes, moves back into the 6p CT during
the differentiation of hES cells to LCLs.
I have also shown a difference in the distribution of centromeres between hES cells and
differentiated cells, although I did not see any evidence for the clustering of centromeres
previously reported in the literature, which may be specific to cell type. In differentiated
cells, centromeres are located at the nuclear periphery and around the nucleolus
(reviewed in Gilchrist et al., 2004). Centromeres in hES cells have a more internal
distribution (figure 3.10 and 3.11), with less associated at the nuclear periphery (figure
3.12). It is not known what determines the nuclear distribution of centromeres. Levels of
histone acetylation at centromeric heterochromatin are observed to alter the position of
centromeres in human and mouse differentiated cells (Taddei et al., 2001), and histone
hypoacetylation only occurs at satellite repeats upon differentiation in mES cells
(Keohane et al., 1996), which if conserved between species would be consistent with my
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data. This difference in centromere distribution in hES cells may reflect a change in the
duration of the cell cycle. Alternatively, it could be influenced by mechanisms of gene
silencing (Fisher and Merkenschlager, 2002). Changes in the nuclear positioning of
centromeres have recently been correlated with the competency of mouse oocytes
(Zuccotti et ah, 2005). It would be interesting to see if other pluripotent cells such as EC
and germ cells show the same internal centromere distribution as the hES cells, and
determine whether this central distribution is necessary for their cellular plasticity.
The number ofPML bodies present in the nucleus has been shown to vary between cell
types. There is no difference between quiescent and proliferating fibroblasts, which
suggests that these changes are not effects of the cell cycle. However, since PML bodies
are linked to transcription, I am surprised to observe the least number in ES cells, which
are thought to be more transcriptionally active than their differentiated counterparts
(Keohane et al., 1996; Ramalho-Santos et ah, 2002; Sato et ah, 2003). This may reflect
another role suggested for PML bodies as a nuclear storage site for excess proteins,
which might not accumulate in the nucleus of hES cells, due to their active state. The
distribution of PML bodies is central in both hES cells and differentiated cell types
(figure 3.11). However, a broader distribution was observed in the nuclei of
immortalised cells (i.e. the Ritva and hES cells). This is probably due to a decrease in
the number of PML bodies present in the nucleus of these cells, but it is interesting to
observe that the increase in number of PML bodies coincides with an increased
localisation in the transcriptionally active centre of the nucleus.
Finally I looked at the distribution of telomeres in the nucleus of differentiated and hES
cells {figure 3.13). Here the effects of nuclear morphology upon spatial arrangement are
similar to that previously described for HSA18 and 19 CTs. In the flat-bottomed nuclei
of fibroblasts and HT1080 cells grown on slides, telomeres have a skewed distribution
toward the bottom of the nucleus. In contrast to this in LCLs and hES cells, grown as
suspension cultures and colonies respectively, telomeres show a near normal
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distribution, reflecting a more spherical shaped end to their nucleus. This illustrates the
role of nuclear morphology in the spatial arrangement of the genome.
In summary, hES cells have a distinct nuclear architecture when compared to more
differentiated cell types, especially in genomic regions involved in pluripotency. Areas
of transcriptional silencing, such as the association of centromeric heterochromatin with
the nuclear periphery seen in differentiated cells, are not established in the hES cell
nucleus (Wiblin et al., 2005; Appendix 1). Determining how the genome is organised in
hES cells, may help to identify the spatial rearrangements in the nuclei of differentiating
cells that facilitate changes gene expression, and allow for a better understanding of
pluripotency. In an attempt to understand the role of this organisation, I wanted to follow
the spatial re-arrangement of the genome though differentiation of a specified lineage.
However, when I began this work the field of hES cells differentiation was in its
infancy. Five years after the first derivation, few protocols for the differentiation of hES
cells into specific lineages were available, with reports of varying success rates. In
comparison, it was possible to differentiate mES cells into many lineages (Smith, 2001).
For this reason, I used mES cells in the remaining results chapters.
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Chapter 4: Directed Differentiation of
Mouse Embryonic Stem Cells
Chapter 4
Directed Differentiation ofMouse Embryonic Stem Cells
4.1 Introduction
First derived in 1981 (Evans and Kaufman, 1981; Martin 1981) mES cells can be
maintained indefinitely in vitro by the presence of Leukaemia Inhibitory Factor (LIF)
(Williams et al., 1988; Smith et al., 1988). Current understanding suggests that LIF acts
through the gpl30 receptor to activate STAT3 in a JAK kinase mediated process
(Yoshida et ah, 1994; Niwa et ah, 1998). This is unlike hES cells, which neither require
nor respond to gpl30 stimulation (Reubinoff et al., 2000; Thomson et al., 1998).
Following the removal of LIF it is possible to differentiate mES cells into almost all
lineages, the only notable absence being trophectoderm, which has never been generated
in vitro (Reviewed in Keller, 1995; Wobus, 2001; Smith, 2001).
ES cell differentiation is a good model in which to study early development. The
expression of genes and proteins during the differentiation of mES cells in vitro closely
resembles the pattern observed during mouse embryogenesis. Perhaps the best example
of this is the differentiation of the haemopoietic system in embryoid bodies (EBs), where
both the development of precursor cells and their response to growth factors parallels
that found in the yolk sac and early fetal liver (Keller et al., 1993). Apart for their
usefulness as a model system, mES also offer some advantages over using primary
tissue. Populations of early precursor cells are difficult if not impossible to access in
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vivo. An example of this is oligodendrocyte precursor cells (OPCs). Oligodendrocytes
are post-mitotic cells responsible for myelinating axons in the CNS. Not only are the
steps required in generating a mature oligodendrocyte under dispute but also the identity
of the precursors cells involved (Noble et ah, 2004). In vivo these OPC populations
appear in the ventral neuroepithelium of the developing brain and spinal cord around
E12.5. It is possible to purify these cells from the rat optic nerve (Raff et ah, 1988;
Barres et ah, 1994) but not in large enough quantities to carry out conventional
biochemical analyses. Furthermore, the progenitor cells that become OPCs cannot be
isolated, which makes the oligodendrocyte lineage difficult to study in primary cells.
Protocols have been developed for the differentiation of mES cells into various neuronal
and CNS lineages, such as neurons (Bain et ah, 1995; Strubing et ah, 1995), astrocytes
(Fraichard et ah, 1995) and oligodendrocytes (Brustle et ah, 1999; Liu et ah, 2000).
However, the resulting cell populations are heterogeneous and although they share the
expression patterns characteristic of a chosen lineage, other cells types including ES
cells often persist within the cultures. To achieve a more homogeneous population many
methods have been explored, including selective culture conditions (Rolletschek et ah,
2001), co-culture with stromal cell lines (Kawasaki et ah, 2000) and FACs sorting
surface markers or GFP expressing cells from within a population (Ying et ah, 2003).
However, perhaps the most efficient way of restricting a population is by conferring
drug resistance on a subset of the population. Previously mES cells have been
genetically modified to allow for the selection of neuroepithelial cells following
differentiation in vitro (Li et ah, 1998; Billon et ah, 2002). With the appropriate
signalling molecules, seen to promote OPCs in vivo, these neuroepithelial cells produced
OPCs and then oligodendrocytes in a similar time frame to their in vivo counterparts. In
this chapter, I aim to outline the differentiation ofmES cells to neural precursors that I
will use in the remaining results chapter, with the OS25 cells adapted by Billon et ah,
(2002).
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4.2 Directed differentiation of OS25 cells
The OS25 cell line was generated from the E14TG2a parental ES line by sequential gene
targeting (Billon et al., 2002). A hygromycin-thymidine kinase (hyg-tk) fusion gene
integrated into the Oct4 (Pou5fl) locus by homologous recombination allows for the
selection of undifferentiated (Oc/4-expressing) cells with hygromycin before the onset
of differentiation, and then negative selection with gancyclovir specifically eliminates
any Oct4 expressing cells remaining after differentiation. A [i-geo cassette inserted into
the Sox2 locus, allows for positive selection with G418 to eliminate everything from the
culture except for Sox2 expressing ES cells and neural precursors (Li et al., 1998; Billon
et al., 2002).
Prior to differentiation the cells were cultured in the presence of 100pg/ml hygromycin-
P for seven days, to obtain a purer population of Oct4 expressing cells. Differentiation
was started by removing LIF from the culture media {figure 4.1). 6 x 105 cells/ml were
plated for two days as hanging drops to form spherical embryoid bodies (EBs). This was
different from the original protocol, where the mES cells formed EBs in suspension
cultures (Billon et al., 2002). I have tried both methods and found that when left in
suspension during the first two days of culture, EBs had a tendency to aggregate together
forming irregular shaped bodies and long chains. The hanging drop method promoted
more evenly sized EBs as the amount of cells starting each EB was constrained to the
number of cells per drop. Therefore, the timing of EB development was more
synchronous across a population formed by this method and it produced more spherical
EBs, which did not aggregate during later stages of differentiation and prevented the
formation of EB chains. I chose the EB method of differentiation as opposed to
differentiation in a monolayer. Even though studies have shown specific cell types can
be isolated from monolayers (Nishikawa et al., 1998), it is still uncertain to what extent
multicellular interaction are needed in the development of specific lineages and in
comparison to using EBs, lower cell numbers have been reported at the end of
monolayer differentiations (reviewed in Hopfl et al., 2004).
119
ES Cells (7 days in hygromycin-p)
<— Day 0 Hanging drops -LIF
i r
Embryoid Bodies - Day 2 Plate out
<— Day 4 + Retinoic acid (RA)
<— Day 6 + RA
<— Day 8 Media change to
(DMEM - F12/NBM + N2 + B27) - RA
M— Day 10 Dissociation & plating
G418 + ganciclovir selection + FGF-2
y r
Day 18 Neural Progenitors
Fig. 4.1 Directed neural differentiation of mES cells. Retinoic acid induced
differentiation of mouse OS25 cells (Oct4-hyg-tk, Sox2pgfeo) into neural
progenitors (protocol adapted from Billon et al., 2002). Images taken under
phase contrast. Scale bar 50pm.
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The hanging drops were knocked together and the EBs cultured in suspension for an
additional two days, before retinoic acid (RA) was added at day 4 to push the
differentiation further. RA functions as a ligand for nuclear receptors, which in turn
transcriptionally regulates RA target genes, by binding to RA response elements
(RAREs) within their promoters. The concentration of RA used affects neuronal cell
identity (Okada et ah, 2004). Here I used 10"6 M RA as in Billon et ah, (2002) but have
extended the time that cells were exposed to RA from two to four days, because RA
induced genes were not expressed after only two days. After four days, the RA was
removed and the media changed to a 50/50 mix ofDMEM-F12 / Neurobasal media plus
N2 and B27 supplements. Increasing the amount of DMEM-F12-N2 in the media lowers
cell viability but promotes neuronal differentiation, whilst increasing the neurobasal
media-B27 proportion improves cell viability, but reduces the efficiency of neuronal
differentiation (Ying and Smith, 2003). EBs were left in this media for two days, to
allow them to adjust to serum free conditions, before being dissociated and plated out as
a monolayer. In another change from the protocol used by Billon et ah, (2002) I found
dissociating EBs in a mixture of 1ml PBS, 1ml dispase (2.4U/ml) and 20pl DNase I
(7mg/ml) rather than trypsin, resulted in an increase in the number of viable cells
(Taylor personal communication). At first, I plated cells on either gelatin or poly-L-
lysine with laminin (figure 4.2A-B). However, whereas the majority of cells plated on
gelatin appeared to have two main processes, those plated on poly-L-lysine were larger,
flatter, multi processed cells with a much slower rate of growth. Due to this apparent
change in cell morphology, from here onwards only gelatin was used. After dissociation
on day 10, G418 was added to the media to select for Sox2 expressing cells and
gancyclovir was added to kill Oct4 expressing cells. Alongside this drug selection, I
added the growth factor FGF-2 (20ng/ml) to the culture to promote cell proliferation and
thereafter the medium was changed every other day until the end of the differentiation
on day 18.
Before and after differentiation the cells were stained with x-gal to determine how
homogenous the cell population was and establish which passage numbers and cell
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Fig. 4.2 Defining the conditions for neural differentiation of OS25 cells.
OS25 cells after 18 days of differentiation plated on (A) poly-L-lysine plus laminin
or (B) gelatin. Differentiation of (C) passage 60 and (D) passage 30 cells, stained
on day 18 with x-gal (blue) for Sox2pgeo expression. X-gal staining for Sox2\Sgeo
expression in (E) day 2 embryoid bodies and (F) day 18 neural precusors.
Expression levels of Sox2 varied across the day 18 population (G) and (H).
Scale bars, 50pm.
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densities resulted in the highest percentage of Sox2 (fi-geo) expressing cells. The Sox2
transcription factor is an early marker of the nervous system and is expressed in neural
stem cells isolated from embryos (Ferri et ah, 2004). I found that it was expressed
throughout my differentiation protocol (figure 4.2E-F; figure 4.6 and table 4.1).
However, differences in the x-gal staining pattern were observed amongst the day 18
cell population (figure 4.2 G-H). Higher passage numbers (>50) produced less Sox2
expressing cells at day 18 than lower passage numbers (<35) which was probably due to
the cells acquiring defects, such as extra chromosomes, in tissue culture rather than
passage number per se (figure 4.2 C-D). I observed similar differences in x-gal staining
at day 18 between starting the differentiation with 7 x 106 cells, plated on 10cm bacterial
dishes used by Billon et al., (2002) and 6 x 105 cells plated in hanging drops that I used.
This was probably due to the effect of cell density on RA concentration (Okada et al.,
2004).
4.3 Analysing markers of pluripotency during differentiation
To check for undifferentiated cells I looked for the presence of three markers of
pluripotent cells, alkaline phosphatase, OctA and the stage specific embryonic antigen 1
(SSEA1) in both day 0 and day 18 populations (figure 4.3). When stained for alkaline
phosphatase undifferentiated cells, which express the gene, turn pink (Chiquoine 1954;
Donovan et al., 1986; Matsui et al., 1992). Differentiated cells should not stain positive
for alkaline phosphatase but I detected alkaline phosphatase expression in both the day 0
and day 18 populations (figure 4.3A). This could have been due to the presence of
undifferentiated cells at day 18, but the morphology of these cells suggested otherwise.
Therefore, there must be expression of alkaline phosphatase by the differentiated cells.
Oct4 expression is confined to the pluripotent cells of the developing embryo and
their in vitro counterparts ES and EG cells (Smith, 2001). However, it has also been
reported to be transiently expressed in the developing embryonic endoderm (Palmieri et
al., 1994) and neurectoderm (Reim and Brand, 2002; Shimozaki et al., 2003) where it
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Day 2 Day 18
Day 18
Fig. 4.3 Neural precursors express two markers of pluripotent mES cells.
(A) Staining of day 2 embryoid bodies and day 18 differentiated OS25 cells
with alkaline phosphatase (pink). Scale bars, 50pm. Immunofluorescence for
(B) Oct4 and (C) SSEA1 (green) on day 0 and day 18 OS25 cells, nuclei
counterstained with DAPI (blue). Scale bars, 10pm.
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may have a role in specifying cell fate. Oct4 was detected in the nucleus of
undifferentiated (day 0) cells {figure 4.3B), but no Oct4 protein {figure 4.3B) or mRNA
(figure 4.6) was seen at day 18. Indeed I found that there was complete switch off of
Oct4 by day 8 of differentiation {figure 4.6).
The final marker of mES cells I looked for was SSEA1, first identified at the
eight cell stage of the blastomere (Solter and Knowles, 1978). This antigen is expressed
by mES cells, but its expression has also been reported in the developing ectoderm (Fox
et al, 1980). I observed expression of SSEA1 by immunofluorescence in both day 0 and
day 18 populations {figure 4.3C). This is consistent with the recent findings of Conti et
al., (2005) who also noted SSEA1 staining in neural precursors. However, it is in
disagreement with the findings ofBillon et al., (2002), who observed the loss of SSEA1
during differentiation of OS25 cells with drug selection. This variation in the expression
ofmarkers could be due to alterations in the differentiation protocol between labs.
4.4 Expression of germ layer markers during differentiation
To ascertain whether I was successfully differentiating cells restricted to the ectodermal
lineage, I analysed the expression of ectoderm, mesoderm and endoderm lineage marker
genes by RT-PCR {figure 4.4). For the ectoderm, I chose to analyse Pax6 an important
transcription factor for neurogenesis that is expressed in sub populations of neural
progenitors (Ericson et al., 1997) and the intermediate filament protein Nestin which is
expressed by progenitor cells in the CNS (Lendahl et al., 1990). Pax6 expression was
detected in the culture from day 0 but it increased 4 days after the addition ofRA (day 8
of differentiation). Nestin was not expressed by mES cells {figure 4.5A) but was induced
following the removal of LIF from the culture {figure 4.4B). Both Pax6 and nestin were
still expressed in cultures at day 18. The presence of Nestin protein in the cell processes
of cells at day 18 was confirmed by immunofluorescence {figure 4.5A).
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Day 0 8 10 18
mES cells Hanging drops Culture in 4 days with RA Media change to Dissociation
-LIF suspension neurobasal media/ & plating
DMEM-F12
+ N2 + B27 G418 + ganciclovir
selection + FGF-2
fi-actin
Fig. 4.4 Expression of ectoderm markers during differentiation of OS25
cells with RA. (A) RNAwas collected at six time points during the differentiation.
(B) RT-PCR analysis of ectoderm, mesoderm and endoderm markers during
differentiation of OS25 cells. Lanes are numbered corresponding to the day of
differentiation or no template (H20), no reverse transcriptase (-) and positive
control (+). RNA from E9.5 dpc embryos was used as a positive control, with
the exception of Ihh where RNA from a mouse ovary was used. To control for
the levels of cDNA, RT-PCR for fi-actin was carried out.
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The markers chosen for the mesoderm lineages were T-Brachyury a marker of early
mesoderm development and Myf5 a regulator of myogenesis (Keller et al., 1993;
Rohwedel et ah, 1998). Expression of these genes was not detected in undifferentiated
cells, or at any time point during differentiation. Similarly the endoderm markers Alpha-
Fetoprotein {AFP), which is the fetal counterpart of serum albumin (Keller et ah, 1993)
and Indian Hedgehog (Ihh) a marker of the visceral endoderm, which has been
suggested to have a role in embryonic ectoderm differentiation (Maye et ah, 2000) were
not expressed in the day 18 population (figure 4.4B). I therefore conclude that my
differentiation protocol is restricting cells to the ectoderm germ layer, from which neural
progenitors are derived.
4.5 Defining the population of neural progenitors
To further characterise the population of differentiated ectodermal cells,
immunofluorescence for markers associated with neural differentiation Nestin, Soxl and
Olig2 was carried out on both mES cells and differentiated day 18 cells {figure 4.5). RT-
PCR had previously shown that Nestin was not expressed by the mES cells, but was
expressed in the day 18 population {figure 4.4B). This result was confirmed by
immunofluorescence with a Nestin antibody (figure 4.5A and table 4.1). Nestin is not
specific to neural progenitors and is present in somatic and pancreatic cells (Selander
and Edlund, 2002). However, it is unlikely that cells other than neural precursors are the
source ofNestin expression here, due to the absence of mesoderm markers Myf5 and T-









































Fig. 4.5 immunofluorescence for markers associated with neural
differentiation. Immunofluorescence on day 0 and day 18 OS25 cells for (A)
Nestin (red), (B) Sox1 (green), and (C) Olig2 (red), nuclei all counterstained
with DAPI (blue). Scale bars, 10|im.
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Table 4.1 Expression of neuroepithelial markers within the ES cell population and
following drug selection on day 18.
The second marker I looked for was the SRY-related transcription factor Soxl, which is
confined to the neuroepithelium of the neural plate and dividing neural progenitors in the
early mouse embryo (Pevny et ah, 1998). Similar to the pattern ofNestin expression, by
immunofluorescence Soxl (antibody gift of Robin Lovell-Badge) was observed
predominantly in the day 18 population, although a few Soxl positive cells were present
in amongst the ES cell population at day 0 {figure 4.5B and table 4.1). However, Soxl is
one of the earliest known markers of neuroectoderm in the mouse embryo (Wood and
Episkopou, 1999) so it is unsurprising that this gene was active amongst cells
spontaneously differentiating in culture. RT-PCR showed that Soxl was upregulated by
day 8 of the differentiation {figure 4.6). Progressive differentiation into neurons and glia
is accompanied by downregulation of Soxl (Pevny et al., 1998). I did not observe a
decrease in the overall level of Soxl mRNA expression towards the end of the
differentiation, perhaps suggesting that my differentiation was not proceeding as far as
neurons and glial cells {figure 4.6). However, by immunofluorescence two different
Soxl expressing cell types could be seen within the day 18 population. The small round
nuclei of the early precursor cells were distinctive by the increased level of Soxl protein
in the nucleus, whereas towards the end of the differentiation, cells with oval shaped
nuclei, which have less expression in the nucleus but more Soxl down their cell
processes were also present {figure 4.5B). The final marker I looked at by
immunofluorescence was the basic helix-loop-helix (bHLH) transcription factor Olig2
(antibody gift of Thomas Jessell). In both Drosophila and Xenopus, bHLH transcription
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Fig. 4.6 Differentiated OS25 cells express genes characteristic of CNS
and neuronal fates. RT-PCR analysis of neuronal and CNS genes on RNA
collected from days 0, 2, 4, 8, 10 and 18 of the differentiation or no template
H20, no reverse transcriptase (-) and RNA from mES cells, E9.5 dpc embryos
or adult mouse brain as a positive control (+). The house keeping gene, GAPDH
is shown as a loading control.
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factors are responsible for neural determination. However, due to the late onset and
restricted pattern of their gene expression in the mouse, people have in the past
precluded them from a role in neural determination (Pevny et al., 1998). More recently,
it has been shown that Olig2 is necessary for both development of oligodendrocytes and
motor neurons (Mizuguchi et ah, 2001; Novitch et ah, 2001; Lu et ah, 2002) but block
astrocyte differentiation (Gabay et ah, 2003; Setoguchi and Kondo, 2004). Olig2 was not
present in the ES cells population, or before day 8 of differentiation but -15% of the
population expressed the gene at day 18 {figure 4.5C and 4.6). The presence of these
three markers confirmed that by day 18 the majority of Sox2 expressing cells were
neural progenitors. I then used RT-PCR to investigate which neuronal and CNS lineages
were present within the population figure 4.6 and 4.7).
The Otx homeobox genes {Otxl and Otx2) are widely expressed in the developing
neurectoderm (Simeone, 1998). Otx2 is expressed throughout the developing epiblast
before becoming restricted to the anterior neuroectoderm, where it is required for
development of the forebrain and midbrain. More constrained in its expression, the
paralog Otxl is expressed in the neurectoderm of the dorsal telencephalon. Interactions
between these two genes are thought to specify midbrain and hindbrain development
(Acampora and Simeone, 1999). Here Otx2 was expressed in day 0 ES cells but
switched off after the addition of RA to the culture, whereas Otxl was present at low
levels throughout the differentiation, similar to the findings of Lee et al., (2000). The
Pax genes {Pax2 and Pax5) perhaps better known for their roles in mesoderm
development (in particular the control of commitment to the B-cell lineage), are also
involved in the development of the dopaminergic and serotonergic neurons of the
midbrain and hindbrain (Stoykova and Gruss, 1994; Rowitch and McMahon, 1995).
Both genes were expressed following the addition of RA to the cultures at day 8,
although others reported expression of these genes after 10 days in cultures without RA
(Lee et al., 2000). Expression of both Pax2 and Pax5 was no longer seen after drug
selection to remove non-Sox2 expressing cells. Similarly, Ploxbl a homeobox gene
expressed in the hindbrain was expressed on day eight following four days with RA, but
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Fig. 4.7 Changes in gene expression observed through OS25 cell
differentiation. (A) Proposed pathway for one of the cell types present in the
differentiating population. (B) The genes shown are expressed in the mES cell
population (red), after the removal of LIF (blue), after the addition of RA (black)
or after the media change to Neurobasal media (green).
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not in the Sox2 expressing cells at day 18. However, previous studies using Noggin to
inhibit BMP signalling have shown that Hox genes are activated in a RA dependant
manor (Okada et al., 2004).
The expression of the Wilms' tumour suppressor gene (WT1) has previously been
reported during the differentiation of glial cells from EC and ES cells (Scharnhorst et al.,
1997; Spraggon personal communication). Here expression of WT1 was apparent
following the removal of LIF and before the expression of Pax2 in the culture. This is
unlike mesoderm differentiation where Pax2 is thought to be responsible for inducing
the expression of WT1. The primers for WT1 give two bands corresponding to the
absence or presence of alternative splice variant of exon 5. The 68kD and 200kD
neurofilament proteins NFL and NFH respectively are two of the three neuron-specific
proteins, which play a role in regenerating myelinated axons (Rohwedel et al., 1998).
NFL was present from day 8 as has been described previously by Rohwedel et al.,
(1998), however expression ofNFH was observed in the ES cells population and down
regulated with the addition ofRA which disagrees with the published expression pattern
where this form is only expressed towards the end of neuronal differentiation. Finally, I
looked at two genes with very specific expression patterns. The glial fibrillary acidic
protein (GFAP) is a specific marker for astrocytes (Reeves et al., 1989), which was seen
to increase in expression towards the end of the differentiation. In contrast, cells
expressing nuclear receptor related-1 (Nurrl) which is specific for dopaminergic
neurons (Rolletschek, 2001; Lee, 2000), were seen briefly when the culture was moved
to neurobasal media, but killed by selection for Sox2 progenitor cells with G418. The
housekeeping gene GAPDH was used as a cDNA loading control.
4.6 Discussion
I have shown that the differentiation of OS25 cells following drug selection gives a
nearly homogenous population of Sox2 expressing neural precursor cells. However,
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GFAP expression would suggest that glial lineages are also present within this
population {figure 4.7). A number of culture conditions affected the percentage of Sox2
expressing cells. Changing the substrate that cells were plated onto from poly-L-lysine
and laminin to gelatin (figure 4.2A-B) had an effect on the cell morphology, which has
been described for other mES cell lines during neuronal differentiation (Conti et al.,
2005). Increasing the cell density or passage number (figure 4.2C-D) reduced the
number of Sox2 expressing cells within the day 18 population. The main difference
between this protocol and those used by other labs is in the addition of growth factors.
Previously FGF-2 has been shown to expand cultures with transient retention of
neuronal differentiation potential (Li et ah, 1998; Okabe et ah, 1996). However,
continuous culture with FGF-2 restricts this to a glial fate (Brustle et ah, 1999), which is
also seen in the culture ofprimary foetal progenitors, and is suggested to resemble the in
vivo progression during formation of the nervous system (Conti et ah, 2005). A similar
role in the maintaining a pluripotent state has recently been described for FGF-2 in the
culture of hES cells (Xu et ah, 2005a). Although the pathway by which this growth
factor acts is still unknown, parallels can be drawn between its use in maintaining the
potential of both neural stem cells and hES cells. Protocols for the development of
terminally differentiated neuronal and oligodendrocyte lineages have shown that cells
will only terminally differentiate following the withdrawal of FGF-2 from the culture
(Gritti et ah, 1995; Okabe et ah, 1996). Recently a protocol to maintain the neuronal
progenitor cells generated from mES cells in culture, has reported that neuronal stem
cells die upon dissociation and passaging in the presence of FGF alone (Conti et ah,
2005). It is now known that to maintain the presence of neural precursors in culture
indefinitely, both FGF and EGF need to be added to the media.
The use of drug selection during this differentiation, limits the end population to the
Sox2 expressing cells of the neuroepithelium. Although this population was specific for
Sox2, different cell types were still present within the culture (figure 4.2E-H). Using
both RT-PCR (figure 4.6) and immunofluorescence (figure 4.3B), I have shown that
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Oct4 was not expressed at day 18 and therefore mES cells were no longer present within
the population. Alkaline phosphatase was expressed by the differentiated cells, although
to use its full name "tissue non specific alkaline phosphatase" perhaps this was not
surprising {figure 4.3A). Similarly, SSEA1 was also expressed in the differentiating
culture (figure 4.3C), however the presence of this antigen in both the developing
ectoderm (Fox et ah, 1980) and neuronal stem cells (Conti et ah, 2005) would suggest
that this is not only a marker associated with pluripotent mES cells, but also the self-
renewing cells of the developing ectoderm. Likewise, in human cells although SSEA1 is
not expressed by the pluripotent hES cells, it is expressed by their differentiated
derivatives, notably putative ectoderm (Henderson et al., 2002).
I have shown that markers of mesoderm and endoderm were not present in the culture at
day 18 (figure 4.4B). This was in part due to the addition ofRA, known promote neural
differentiation but also to suppress mesodermal gene expression (Bain et al., 1996).
Different concentrations of RA produce different neuronal cell types. Here the 10"6 M
used is indicative of hindbrain and spinal cord development as opposed to forebrain or
midbrain development (Okada et al., 2004), which was confirmed by both
immunofluorescence and RT-PCR analysis.
In the mES cells population, the early CNS genes Otxl and Otx2 were expressed
alongside the transcription factors Oct4, Sox2, Pax6 and the neurofilament protein NFH,
which is not normally expressed until toward the end of differentiation (figure 4.6,
Rohwedel et al., 1998). Following the removal of LIF none of the genes detected so far
were silenced, but three more genes, Soxl, WT1 and Nestin were expressed. I have
shown by immunofluorescence (figure 4.5B) that a few Soxl positive cells are present in
the day 0 population, although Soxl was predominantly expressed at day 18. In the
developing chick spinal cord, Sox genes inhibit neuronal differentiation (Bylund et al.,
2003); until genes such as Neurogenin-2 are expressed, which promote differentiation by
suppressing Sox gene expression. After the addition of RA to the culture for four days,
Oct4, Otx2 and NFH expression was no longer detected in the culture. However, the
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mesencephalic genes Pax2 and Pax5 together with Hoxbl, the neuron specific protein
NFL, the astrocyte marker GFAP and the transcription factor Olig2 were now expressed.
01ig2 is regulated by the expression of Pax6 and Nkx6 (Novitch et ah, 2001 and 2003),
which coincides with the RT-PCR analysis as Pax6 increased in expression towards day
8 when Olig2 was first expressed in the culture {figures 4.4 and 4.6).
A change to neurobasal media brought with it expression of the midbrain dopaminergic
neuron specific marker Nurrl. However, following seven days in drug selection only
seven of the genes detected here were still expressed, the neuroepithelial genes, Soxl
and Sox2, the markers of neural progenitors Pax6, Nestin, Olig2, the astrocyte specific
marker GFAP and low levels of the early CNS marker Otxl. Upon terminal
differentiation, Nestin would be downregulated and replaced by expression of
neurofilament proteins (Dahlstrand et ah, 1992), but while the Sox genes are expressed,
the cells will not undergo terminal differentiation. For this reason in day 18 cultures,
Nestin was still present and genes active later in differentiation such as NFH and Otx2
were not expressed, unlike protocols without drug selection (Rohwedel et ah, 1998; Lee
et ah, 2000). In comparison to protocols that use either the OS25 cells or their parental
clonal line, which only has Sox2 under selection, a similar percentage of the cells were
found to be positive for Soxl or Nestin at the end of the differentiation (Li et ah, 1998;
Billon et ah, 2002; Perry et ah, 2004).
Drug selection for Sox2 allowed a population of neural progenitors to be isolated, but
due to the absence of EGF in the media these cells were not able to proliferate and as
markers ofmore terminal differentiation repressed the Sox2 gene, the cells died and the
population size was greatly reduced. This differentiation could be improved by the
addition of EGF alongside FGF-2 to allow for the expansion of the self-renewing neural
precursors (Conti et ah, 2005). Further refining the specificity of the end population
could be achieved, if this protocol was applied to one of the cell lines where Soxl or
Olig2 are under selection (Ying et ah, 2003; Xian et ah, 2003; Gabay et ah, 2003). This
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would define a more specific population, although it would also decrease the cell
number making biochemical analysis difficult.
The cells produced by the differentiation protocol described here are used in the next
chapter, to investigate aspects of nuclear architecture previously shown for human cells
in chapter 3, this time following the differences in spatial organisation down defined
early neural lineages.
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Chapter 5: Nuclear Reorganisation ofMouse ES Cells
and ES Cell-Derived Neural Precursors
Chapter 5
Nuclear Reorganisation ofMouse ES Cells and
Mouse ES Cell-Derived Neural Precursors
5.1 Introduction
Organisation of the mouse genome into chromosomes differs from that in humans and
many other mammals. Differences in chromosome size and gene density are smaller
between mouse chromosomes than between human chromosomes. Disregarding the Y-
chromosome, the size of human chromosomes vary about fivefold (47-246 Mbp)
whereas the size of mouse chromosomes only differs about threefold (61-195 Mbp).
Gene density also varies about sixfold (3.9-23.3 gene/Mbp) between human
chromosomes, whereas mouse chromosomes vary approximately twofold (7.4-15.6
gene/Mbp) based on NCBI mouse build 34, May 2005 and human build 35, June 2004.
The position of centromeres is also different between mouse and human genomes. In
humans, centromeres are mainly located toward the centre of the chromosome
(metacentric), although some are located nearer to one end of the chromosome
(acrocentric), whereas in mouse, centromeres are located towards the telomeres
(telocentric).
Previous studies have described the spatial arrangement of the mouse genome within the
nucleus ofmany cell types, including during ectoderm development, using neurons and
oligodendrocytes (Manuelidis 1985; Martou and De Boni 2000; Nielsen et ah, 2002).
These studies show changes in nuclear organisation as cells undergo terminal
differentiation. However, when I started this work, there was no published research on
the reorganisation of the genome in mES cells as they acquire a particular cell fate.
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Therefore, in this chapter I have used mES cells, differentiated towards a neuroepithelial
lineage using the protocol that I described in chapter 4, to analyse the changes in nuclear
organisation that occur early in differentiation. Briefly, this enables Oct4+, Sox2' mES
cells to be compared with an Oct4~, Sox2: cell population the majority of which
expressed the markers of neural precursors Soxl and Nestin at day 18.
5.2 Distribution of chromosome territories changes during the differentiation of
mES cells
I started investigating the nuclear organisation of mES cells by 2D FISH with biotin
labelled chromosome paints for Mus musculus chromosome (MMU) 3, 6, 16 and 17
(figure 5.1 A and B). MMU6 and 17 contain the pluripotency genes Nanog and Oc.t4
respectively, whereas MMU3 and 16 contain the genes Nestin and 01ig2, which are
important in neural progenitors (figure 5.2). I compared the distributions of these four
CTs in 3:1 methanokacetic acid fixed nuclei from undifferentiated mES cells, with their
distributions in cell nuclei fixed after 18 days of differentiation towards an ectodermal
lineage (chapter 4). Fifty images of nuclei, taken at each time point were analysed
through a 2D erosion script, described previously (section 3.2, and figure 5.1C). In the
differentiated population both MMU17 and 3 were more centrally localised in
comparison to their distributions in mES cells (shell 5; p=0.005 and p=0.033,
respectively). Whilst MMU6 did not move into the centre of the nucleus, but moved
significantly away from the nuclear periphery during the differentiation (shell 1;
p=<0.001) the distribution of MMU16 significantly increased at the nuclear periphery
(shell 1; p=0.003). There is no previous study of CT arrangement during the
differentiation of mES cells, although recently two papers from the Misteli Lab have
reported similar findings for more terminally differentiated cells. The first analysed CTs
in mouse primary tissue and concluded that the distribution of CTs was tissue-specific
(Parada et ah, 2004). The second followed the position of MMU6 during T-cell

















Fig. 5.1 The distribution of MMU3, 6, 16 and 17 territories in mES and
differentiated day 18 cells. (A) 2D FISH with a BAC probe containing Oct4
(red) and a MMU17 paint (green) on a metaphase spread, DNA counterstained
with DAPI (blue). (B) mES or differentiated day 18 nuclei hybridised with BAC
probes containing either Nanog or Oct4 (red) and chromosome paints for 6 and
17 (green), counterstained with DAPI (blue). (C) Distribution of chromosome
paint hybridisation signals within the nucleus of mES (white) and day 18
differentiated cells (black) analysed by erosion of 2D images into five concentric
shells from the edge (1) to the centre (5) of the nucleus. The mean (±s.e.m)
proportion of hybridisation signal, normalised to the amount of DAPI signal, is
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Fig. 5.2 The genomic regions surrounding Nanog, Oct4, Nestin and Olig2
in the mouse. Green boxes show the positions of (A) Nanog on MMU6, (B)
H2-Q1, Oct4 (Pou5f1) and Flotl on MMU17, (C) Nestin (NM_016701) on MMU3
and (D) Olig2 on MMU16. Red boxes show the positions of the BACs used.
Images adapted from ensembl v31, May 2005.
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have shown for the day 18 population of neural precursors (Kim et ah, 2004). However,
Kim et al., (2004) also showed that the distribution of MMU6 changes again as the T-
cell precursors undergo terminal differentiation.
In a study of CT arrangement in mouse cells, Mayer et ah, (2005) suggested that the
position of CTs in mES cells correlated equally with chromosome size and gene density.
I have previously shown that radial organisation of CTs in hES cells is dependant on
gene density (section 3.2). To investigate whether this was true ofmouse CTs, I divided
the proportion of signal/DAPI in the first shell of the erosion script by the proportion of
signal/DAPI in the fifth shell of the erosion script (table 5.1).





3 159 1311 8.25 1.69 1.17
16 97 838 8.64 0.90 1.05
6 150 1454 9.69 1.85 0.86
17 93 1227 13.19 0.94 0.81
Table 5.1 Nuclear position of MMU in mES and differentiated cells. Chromosome
size and gene density (from NCBI build 34, http://www.ensemble.org/Mus_Musculus)
and the proportion of hybridisation signal in shell 1 divided by the proportion in shell 5
for the MMU used.
If the chromosomes had a radial distribution arranged according to gene density, they
would be arranged 3, 16, 6 and 17 from the nuclear periphery to the centre of the
nucleus. This distribution was observed in the differentiated day 18 cell population, but
not in the mES cell nuclei. In the undifferentiated cells, the distribution has some
similarity to chromosome size. Mayer et al., (2005) have suggested that MMU16 and 17
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should not be included in the radial analysis, because they may contain nucleolar
organising regions that are tethered to the nucleoli and thus spatial distribution of these
CTs would be biased. However, since these CTs would be under the same constraints in
both cell populations, I assume the fact that they may be tethered to another body such
as the nucleolus, only increases the significance of this spatial reorganisation. I therefore
conclude that the distribution of CTs in mouse nuclei changed during differentiation of
mES cells towards ectodermal lineages, and that a radial organisation according to gene
density was acquired during the differentiation.
5.3 The position of genes within the interphase nucleus changes as mES cells
differentiate
IfCT position changes during the differentiation ofmES cells, then the radial position of
specific gene loci on these chromosomes may also change to follow that of their host
chromosome. This is of particular interest since several genes have been reported to
relocalise away from the nuclear periphery when activated (Zink et al., 2004; Williams
et al., 2006). I investigated the position of Oct4, Nanog, Nestin and Olig2 within the
nuclei of mES cells and cells differentiated for 18 days, by 2D FISH with dig labelled
BACs for each gene. I used the 2D erosion script to segment the nuclei and manually
counted the number of BAC signals in each shell (figure 5.3A). Consistent with the CT
result for MMU17, Oct4 was more centrally located in the nuclei of differentiated cells
when compared with mES cells, which express the gene (figure 5.3B; table 5.2). The
genes surrounding Oct4 in the MHC complex may be influencing this unexpected
nuclear relocalisation of Oct4. Unlike hES cells, mES do not express the MHC class 1
genes (Tian et al., 1997), but as the cells differentiate these genes are switched on and
have previously been shown to loop out of the HSA6 territory in differentiated cells
(Volpi et al., 2000). The position of Nanog also followed its MMU6 CT and moved
away from the nuclear periphery in differentiated cells, which do not express the gene.
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Fig. 5.3 The position of pluripotent and neural genes in mouse nuclei. (A)
2D FISH with a BAC probe containing Oct4 (red) on a mES cell nucleus,
counterstained with DAPI (blue). The last image shows the nucleus divided into
five shells of equal area by the erosion script. (B) Distribution of signals from
Nanog, Oct4, Nestin and Olig2 containing BACs within the nucleus of mES and
differentiated day 18 cells, by erosion of 2D images into five shells of equal
area. The number of probe signals in each shell was counted and the proportion
of probe normalised to the amount of DAPI signal, is shown for each shell
(n=50). Scale bar, 10pm.
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population (Clark et al., 2004). For the genes activated during differentiation, Nestin on
MMU3 moved with its CT towards a more central nuclear position in the differentiated
cell population, whereas Olig2 on MMU16 was the only gene not to follow the
distribution pattern of its host CT. There, as the distribution of the CT significantly
increased at the nuclear periphery, the proportion of the Olig2 signal increased in the
centre of the nucleus. This predicts that there should be a re-localisation of Olig2 relative




Radial gene position Radial CT position
Oct4 mES cells Yes Equidistant Equidistant
Mouse differentiated
cells
No Towards centre Towards centre
Nanog
mES cells Yes Towards periphery Towards periphery
Mouse differentiated
cells
No Towards periphery Equidistant
Nestin mES cells No Equidistant Towards periphery
Mouse differentiated
cells
Yes Towards centre Towards centre
ong2 mES cells No Towards periphery Equidistant
Mouse differentiated
cells
Yes Towards centre Towards periphery
Table 5.2 The radial position of four loci in pluripotent and differentiated cells. The
radial position of the four genes and their respective CTs analysed in mES and
differentiated day 18 cells.
These results disagree with the findings of Zink et ah, (2004) who showed that the
position of genes within human nuclei varied among cell types in a transcription
dependent manner, as only two of the genes analysed here moved in the predicted
direction. Williams et al., (2006) recently described the relocation of the neuronal gene
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Mashl away from the nuclear periphery, during the differentiation of mES towards a
neuronal lineage. They showed that this movement only occurs in cell types that express
the gene. I conclude that the radial position of some genes within the nucleus change
during differentiation, in a transcription dependent manner. This is dependent not only
on the activity of the gene in question, but also on the expression patterns of adjacent
genes as seen for Oct4. The results suggest that the repression of the pluripotent genes,
Oct4 and Nanog, occurs by a mechanism independent of nuclear organisation.
5.4 The position of genes relative to their CTs change during mES cell
differentiation
In mouse, Hox genes induced upon the differentiation of ES cells with RA have also
been shown to relocate towards the nuclear interior (Chambeyron and Bickmore, 2004).
Although in this case, the movement did not accompany changes in the position of their
host CT, rather the relocation of the genes outside their CT (Bickmore et ah, 2004).
Therefore, I analysed the nuclear position of Oct4, Nanog, Nestin and Olig2 relative to
their CTs in mES cells and cells differentiated towards an ectodermal lineage. BACs
containing the genes labelled with dig-dUTP and the corresponding commercial
chromosome paints for MMU17, 6, 3 and 16 labelled with biotin, were hybridised to 3:1
methanol:acetic acid fixed mES and differentiated cell nuclei. Unlike hES cells (section
3.4) where NANOG remained in the HSA12p CT but the whole CT moved, Nanog was
found significantly closer to the edge of its CT in mES cells than in differentiated cells,
where the gene is not expressed (p=0.016, figure 5.4A; table 5.3). The other pluripotent
gene analysed, Oct4, was seen to move significantly nearer to the edge of its CT in the
differentiated cell population, which do not express the gene than in undifferentiated
cells (p=<0.001, figure 5.4B and C). However, as described above, the genes
surrounding Oct4 in the MHC class 1 region are not active in mES cells (Tian et ah,
1997) and switch on during the differentiation. I conclude that this region moving out of
its CT is likely to be due to the activation of class I genes. However, when I compared
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A Nanog
Outside of territory Territory edge Inside territory
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C Day 18
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Fig. 5.4 Intrachromosome territory organisation of Nanog and Oct4 in
mouse nuclei. (A) Distribution of a BAC containing Nanog relative to the MMU6
CT, in nuclei from mES and differentiated day 18 cells. Negative distances
indicate localisation outside of the CT (r?=100). Distribution of Oct4 and two
flanking loci on MMU17 in the nuclei of (B) mES and (C) differentiated day 18
cells. Negative distances indicate localisation outside of the CT (n=100).
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the distributions of two alleles either side of Oct4, {Flotl on the class 1 side and H2-Q1
on the centromeric side nearest the class III genes), in mES and differentiated cell
populations, neither of these genes significantly changed their positions relative to the
MMU17 CT (H2-Q1 p=0.318; Flotl p=0.074). This result was unexpected, but might be
explained by the bi-modal distribution of H2-Q1 in the day 18 population, which is not
reflected by the statistics. Further analysis of the genes flanking Oct4 is needed to






Probe name Position relative to CT edge
mES (pm) Day 18 (pm)
Nanog 6.F2 123.3 RP24-230P19 0.17±0.07 0.38±0.06
H2-Q1 17.B2 33.8 RP24-273L24 -0.03±0.06 -0.12±0.06
Oct4 17.B2 34.0 RP23-75C13 0.44±0.05 0.13±0.06
Flotl 17.B3 34.3 RP24-180B11 0.09±0.05 0.22±0.05
Nestin 3.F1 88.4 RP23-312C21 0.15±0.10 0.12±0.07
Olig2 16.C4 91.6 RP23-81F15 0.40±0.04 0.20±0.07
Table 5.3 Intra-CT position of loci in mES and differentiated day 18 cells.
Cytogenetic and genomic positions (from NCBI build 35,
http://www.ensembl.org/Mus_musculus) of each locus, together with the name of the
BAC used in FISH. Mean (±s.e.m.) position, in pm, of loci relative to the edge of the
CTs in mES and differentiated day 18 cell nuclei. Negative values indicate the positions
outside the visible limits of the CT.
I then investigated CT organisation of the two loci activated in neural precursor cells,
Nestin and Olig2 {figure 5.5). Nestin which is expressed by 90% of the differentiated
population {figure 4.5A; section 4.3), does not significantly change its position relative
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Fig. 5.5 Intrachromosome territory organisation of Olig2 and Nestin in
mouse nuclei. (A) Hybridisation of a BAC probe containing Olig2 (red), and
MMU16 paint (green), within the nuclei of mES and day 18 differentiated cells
counterstained with DAPI (blue). Histograms of the distribution of FISH signals
from BACs containing (B) Olig2 and (C) Nestin, relative to the edge of MMU16
and 3 CTs respectively, in the nuclei of mES cells (white) and day 18 differentiated
cells (black). Negative distances indicates localisation outside the visible limits
of the CT (n=100). Scale bar, 10pm.
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Nestin loci are found outside of the CT even in the mES cell population where the gene
is not expressed. As Nestin is expressed within the first 24 hours of mES cell
differentiation (Meshorer et ah, 2006), this gene might have moved out of its CT prior to
expression. Alternatively, out of the four genes analysed here, it is noteworthy that
Nestin is embedded in a local region of high gene density. Therefore, it is possible that
its immediate surroundings are dictating the genes position relative to its CT. Expression
of 01ig2 was not detected in mES cells by either RT-PCR or immunofluorescence,
however -15% of the differentiated population expressed the gene, as determined by
immunofluorescence for the 01ig2 protein (figure 4.5C; section 4.3). The position of
Olig2 changed significantly relative to its CT during the differentiation (p=0.013). This
is due to an increase in the percentage of loci found well (>0.2pm) outside the CT, from
7% in mES cells to 16% in differentiated cells and a reduction in the number of loci
found deep within the CT (>0.6um) from 29% in mES cells to 20% in differentiated
cells. This change in position likely reflects the increased proportion of Olig2 expressing
cells in the differentiated population.
5.5 Chromatin decondensation of the Oct4 region in mouse
The movement of loci relative to the surface of CTs is generally accompanied by
cytologically detectable changes in chromatin condensation (Chambeyron and
Bickmore, 2004). To investigate this further I carried out FISH with Oct4 and two
flanking BAC clones, containing Flotl and H2-Q1, in mES and differentiated cells
(figure 5.6A). The interphase distance (d) was measured between Oct4 and Flotl or H2-
01 BACs (figure 5.6B). The distribution of these distances, always conformed to that
expected from the random walk model of chromatin structure (s.d. = 0.52-0.6;
median/mean -1.0) (Sachs et ah, 1995; Chambeyron and Bickmore, 2004). The mean-
squared interphase distance (<d2>) between Oct4 and Flotl (genomic distance, 120kb)
was not significantly different between mES cells and the differentiated population
(<d2>=0.36±0.03 and 0.42±0.05 pm2 respectively, p=0.861). However, there was a
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Fig. 5.6 Chromatin decondensation of the Oct4 region in mES and
differentiated cells. (A) 2D FISH with BAC probes containing Oct4 (green)
and H2-Q1 (red), within the nuclei of mES and differentiated day 18 cells,
counterstained with DAPI (blue). (B) The distribution of squared interphase
distances (d2) in |±m2 measured between probes for Oct4 and Flotl or H2-Q1,
in the nuclei of mES and differentiated day 18 cells (n=100). Numbers show
the mean d2 value (±s.e.m). Scale bar, 10pm.
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significant increase between Oct4 and H2-Q1 (genomic distance, 140kb) in the
differentiated population when compared to the mES cells (<d >=0.73±0.09 and
0.40±0.04 urn2 respectively, p=0.002). Therefore, there is decondensation upon
differentiation, but not as I had expected because the distance between H2-Q1 and Oct4
is greater than between Oct4 and Flotl. This probably reflects high-level expression of
the class III genes. The large d2 values measured around Oct4 in both cell populations
are consistent with the presence of an open chromatin fibre (Gilbert et ah, 2004). In
conclusion, not only does Oct4 change its location within the nucleus during
differentiation, but as previously shown for hES cells (section 3.4) there are differences
in the condensation of the chromatin fibre between mES and differentiated cells.
5.6 Gene association with centromeric heterochromatin
The position of genes relative to centromeric heterochromatin in somatic cells has been
associated with gene silencing (Brown et al., 1997). To determine whether pluripotent
genes associate with centromeric heterochromatin when they are repressed during
differentiation, I carried out 2D FISH on mES and differentiated day 18 cells with dig-
dUTP labelled BACs containing the genes Oct4 or Nanog {figure 5.7A). I then counted
the percentage of nuclei where both, one or neither of the gene loci associated with the
bright heterochromatic foci in the DAPI stained nuclei. For both genes, the percentage of
loci found to associate with the heterochromatic foci was similar in mES and
differentiated cells (figure 5.7B). I therefore concluded that the association of these two
genes with centromeric heterochromatin was not responsible for their silencing in mES
cell differentiation. This is in agreement with recent data for the neuronal gene, Mashl,
during mES cell differentiation, which also showed that gene repression was not due to




Fig. 5.7 The percentage of Oct4 loci associated with heterochromatic foci
in the DAPI. (A) 2D FISH with a BAC containing the gene Oct4 (green) on
OS25 mES and differentiated day 18 cells, nuclei counterstained with DAPI
(blue). (B) The percentage of nuclei in mES (white bars) or differentiated day
18 cells (black bars) that have both BAC signals associated with DAPI foci
(Both), only one of the signals associated (One), or neither of the signals
associated (Neither) for BACs containing either Oct4 or Nanog genes (n=50).
Scale bar, 10pm.
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5.7 Histone modifications in mES cells
During differentiation, the mouse genome is progressively silenced as cell fate becomes
more restricted, as is evident from microarray data (Ramalho-Santos et al., 2002; Sato et
al., 2003). This is accompanied by the acquisition of histone modifications associated
with gene activation and gene silencing (reviewed in section 1.2.1). To investigate
changes in the global levels of histone modifications between mES and differentiated
day 19 cells, I carried out western blots on protein extracts from both populations {figure
5.8). These were quantified using Advanced Image Data Analyser (AIDA) software to
2 2
measure the intensity of the bands, expressed as the Quantum Level per mm" (QL/mm ),
relative to a GAPDH loading control. Whereas the level of H3-K9me2, a marker of gene
silencing, increased during the differentiation the levels of H3-K9ac and H3-K4me2,
which are associated with gene expression, decreased in agreement with the progressive
silencing of the genome during differentiation. This result was confirmed by previous
analysis during the differentiation of both mES cells following LIF withdrawal (Lee et
al., 2004) and adult neural stem cells induced to differentiate towards neurons,
oligodendrocytes or astrocytes (Hsieh et al., 2004).
The distribution of these histone modifications within the nuclei of mES and
differentiated cells was then analysed by immunofluorescence. H3-K4me2 was
visualised throughout the interphase nuclei of mES cells, differentiated cell populations
and on metaphase chromosomes (figure 5.9). However, the histone modification was not
present on blocks of heterochromatin, or at the nuclear periphery in the differentiated
population. This corresponds with the distribution ofH3-K4me2 throughout the genome,
as the vast majority of sites show a punctate pattern, typically occurring at sites of ~1-
2kb from the promoters of active genes and regulatory elements (Roh et al., 2004;
Bernstein et al., 2005). Similar to H3-K4me2, H3-K9ac staining was apparent throughout
the nuclear interior in both mES and differentiated cells, however the nuclear rim was
devoid of staining in the day 19 population and this modification was not detected on
metaphase chromosomes (figure 5.10A and B). It is likely that H3-K9ac is present on
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Fig. 5.8 Changes in the levels of histone modifications between mES and
differentiated day 19 cells. (A) Total protein extracts harvested from mES and
differentiated day 19 cells stained with coomassie blue as a protein loading
control. (B) Western blots for the histone modifications H3-K4me2, H3-K9ac
and H3-K9me2> with the housekeeping protein GAPDH used as a loading
control. (C) Quantification of the western blots using AIDA software to measure





Fig. 5.9 Immunofluorescence for H3-K4me2 in mES and differentiated
cells. (A) mES and differentiated day 19 nuclei stained with an antibody for
H3-K4me2 detected using FITC (green), counterstained with DAPI (blue). Inserts
show H3-K4me2 on metaphase chromosomes. (B) Enlarged view of the staining











Fig. 5.10 Changes in the levels of histone modifications at H3-K9 detected
by immunofluorescence. mES and differentiated day 19 nuclei stained with
antibodies for (A and B) H3-K9ac and (C) H3-K9me2 detected using FITC




























these metaphase chromosomes, but not detectable by immunofluorescence, which could
be distinguished by using a microarray. This pattern of H3-K9ac staining was previously
reported for human fibroblasts and HT1080 fibrosarcoma cells (Gilchrist et ah, 2004).
The level of H3-K9me2 detected by immunofluorescence was substantially decreased in
the mES cell population {figure 5.10C), consistent with the result obtained by western
blotting. In mES cells, this modification appeared as distinct foci scattered across
interphase nuclei and along the metaphase chromosomes. However, H3-K9me2 was
abundant throughout the nucleus of the differentiated cells including the nuclear
periphery, which again enforces the role of the nuclear periphery in gene silencing.
To investigate the presence of these modifications at specific gene loci, I carried out
ChIP with anti H3-K4me2 and H3-K9ac antibodies and looked for the presence of the
Oct4 promoter and Olig2 exon 1 sequences by Real-Time PCR (Schoorlemmer et al.,
1994; Xian et ah, 2005; figure 5.11). Both of these modifications were present at the
Oct4 promoter in mES cells, which express the gene, but not in the differentiated
population where the gene is silenced. Hyperacetylation of the Oct4 promoter region in
mES cells has been reported previously, therefore confirming this result (Hattori et al.,
2004; Kimura et al., 2004). At Olig2 exon 1, H3-K4me2 was present in both the mES
cell population, which do not express the gene and the differentiated population, where
the gene was expressed. However, H3-K9ac was only detected at Olig2 exon 1 in the
differentiated cells where the gene is expressed. Therefore, H3-K4me2 and possibly H3-
K9ac of exonl precede Olig2 activation. Both H3-K9ac and H3-K27me3 were shown to
precede transcriptional activation of the Mashl locus during neuronal differentiation
(Williams et al., 2006) and interestingly, H3-K27me3 is present at the Olig2 locus in
mES cells (Azuara et al., 2006). This would suggest that Olig2 might be kept poised for
transcription in mES cells, via protein associating with these histone modifications








Oct4 promoter Olig2 exon 1
Oct4 promoter Olig2 exon 1
Fig. 5.11 Histone H3 modifications at Oct4 and Olig2. (A) Maps of Oct4 and
Olig2 showing the regions analysed by ChlP. Open bars represent the exons
and the black bars underneath indicate the PCR products detected by ChlP.
(B) Quantification of ChlP by real-time PCR. The graphs show the mean levels
of product amplified from samples after ChlP with antibodies for H3-K4me2 and
H3-K9ac (after subtraction of mock IP levels). The analysis was carried out on
chromatin prepared from undifferentiated ES cells (open bars) and cells after
18 days of differentiation (filled bars).
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5.8 Centromere localisation in OS25 cells
I have previously shown differences in the location of centromeric heterochromatin
between hES cells and differentiated cell-lines (section 3.5). To determine if this was
also true of mES cells, I carried out 3D FISH with a mouse minor satellite (R198,
Kipling et al., 1994) on 4% PFa fixed nuclei from mES and differentiated cells {figure
5.12A). I then took a series of images through the z-plane of each nucleus, and used the
script (described in section 3.2) to determine which plane each centromere was located
in, by using the point of greatest signal intensity. Unlike hES cells, centromeres were
distributed randomly throughout the z-plane of both mES and differentiated cell
populations {figure 5.12B). In a recent study, Mayer et al., (2005) found mES cells to
have a significantly different distribution of centromeres in comparison to fibroblasts,
lymphocytes, myoblasts, myotubes and macrophages. The images of centromere
position before and after ectoderm differentiation appeared to show a more peripheral
distribution of centromeres in the differentiated population. In mouse, repositioning of
centromeres to the nuclear periphery has been described during myogenesis and is well
documented for differentiated cells such as lymphocytes (Chaly and Munro, 1996,
Vourc'h et al., 1993; Weierich et al., 2003).
To compare the proportion of centromeres at the nuclear periphery in mES and
differentiated cells, I carried out an immunoFISH with an antibody to the nucleolar
protein fibrillarin and a mouse minor satellite probe (R198) {figure 5.13C). Fibrillarin
localises in the dense fibrillar centres of the nucleolus, so unlike the protein nucleolin, it
does not highlight the nucleolus in its entirety {figure 5.13A). However, unlike fibrillarin
the antibody to nucleolin did not survive the 3D FISH protocol. The number of
centromeres found to associate with the nuclear periphery, nucleolus and neither of these
compartments were then counted {figure 5.13D). The number of centromeres located at
the nucleolus or not associated with either of the compartments did not change during
the differentiation of mES cells (p=0.608 and p=0.304, respectively). However, the
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Fig. 5.12 Centromere localisation in mouse cells. (A) Localisation of minor
satellite (R198 probe, green) in single image frames, taken at 0.5pm intervals,
through the z-axis of mouse OS25 cell nuclei before and after 18 days of
differentiation, nuclei counterstained with DAPI (blue). (B) The mean (±s.e.m.)
distribution of minor satellite through the z-plane from top (0) to bottom (1) of










Fig. 5.13 Centromere localisation relative to the nucleolus in mouse cells.
Immunofluorescence with antibodies to (A) fibrillarin and (B) nucleolin to locate
the nucleolus in mES cells. (C) ImmunoFISH to locate centromeres (R198
probe, red) and nucleoli (fibrillarin, green) in single frames, taken at 0.75pm
intervals through the z-axis of OS25 cell nucleus after 18 days of differentiation,
counterstained with DAPI (blue). (D) Mean proportion (±s.e.m.) of centromeres
per cell that are associated with the nucleolus (left), the nuclear periphery
(middle), or neither of these nuclear compartments (right), in mES cells (white)
and after 18 days of differentiation (black) (n=25) Scale bar, 5pm.
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of differentiated cells (p=0.001), this would be consistent with the general move of CTs
(i.e. chromosome arms) to the centre of the nucleus upon differentiation, as something
has to take their place at the nuclear periphery. Mayer et al., (2005) used a similar
approach to look at centromere position in mES cells and found 58% of centromeres at
the nucleolus, 64% at the periphery and 6% in neither of these areas. This differs from
the 37% of centromeres I found at the nucleolus of mES cells, 45% at periphery and
35% in neither of the areas, although Mayer et al., do not describe how they defined the
nucleolus in their study. Therefore, these differences could be explained by how the two
studies determine where the boundaries of nucleolar and nuclear periphery
compartments are placed. This would also account for the decreased number of
centromeres at the nucleolus in differentiated cells seen by Mayer et al., (2005) that I
have not observed during the differentiation of ectodermal cells. However, both studies
show an increase in the number of centromeres present at the nuclear periphery in
differentiated cells. This is in agreement with the many reports of centromeres being
located at, or moving to, the periphery in terminally differentiating murine cells
(Vourc'h et al., 1993; Martou and De Boni, 2000), and during the differentiation of hES
cells (section 3.5).
A property of centromeric heterochromatin that was very apparent from the DAPI
stained nuclei of mES differentiating toward the ectodermal lineages, was its ability to
cluster forming chromocentres (Hsu et al., 1971). I investigated this further by fixing
cells at six time points during the differentiation and carried out 3D FISH on these cells
using a mouse minor satellite probe. I then proceeded to count the visible probe signals
(representing the minor satellite) and the bright spots of heterochromatin in the DAPI
(representing the major satellite) {figure 5.14A and B). The average number of minor
satellite signals visualised in the mES cells was 36.3, but by day 2 the number of signals
visible was significantly lower at 30.6 (p=0.025). Similarly, by using the DAPI staining
as a guide the number of distinct heterochromatic bright spots also significantly
clustered between 20.5 at day 0 and 17.7 at day 2 (p=0.034). This clustering of both
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Fig. 5.14 Centromere clustering during the differentiation of OS25 cells.
3D FISH was carried out on cells fixed at six time points throughout the
differentiation and the number of signals from (A) R198, a mouse minor satellite
probe and (B) DAPI foci were counted. Numbers show averages ±s.e.m. (n=25).
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were 22.7 minor satellite signals (37% decrease) and 12 major satellite signals (41%
decrease). Previously chromocentres have been shown to cluster in murine neuronal
cells (Manuelidis et al., 1984) Sertoli cells (Haaf et al., 1990) and during myogenesis
(Brero et al., 2005; Terranova et al., 2005). In contrast to all of those studies, in a recent
paper Meshorer et al., (2006) generated neuronal precursors from mES cells and report
that the number of heterochromatic foci increased during differentiation. The number of
foci they reported for neuronal progenitors was similar to the number seen in the
differentiated day 18 cell population, but I have never seen heterochromatic foci cluster
to that extent in an undifferentiated ES cell.
To confirm the clustering of centromeric heterochromatin during ectodermal
differentiation, telomere FISH was carried out using both mES and differentiated cells
(figure 5.15). The result was as expected, with the half of the telomeres that are adjacent
to centromeres forming clusters, as previously described for 3T3 cells and bone marrow
cells (Cerda et al., 1999). Cerda et al., (1999) amongst others have speculated that the
Rabl distribution, seen in plants is present in some murine cell types. Although I have
not seen the classic Rabl distribution, with centromeres clustered at one pole and
telomeres at the other, I have seen the clustering of all but two centromeres towards one
side of the nucleus on numerous occasions (figure 5.16). This distribution was seen in
60% of the OS25 cells 4 days into the differentiation and could be related to cell cycle.
5.9 Reorganisation of centromeric heterochromatin in knockout ES cells
Whether centromeres are clustering or un-clustering during differentiation, the question
remains as to what is responsible for the movement of centromeric heterochromatin.
There are three epigenetic hallmarks of centromeric heterochromatin, a high level ofH3-
K9me3, deacetylated histone H4 and DNA methylation (reviewed in Richards and Elgin,
2002), which are known to change during differentiation (O'Neill and Turner, 1995;
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Fig. 5.15 Telomere FISH on undifferentiated and differentiated OS25 cells.
Localisation of telomeres (PNA probe, green) in single frames, taken at 0.75pm
intervals, through the z-axis of (A) undifferentiated and (B) differentiated for 18
days, OS25 cell nuclei counterstained with DAPI (blue). (C) The number of
signals counted after telomere FISH on mES and differentiated day 18 cells





Fig. 5.16 Centromere localisation in OS25 cells after 4 days of differentiation.
Centromeres were localised following 3D FISH with a minor satellite probe
(R198, red). (A) Single frames taken at 0.5pm intervals, through the z-axis of
OS25 cell nuclei after 4 days of differentiation. (B) A single nucleus, representing
the centromere distribution observed in the majority of cells, at day 4 of
differentiation. Arrows mark two centromeres that do not associate with the
main group. Nuclei counterstained with DAPI (blue). Scale bars, 5pm.
168
responsible for the nuclear reorganisation and clustering of centromeric heterochromatin
during the differentiation ofmES cells, I examined this aspect of nuclear organisation in
cells with null mutations in the enzymes responsible.
I started by asking whether H3-K9me3 was involved in centromere clustering. Suv39hl
and Suv39h2 histone methyltransferase (HMTase) catalyse H3-K9me3 at pericentric
heterochromatin (Peters et al., 2001). Suv39h also creates a binding site for the
heterochromatin protein 1 (HP1; Lachner et al., 2001). When both of these HMTase
were knocked out, the phenotype was embryonic lethal as only 33% of the expected
number of mice were born, fibroblasts derived from E12.5 foetuses showed
chromosomal instability and the few mice that were viable showed an increased
incidence of tumours (Peters et al., 2001). However, the double null mES cells are viable
and can be differentiated. I differentiated the double knockout mES cells for Suv39hl
and Suv39h2 made by Peters et al., (2001) and the wild type parental (WT41) cell line
towards an ectodermal lineage using the protocol described in section 4.2, however this
time no drug selection was used (figure 5.17C and D). RT-PCR performed on RNA
samples taken during the differentiation of both the knockout and wild type mES cells,
showed that Oct4 switched off and the neural precursor gene SoxJ switched on during
the differentiation of Suv391T" cells (figure 5.17A and B). Cells were taken at five time
points throughout the differentiation, fixed in 4% PFa for 3D FISH with a mouse minor
satellite (R198) (figure 5.18A) and the number of signals from minor satellite (R198)
and major satellite (DAPI foci) were counted (figure 5.18B and C). Centromere
clustering was evident during the differentiation of both the Suv39h"/_ and WT41 cells,
as previously seen in the OS25 cell line. Due to the cells not being under drug selection,
the starting population was slightly more heterogeneous. This was reflected in the
number ofminor satellite signals counted at day 0, being 30.2 for Suv39h_/" and 31.0 for
WT41, in comparison with 36.3 for OS25 cells under positive selection for Oct4
expression with hygromycin. However, the number of chromocentres present at day 2 of
Suv39h_/" differentiation was similar to the OS25 cell differentiation, being 30.6 for
minor satellite and 18.8 for DAPI foci in the Suv39hcells and 30.6 for minor satellite
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Fig. 5.17 Differentiation of Suv39h-'- and WT41 cells. RT-PCR analysis for
Oct4, Sox1 and Actin expression during the differentiation of (A) SUV39IT'- and
(B) WT41 cells. Lanes are numbered corresponding to the day of differentiation
or no template (H20), no reverse transcriptase (-) and positive control (+).
Brightfield images taken under phase contrast during the differentiation of (C)
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Fig. 5.18 Centromere clustering during the differentiation of Suv39h-/- and
WT41 cells. (A) 3D FISH with a mouse minor satellite probe (R198, red) was
carried out on cells fixed at five time points during the differentiation of
SUV39IT/- cells, nuclei counterstained with DAPI (blue). The signals from (B)
minor satellite (R198) and (C) DAPI foci were counted for SUV39IT/- (black bars)
and WT41 cells (red bars), numbers show the mean (is.e.m.) (n=25). Scale
bar, 5pm.
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and 17.7 for DAPI foci in OS25 cells. There was a significant decrease in the number of
DAPI foci by day 4 and minor satellite signals by day 6 (p=<0.001). This suggests that
after the initial clustering following the removal of LIF (seen in the OS25 cell
population), the second wave of clustering accompanies the change in gene expression
following RA treatment of the cells. I conclude therefore that trimethylation ofH3-K9 at
major and minor satellites, is not required for centromere clustering. This is in
agreement with Brero et ah, (2005), who have also shown centromeres to cluster during
the differentiation of Suv39h~ ~ cells.
Recently it has been disputed as to whether histone deacetylases (HDACs) are important
for centromere clustering (Gilchrist et al., 2004; Terranova et ah, 2005). However, one
of the proteins responsible for the recruitment of HDACs to centromeric
heterochromatin, the methyl CpG-binding protein MeCP2 (Jones et ah, 1998; Nan et ah,
1998), has also been implicated in large-scale chromatin reorganisation during terminal
differentiation (Brero et ah, 2005). Expression of MeCP2 is known to increase during
neuronal differentiation in humans (LaSalle et al., 2001), rats (Jung et ah, 2003) and
mice (Cohen et al., 2003) and is concentrated at pericentric heterochromatin (Lewis et
al., 1992). To investigate whether MeCP2 was essential for centromere clustering, I have
taken both the MeCP2 knockout and their wild type (CGR8) mES cells (Tate et al.,
1996) through the ectodermal differentiation protocol described previously (section 4.2;
figure 5.19C and D). The genotypes of the cell types used in this experiment were
checked by PCR for the presence of the LacZ and Neomycin inserts in the knockout
cells {figure 5.2IB).
The MeCP2 knockout and wild type cells both appeared to differentiate normally until
day 18 when clumps of what appeared to be undifferentiated cells materialized in the
MeCP2 knockout cultures. RT-PCR showed that in wild type (CGR8) cells, Ocl4
switched off after 4 days, although only a very low level of Soxl expression was seen in
the day 18 population {figure 5.19B). The knockout mES cells also switched off Oct4 by
day 8 of differentiation in the absence of MeCP2, but expression of Oct4 was evident in
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Fig. 5.19 Differentiation of MeCP2 and CGR8 cells. RT-PCR analysis for
Oct4, Sox 7, MW and Actin expression during the differentiation of (A) MeCP2
and (B) CGR8 cells. Lanes are numbered corresponding to the day of
differentiation or no template (H20), no reverse transcriptase (-) and positive
control (+). Brightfield images taken under phase contrast during the differentiation
of (C) MeCP2 and (D) CGR8 cells. Scale bars, 50|im.
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the culture again at day 18, alongside the expression of the neural gene Soxl {figure
5.19A). One of the other cells types reported to express Oct4, are germ cells (Pesce and
Scholer, 2000). To check the Oct4 expressing cells in the differentiated MeCP2
population were not germ cells, I looked for the expression of mouse vasa homolog
(.Mvh), which some people believe is only expressed by germ cells (Fujiwara et ah,
1994). However, by RT-PCR this gene was expressed not only in the day 18 population
of MeCP2 cells, but also in the undifferentiated day 0 populations of both MeCP2 and
CGR8 cells {figure 5.19A and B). The result in undifferentiated cells has since been
repeated by immunofluorescence and western blot (Bolcun-Filas personal
communication). IfMvh is only expressed by germ cells, this would mean I started the
differentiation with germ cells present in the cultures, a concept that has been discussed
recently (Zwaka and Thomson, 2005). However, until a clear distinction can be made
between germ cells and ES cells, I cannot further identify the population of cells seen in
the MeCP2 differentiation at day 18. These cells should be removed from future
experiments by selective culture conditions, such as NS-A media plus N2 that does not
support the propagation of ES cells and thereby eliminates them from the culture (Conti
et ah, 2005).
To analyse the centromere clustering in the day 18 populations the cells were replated
onto glass coverslips and during this process, the clumps of strange undifferentiated cells
were lost from the MeCP2 population. This was due either to the cells not sticking to the
glass surface of the coverslip, or cell death following the dissociation of the cells from
their clumps. The differentiated cells that adhered to the coverslips were fixed in 4% PFa
for 3D FISH and hybridised to the R198 probe (figure 5.20A). In both knockout and
wild type populations, the clustering of centromeric heterochromatin occurred in parallel
during differentiation (figure 5.20B and C). The MeCP2 cells went from an average of
31.6 minor satellite signals at day 0 to 28.1 signals at day 6 (p=0.009), whereas the
major satellite (DAPI foci) averaged 19 on day 0, 19.2 at day 6 (p=0.742) and 14 by day
10 (p=<0.001). By day 18 the average minor satellite signal had decreased by 32% in
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Fig. 5.20 Centromere clustering during the differentiation of MeCP2 and
CGR8 cells. (A) 3D FISH with a mouse minor satellite probe (R198, red) was
carried out on cells fixed at four time points during the differentiation of MeCP2
cells, nuclei counterstained with DAPI (blue). The signals from (B) minor satellite
(R198) and (C) DAPI foci were counted for MeCP2 (black bars) and CGR8
cells (red bars), numbers show the mean (±s.e.m.) (n=25). Scale bar, 5pm.
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by 22.6% in MeCP2 cells and 21.1% in CGR8 cells. Therefore, I conclude that although
the absence of MeCP2 may affect the cells ability to differentiate, it does not effect the
clustering of centromeres during differentiation. Brero et ah, (2005) also showed that
centromeres clustered in muscle tissue of MeCP2 knockout mice. However, they
conclude that this clustering was due the functional redundancy of MeCP2 and other
MBD proteins.
If this were the case, I wanted to know what would happen to centromere clustering if
these proteins were unable to bind the chromatin fibre. MBD proteins only bind
methylated DNA, so I analysed centromere clustering in a cell line that had reduced
levels ofDNA methylation. The methyltransferases Dnmt3a and Dnmt3b are responsible
for establishing DNA methylation de novo (Okano et ah, 1999). Dnmt3a and Dnmt3b
are both constitutively expressed in ES cells and early embryos, however in the
ectoderm; Dnmt3a is expressed by neural precursors, postmitotic CNS neurons and
oligodendrocytes, whereas Dnmt3b is only expressed during a small window between
E10.5 and 13.5 in the ventricular zone of the CNS (Feng et ah, 2005). The double
knockout of Dnmt3a and Dnmt3b (Dnmt3~~) is embryonic lethal in the mouse, and
mutations in human DNMT3B cause ICF (immunodeficiency, centromere instability,
facial anomaly) syndrome (Okano et ah, 1999). This disease is characterised by an
aberrant chromatin structure at pericentric heterochromatin (Xu et ah, 1999). Despite the
fact that these cells still have Dnmtl, amount ofDNA methylation in Dnmt3~" mES cells
eventually declines in culture to negligible levels (Chen et ah, 2003a).
Here, I have used the double knockout cell line for DnmtS7" cells, and their wild type
(Jl) cells (Okano et al., 1999). To check the methylation status of the cell lines I
digested DNA from both cell types with Mspl and Hpall. Mspl cuts DNA regardless of
its methylation status, whereas its isoschizomer Hpall is blocked by CpG methylation.
This confirmed that the Dnmt3~" cells have decreased levels of DNA methylation in
comparison to the Jl cells {figure 5.21A). However, to double check the cell types used,
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Fig. 5.21 Differentiation of DNMT3-'- and J1 cells. (A) Digests with Msp1 and
Hpall to show the DNA methylation status of DNMTS-'-and the wild type (J1)
cells. (B) Cell lines were also checked by PCR for LacZ, Neomycin (Neo) and
Zeocin (Zeo). RT-PCR analysis for Oct4, Sox1, MVH and Actin expression
before and after the differentiation of (C) DNMT3-7- and (D) J1 cells. Lanes are
numbered corresponding to the day of differentiation or no template (H20), no
reverse transcriptase (-) and positive control (+). Brightfield images taken under
phase contrast before and after the differentiation of (E) DNMT3-'- and (F) J1
cells. Scale bar, 50pm.
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by PCR {figure 5.2IB). The cells were then differentiated towards ectodermal lineages
following the protocol described previously (section 4.2; figure 5.21E and F). Whereas
the wild type J1 cells differentiated as expected into numerous cell lineages, the Dnmt37"
cells were restricted in their fate. Morphologically the day 20 Dnmt37" cell population
consisted of cells that looked like clumps of undifferentiated mES cells and others that
might be radial glia. RT-PCR analysis of this population showed that the pluripotent
gene Oct4 was expressed alongside the neural gene Soxl in the differentiated cells
figure 5.21C). However, Soxl expression was also seen in the undifferentiated
population, which means either cells were spontaneously differentiating in the mES cell
population or that Soxl is not repressed in Dnmt37" mES cells. Both populations were
also found to express Mvh. However, no conclusions could be made from these PCRs
because the wild type population also expressed Oct4, Soxl and Mvh at both time points
figure 5.2ID). This was mainly due to the density at which the wild type J1 cells
proliferated, which was substantially faster than the other cell lines I have used and as
such, the concentration of cells to RA and growth factors needs to be optimised before
future differentiations. Despite this the cells from both Dnmt3~" and J1 differentiations
were fixed in 4% PFa for 3D FISH and hybridised to the R198 probe figure 5.22A). As
previously seen for the MeCP2 cells, the clumps of supposed undifferentiated cells in
the cultures, did not survive the 3D FISH protocol. The differentiated cells from both
populations, which adhered to the glass coverslips, were clearly differentiated cells by
the uniform oval shape of their nuclei and large heterochromatic foci. In Dnmt3 ~ cells,
both minor satellite and DAPI foci (major satellite) clustered by day 8 figure 5.22B and
C). Minor satellite averaged 31.5 signals on day 0 to 25.2 signals on day 8 (p=0.009) and
major satellite averaged 18.5 signals on day 0 to 14.4 signals on day 8 (p=<0.001). By
day 20 the average number of minor satellite signals had dropped by 35.9% in Dnmt3~~
cells and 34.7% in the J1 cells, whereas the number ofDAPI foci analysed had decrease
by 25.9% in Dnmt37" cells and 16.4% in the J1 cells. Therefore, I conclude that DNA
methylation is not necessary for the clustering of centromeric heterochromatin. This
conflicts with the paper from Brero et al., (2005), which suggests that DNA methylation
is necessary to promote clustering of centromeres.
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Fig. 5.22 Centromere clustering during the differentiation of DNMT3-'- and
J1 cells. (A) 3D FISH with a mouse minor satellite probe (R198, red) was
carried out on cells fixed at three time points during the differentiation of
DNMT3-/- cells, nuclei counterstained with DAPI (blue). The signals from (B)
minor satellite (R198) and (C) DAPI foci were counted for DNMT3-'- (black bars)




I have shown that the position of four CTs within mouse nuclei, changes during
differentiation (figure 5.1). One of these the CTs for MMU6 contains the region
surrounding the pluripotent gene Nanog. In humans, this region is part of HSA12p, the
CT shown to occupy a more peripheral position in the nuclei of differentiated cells in
comparison to hES cells. However in mouse, MMU6 moved away from the nuclear
periphery during differentiation. This result has been reported previously, during the
differentiation of T-cell precursors (Kim et al., 2004), suggesting that perhaps the
location of this CT in murine precursor cells may confer some transcriptional advantage
upon the chromosome. The global gene expression on MMU6 is known to vary with cell
type. One study showed that more genes are highly expressed on this chromosome in
mES cells than in differentiated cell types, however only 346 genes were analysed, 8 of
which were identified as being highly expressed on MMU6 (Tanaka et al., 2002;
Thomson personal communication). Therefore, it is possible that more genes on MMU6
are expressed in neural progenitor cells, in comparison to mES cells, which would
explain the position of this CT in the differentiated day 18 cell population. Following the
differentiation of mES cells towards ectodermal lineages, the four CTs analysed were
arranged within the nucleus according to gene density. This distribution has previously
been shown for human nuclei (Croft et al., 1999; Boyle et al., 2001) primates (Tanabe et
al., 2002) and chickens (Stadler et al., 2004), therefore its presence in murine cells
would further imply a functional significance to the arrangement.
The position of genes within the nucleus was also found to change during
differentiation, although this seemed to be dependent on transcriptional activity of both
the gene and its surrounding region (figure 5.3). Previous studies into gene position
within the nucleus have shown both genes moving away from the nuclear periphery
when expressed (Zink et al., 2004; Williams et al., 2006) and no gene movement
following activation (Nielson et al., 2002; Parreira et al., 1997). The genes studied here
all followed the position of their CTs with one exception, the neural precursor gene
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Olig2. This gene looped out of its CT and towards the centre of the nucleus in
differentiated cells. If this relocalisation of Olig2 is dependant of gene expression, then
the proportion of loci in the nuclear centre should increase if a purer population of Olig2
positive cells could be obtained. In my system only 15% of the day 18 population
expressed Olig2. A recent report indicated that the percentage of Olig2 expressing cells
could be increased to 33% by adding sonic hedgehog to the culture (Xian et al., 2005).
Alternatively, GFP under the control of the Olig2 promoter could be used to FACs sort
an Olig2 positive population for analysis. The distribution of both Olig2 and Nanog loci
relative to their CTs was consistent with their expression {figure 5.4A and 5.5B).
However, Nestin was looped outside of its CT in mES cells, which do not express the
gene {figure 5.5C). This might be explained by expression of the gene-dense region
surrounding Nestin in mES cells. However, it also poses the question; do genes move
outside of their CT prior to transcription? Ragoczy et al., (2003) has suggested that
looping out of CT represents a poised state, prior to gene expression. Whilst
Chambeyron and Bickmore, (2004) have shown that movement of the Hox locus outside
of its CT, represents a transcriptionally active state.
In both hES cells and lymphocytes, OCT4 was located in the centre of the nucleus
(figure 3.5) whereas in mouse Oct4 moves towards the centre of the nucleus during
differentiation {figure 5.3B). This is likely due to differences in the expression of the
region surrounding Oct4. The relocation also accompanies the movement of Oct4
towards the edge of its CT in the differentiated cells, which is opposite to the result
observed for hES cells {figure 5.4B and C). Again, this was attributed to the late
expression of the class 1 MHC genes in mouse; however, the mean position of two loci
adjacent to Oct4, H2-Q1 and Flotl did not change relative to the MMU17 CT. Therefore
further investigation is need to find out whether other genes flanking Oct4 change
position relative to their CT, or if the almost bi-modal distribution of H2-Q1 represents
different cell types, and expression pattern of these genes within the differentiated day
18 population. The movement of Oct4 to the edge of the CT was also accompanied by
the decondensation of the surrounding region in differentiated cells (figure 5.6), as
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previously shown for human cells (figure 3.8). Therefore, it is possible that Oct4's
position, away from its neighbouring genes and towards the edge of the CT, allows for
the association with a transcriptionally silent region of the nucleus such as centromeres.
The association of genes with centromeric heterochromatin is thought to promote gene
silencing (Brown et al., 1997, 1999; Su et al., 2004). However, here I have shown that
neither Oct4 nor Nanog relocated to centromeric heterochromatin when silenced (figure
5.7), a result also described for the neuronal gene Mashl in ES cells (Williams et al.,
2006).
Accompanying the spatial reorganisation of the genome are changes in global levels of
histone modifications such as decreased H3-K9ac, H3-K4me2 and increased H3-K9me2
(figure 5.8). By immunofluorescence, I have shown that the markers of gene expression
(H3-K9ac and H3-K4me2) are not present at centromeric heterochromatin or the nuclear
periphery in differentiated cells (figure 5.9 and 5.10). This result has been reported
previously for H3-K9ac in human fibroblasts and fibrosarcoma cells (Gilchrist et al.,
2004) and another marker of hyperacetylated chromatin, H4-K8ac in human fibroblasts
and mouse myoblasts (Sadoni et al., 1999). H3-K9me2 however, increases across the
nucleus during differentiation, including at the nuclear periphery (figure 5.10C). A
similar result was observed between quiescent and cycling lymphocytes, were H3-
K9me2 increases as the cells come out of quiescence, suggesting that histone
hypomethylation is a useful indicator of epigenetic plasticity (Baxter et al., 2004).
However, as lymphocytes come out of quiescence their level of H3-K4me2 also
increased, unlike during differentiation. I would suggest that hypomethylation of H3-
K9me2 is a useful indicator of plasticity but not H3-K4me2 as high levels of this histone
modification are also present in mES cells.
Gene expression during oligodendrocyte development has previously been shown to
accompany progressive chromatin modifications at gene promoters (Kondo and Raff,
2004; Song and Ghosh, 2004). In mES cells both H3-K4me2 and H3-K9ac modifications
were present on the Oct4 promoter, however in the day 18 population both of these
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modifications had been lost from the region {figure 5.11). H3-K4me2 was also detected
on the first exon of 01ig2 in mES cells, before the gene was expressed, whereas H3-
K9ac is only present in the differentiated cells where the gene is expressed. Similarly,
Williams et al., (2006) showed that H3-K27me3 was present at the Mashl locus prior to
differentiation, although they see H3-K9ac of this gene in undifferentiated mES cell.
This could reflect differences in the expression patterns of Mashl and Olig2, or the
homology of the starting population, as Williams et ah, (2006) did not treat the cells
with hygromycin before beginning their differentiation.
I found an increased association of centromeric heterochromatin with the nuclear
periphery during differentiation (figure 5.13D). During the differentiation of mES cells
centromeres clustered forming chromocentres. Following two days of culture as hanging
drops without LIF there was a significant clustering of centromeric heterochromatin,
analysed by both 3D FISH with a mouse minor satellite and by counting DAPI foci
(figure 5.14). The clustering continued progressively throughout the differentiation until
on day 18 there was a 37% percent decrease in the number ofminor satellite clusters and
41% decrease in the number of major satellite clusters detectable by FISH (table 5.4).
This result was confirmed by telomere FISH, which showed that 50% of the telomeres
also clustered as expected by day 18 (figure 5.15).
Using mutant ES cells, I showed that this is independent of H3-K9me3 at pericentric
heterochromatin, catalysed by Suv39h. When Suv39h"" cells were differentiated towards
an ectodermal lineage, the centromeres clustered at the same rate as during the OS25
differentiation (figure 5.18; table 5.4). The heterochromatin protein HP1 is also lost
from heterochromatin in Suv39h"~ cells (Fachner et al., 2001), which also suggests that
this protein is not necessary for centromere clustering. Brero et al., (2005) recently
suggested that MeCP2 along with other MBD proteins was involved in centromere
clustering during differentiation, although here I have shown that centromeres cluster
during the differentiation ofmES lacking MeCP2 (figure 5.20; table 5.4).
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Cell Type
% Decrease in number of signals
Minor Satellite DAPI foci
Time Point (Day)
OS25 37 41 18
Suv39h_/" 38 49 8
CGR8 23 32 8
MeCP2 32 23 18
WT41 32 21 18
Dnmt3_/~ 36 26 20
J1 35 16 20
Table 5.4 The percentage decrease in centromeric signals during differentiation of
mutant and wild type mES cells. The number of signals counted on day 0 divided by
the number counted at the end time point of differentiation, expressed as a percentage.
I also analysed centromere clustering in cells with a reduced level of de novo
methylation. Similar to previous results Oct4 did not switch off completely during the
differentiation of Dnmt3_/" cells (Jackson et al., 2004) although due their rapid
proliferation it did not switch off in the wild type cells either. However, centromeres still
clustered during differentiation of the Dnmt3"" cells as for the other cell types (table 5.4;
figure 5.22). Perhaps the clustering in Dnmt3"~ cells is due to a redundancy in Dnmt3
and one of the other methyl transferases is responsible for centromere clustering in this
population of cells, therefore the cells where centromeres do not cluster would die off
during differentiation. Some mutant lines clustered less than the OS25 cells, although
this was due to spontaneous differentiation in the starting population and the increased
cell densities from culturing without the drug selection. I conclude that DNA
methylation does not induce clustering. This opposes the hypothesis put forward by
Brero et al., (2005), however they were using a myogenic differentiation, whereas I have
used an ectodermal differentiation, therefore this affect could be cell type specific.
Perhaps more importantly, they formed this hypothesis based on the over expression of
MeCP2, whereas here I have used MeCP2 null cells. This would suggest that increasing
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the level of MeCP2 within the nucleus can induce clustering, but as I have shown it is
not necessary for chromocentre formation during differentiation.
To my knowledge, this is one of the first reports that DnmtS" can differentiate into
ectoderm in vitro. Most factors shown to influence glia are present in what is essential
an astrogliogenic JAK-STAT pathway leading to GFAP expression (Nakashima et ah,
1999; Song and Ghosh, 2004; Sun et ah, 2001; He et ah, 2005). The demethylation of a
CpG site within the binding element of the STAT transcriptional activator, is required
for binding of STAT3 to the GFAP promoter and expression of GFAP (Teter et al.,
1994; Takizawa et al., 2001). Evidence from Dnmtl7" cells, which display precocious
astroglial differentiation in vivo, shows that the JAK-STAT pathway needs to be
inhibited by DNA methylation to form neurons (Fan et al., 2005). In DnmtS7" cells, LIF
signalling through the STAT3 pathway is normal (Jackson et al., 2004). Therefore, as
some astrocytes do not express either Dnmt3a or Dnmt3b (Feng et al., 2005), it is not
surprising that when pushed towards an ectodermal pathway the DnmtS7" cells would






At the beginning of my PhD, I set out to investigate whether there are cytologically
distinctive features of nuclear organisation in ES cells, and to determine how these
might change during differentiation. Initially I identified the spatial distribution of CTs,
centromeres and genes within the hES cell nucleus (chapter 3), however at that time,
protocols for the in vitro differentiation of these cells were not well developed.
Therefore, to study changes in nuclear organisation that accompany the differentiation of
ES cells towards a specific lineage, I switched to analysing mES cells, which have more
established differentiation protocols (chapter 4). This facilitated, not only the study of
nuclear architecture during differentiation, but also enabled questions relating to the role
of chromatin silencing factors in neural development to be addressed (chapter 5). To
date, this thesis is the only global comparison of mouse and hES cell nuclear
organisation, and provides direct evidence for the spatial rearrangement of the genome
throughout differentiation. Recently however, there has been increasing interest in
epigenetic features that might contribute to the pluripotency of stem cells, and I will try
to set my findings within this context.
6.1 Human ES cells have a distinctive nuclear organisation
In chapter 3, I demonstrated that the classic radial distribution of CTs found in
differentiated cells is already established in hES cells. Since undifferentiated ES cells do
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not express lamins A/C this suggests that the anchoring of gene-poor chromosomes to
the nuclear periphery is independent of this nuclear lamin, as has been previously found
for emerin (Boyle et ah, 2001; Meaburn et ah, 2005). The 12p CT, which contains genes
important for ES cell function, occupies a more central position in the hES cell nucleus
than in a LCL. Interestingly, Kuroda et ah, (2004a) have also described a change in the
position of chromosome 12 during adipocyte differentiation, in this case the change was
not statistically significant, however they compared a terminally differentiated cell to an
already committed progenitor, not a pluripotent stem cell. This suggests that relocation
of the 12p CT might be characteristic of differentiation towards many lineages.
However, whether this change in position is a consequence of higher levels of
chromosome 12 gene expression in hES cells, or is functionally related to pluripotency
remains to be determined. It has been suggested that HSA12p is transcriptionally
advantageous to hES cells, due to the recurrent gain of chromosome 12, including
isol2p, in these cells (Draper et al., 2004). To date, no significant change in the number
of genes expressed on chromosome 12 between hES and differentiated cells has been
reported. In contrast, hEC cells show a four-fold increase in the number of genes highly
expressed on chromosome 12, when compared to hES cells (Sperger et al., 2003).
Therefore, it would be interesting to compare the location of the 12p CT in hES and hEC
cells with their differentiated counterparts, to determine whether maintaining a higher
level of gene expression on chromosome 12 would affect the movement of this CT
during EC cell differentiation, following the repression of the pluripotent genes.
It is unlikely that 12p is the only CT to change position during differentiation. Whatever
this CT displaces by moving towards the periphery, may move into the space vacated by
it in the centre of the nucleus. I have also shown that centromeres can relocate from the
nuclear interior to the periphery during development, which agrees with the distribution
previously shown for differentiated cells (reviewed in Gilchrest et al., 2004). It is still
not known what determines the nuclear distribution of centromeres. Levels of histone
acetylation have been reported to alter their position in both mouse and human cells
(Taddei et al., 2001), which in the mouse, only occurs at satellite repeats upon
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differentiation of ES cells (Keohane et al., 1996). This would be consistent with my
data; however, other important changes to the hES cell nucleus, such as the association
of lamin AJC with the nuclear periphery (Constantinescu et al., 2006), might also
influence this relocation.
I have shown that in hES cells the gene-dense lip 15.5 region loops out of its CT
whereas lip 13 is active from within the CT, as previously shown for differentiated cells
(Mahy et al., 2002b). In accordance with this, a recent study by Brown et al., (2006) has
shown that the fi-globin gene (lip 15.4) is predominantly located within the lip CT in
both non-expressing hES cells and expressing erythroid cells. Together these results
suggest that some regions of the genome occupy a set position relative to their CT
regardless of cell type/ transcriptional status, which is likely to be influenced by the
surrounding genomic environment. In contrast, other genomic regions that contain
domains of co-ordinately regulated genes e.g. Hox, MHC, EDC (Chambeyron and
Bickmore, 2004; Volpi et al., 2000 and Williams et al., 2002), relocate to positions
outside of their CTs coincident with their expression.
I have shown that NANOG, an important transcription factor for the maintenance of
pluripotency, moves with its CT away from the nuclear centre during differentiation,
whereas no change in radial nuclear position of 6p or OCT4 was detected between hES
cells and differentiated cells. However, compared with LCLs, OCT4 is located
significantly closer to, or just beyond the CT edge in hES cells. The chromatin structure
surrounding OCT4 has not been studied in hES cells but, in mouse, increased DNA
methylation, H3-K9 methylation and histone deacetylation of the Oct4 promoter are
seen in differentiated cells compared with mES cells (Hattori et al., 2004; Feldman et al.,
2006). The data I have presented would be consistent with a similar remodelling at the
OCT4 locus in hES cells, and might contribute to its transcriptional regulation.
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6.2 Nuclear reorganisation during the differentiation of mouse ES cells
The differentiation of mES cells into ectodermal lineages has been achievable for the
last ten years. However, one of the biggest problems facing the stem cell field is that of
obtaining a pure population of differentiated cells. No differentiation protocol to date,
has obtained a single lineage from an ES cell without the use of selection, and even with
selection, the population is constrained by marker genes which are unlikely to be
expressed by a single cell type. Therefore, using the OS25 cells described previously
(Billon et al., 2002); in chapter 4, I differentiated mES cells into a restricted population
of Oct4 negative, Sox2 positive cells. This resulted in a mixed population of neuronal
and glial precursor cells, which I maintained in their progenitor state by adding bFGF
(Li et al., 1998; Okabe et al., 1996). The balance between cell density and concentration
of bFGF is key to this differentiation, as low levels of bFGF are known to increase
neuronal differentiation, while higher levels expand glial progenitors (Dono et al., 1998;
Qian et al., 1997). In addition, bFGF also regulates the expression of epithelial growth
factor receptor (EGFR), which correlates with the appearance of astrogliogenic
progenitors (Lillien and Raphael, 2000). In comparison to protocols that use either OS25
cells or their parental cell line, which has only Sox2 under selection, a similar percentage
of cells were expressing Soxl or Nestin at the end of the differentiation (Li et al., 1998;
Billon et al., 2002; Perry et al., 2004). However, the absence of EGF in my culture
media restricted the ability of these cells to proliferate and as markers ofmore terminal
differentiation repressed Sox2, the cells died and the population size was greatly
reduced. This differentiation would be improved by the addition of EGF alongside
bFGF, to allow for the expansion of these self-renewing neural precursors (Conti et al.,
2005).
In chapter 5, I compared the nuclear organisation of mES cells with cells differentiated
towards an ectodermal lineage, using the protocol described in the previous chapter. I
have shown that in mES cells the distribution of CTs has some similarity to chromosome
size, whereas in the differentiated day 18 cell population CTs were arranged according
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to gene density. Therefore, the distribution of CTs in mouse changes during
differentiation of ES cells towards ectodermal lineages. This result led me to analyse the
radial position of specific gene loci on these chromosomes, which was of particular
interest since several genes have been reported to relocate away from the nuclear
periphery when expressed (Zink et al., 2004; Williams et al., 2006). Out of the four
genes analysed, none associate with the nuclear periphery when repressed {table 6.1).
The two genes analysed that become expressed during the differentiation, Nestin and
Olig2, both moved to a more central location in the nucleus. However, Oct4 and Nanog,
which were repressed during the differentiation also moved away from the nuclear
periphery. The relocalisation of these pluripotent genes during differentiation reflects the
movement of their respective CTs towards the nuclear centre. 1 therefore concluded that
although expression of some neural genes is accompanied by relocation away from the
nuclear periphery, the repression of the pluripotent genes Oct4 and Nanog occurs by a
mechanism independent of this.
I also located each of these genes relative to their CTs. Unlike in hES cells, where
NANOG remained in the interior of its CT and the whole CT move, in mES cell, Nanog
was found significantly closer to the edge of its CT when compared to the differentiated
day 18 cells. In contrast Oct4, moved significantly nearer the CT edge when repressed in
differentiated mouse cells, than in mES cells. I think that this is likely to be due to the
activation of the surrounding MHC class I genes, which are not active in mES cells
(Tian et al., 1997) and the expression of the class III genes, as I have shown a
decondensation of the chromatin fibre between Oct4 and H2-Q1 during differentiation.
Similarly, Nestin also located outside of its CT in a proportion of cells when not
expressed, which is probably due to the surrounding genomic environment. The
distribution of Olig2 however, was found to change significantly during the
differentiation, although the majority of loci were still located within the CT, there was a
9% increase in loci found >0.2pm outside of its CT. This likely reflects the -15%



















































































Table 6.1 The position of four loci in pluripotent and differentiated cells. The radial
position of the four genes and their respective CTs, and the position of these genes
relative to their CTs analysed in mES and differentiated cells in chapter 5, alongside
results for two of the genes analysed in hES cells and LCL in chapter 3. Human cell
lines are highlighted in green. Replication timings are taken from Perry et ah, (2004).
It is interesting that both Oct4 and Nanog show different patterns of nuclear organisation
between mouse and hES cells, whereas the differentiated cell types analysed from both
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species show the same spatial arrangement for these genes. This probably reflects the
similarity in expression of their surrounding genomic regions, between mouse neural
precursors and human lymphoblasts. Recent a study of a and (3-globin genes in mouse
and hES cells illustrated the importance of this underlying chromosomal context in
cross-species comparisons (Brown et ah, 2006). In the human genome, a-globin is
within a very gene dense region of open chromatin on HSA16 (102 genes within 2Mb)
and predominantly locates outside of its CT, whereas in the mouse genome this gene is
situated in a relatively gene-poor region (21 genes within 2Mb) and is frequently located
within the CT irrespective of transcriptional status. It has also been suggested that some
genes are located to centromeric heterochromatin when silenced (Brown et ah, 1997;
Skok et ah, 2001), however this was not seen for either Oct4 or Nanog.
6.3 Epigenetic modifications and ES cell differentiation
I have shown that there is a global increase in H3-K9me2, whereas levels of both H3-
K9ac and H3-K4me2 decrease following the differentiation of mES cells. This is
confirmed by other analyses published during the course ofmy PhD (Lee et ah, 2004;
Hsieh et ah, 2004). However, in the latter stage of this project, I began work using ChIP
to identify these modifications at specific gene loci. Preliminary results show that both
H3-K4me2 and H3-K9ac are present at the promoter region of Oct4, where the gene is
expressed in mES cells but not in the differentiated cell population. This is confirmed by
previous studies, which show the Oct4 region to be hyperacetylated in mES cells
(Hattori et ah, 2004; Kimura et ah, 2004). However, both of these modifications were
also present at the Olig2 promoter in mES cells, well in advance of gene expression.
Another histone modification, H3-K27, which is thought to prevent early gene
expression (Bernstein et ah, 2006a; Boyer et al., 2006) has also been reported at the
Olig2 locus in mES cells (Azuara et al., 2006). This combination of epigenetic markers
prior to expression was also reported for the neuronal gene Mashl, in mES cells
(Williams et al., 2006). It is interesting to note that this change in histone modifications
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has been shown to accompany a change in the replication timing of some genes during
differentiation (Perry et ah, 2004; Azuara et al., 2006). In the case ofMashl, Olig2 and
Nanog this coincides with their relocation within the nucleus (Williams et al., 2006; and
this thesis) whereas Oct4, which is early replicating throughout the differentiation, does
not change its position within the nucleus (table 6.1).
6.4 Progressive centromere clustering during differentiation
In chapter 5, I have shown that unlike hES cells, centromeres were distributed
throughout the z-plane of both mES cells and their differentiated counterparts, although
in agreement with Mayer et al., (2005) significantly more centromeres were located at
the nuclear periphery in differentiated cells. This would be consistent with the general
movement of CTs toward the centre of the nucleus. It was also very apparent during this
differentiation that centromeres were progressively clustering to forms chromocentres,
shown previously in neuronal cells (Manuelidis, 1984) and during myogenesis (Brero et
al., 2005; Terranova et al., 2005). A recent study reported that only major satellite is
involved in this clustering, whereas minor satellite is located at the periphery of the
clusters and forms individual entities (Guenatri et al., 2004). However, my data would
suggest that both major and minor satellite sequences cluster during differentiation.
To investigate epigenetic mechanisms that might be responsible for the nuclear
reorganisation and clustering of centromeric heterochromatin, I analysed this clustering
during the differentiation of mES cells with null mutations for Suv39h, MeCP2 and
Dnmt3a/3b. In the Suv39~ ~ cells both the differentiation and the centromere clustering
occurred as normal, therefore H3-K9me3 at major and minor satellites is not required for
centromere clustering, which was later confirmed by Brero et al., (2005). However,
whereas Brero et al., (2005) have reported that over-expression of MeCP2 can induce
clustering in the absence of differentiation in myoblasts. Therefore, they suggested that
DNA methylation and MeCP2 are both needed to promote chromocentre clustering.
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However, using knock-out ES cells I have shown that neither DNA methylation nor
MeCP2 is necessary for the clustering of centromeric heterochromatin during
differentiation. This is particularly interesting because mutation in Dnmt3b causes an
aberrant chromatin structure at pericentric heterochromatin (Xu et al., 1999). Therefore,
over expression ofMBPs might cause excess clustering in interphase nuclei (Brero et al.,
2005), but DNA methylation is not necessary for their formation during differentiation.
6.5 Future directions
The finding that CT 12p was located in a different position in the hES cell nucleus when
compared to a LCL, poses an interesting question, do large regions of the genome that
are involved in stem cell function all change position during differentiation, or is this
result specific to chromosome 12p? The most enriched region of 'stem cell' genes is on
HSA 17, which is the other chromosome to be gained by hES cells in culture (Ramalho-
Santos et al., 2002; Draper et al., 2004). However, being one of the most gene-dense
chromosomes, HSA 17 is situated towards the nuclear centre in differentiated cells
(Boyle et al., 2001). Therefore, it is unlikely that this CT would change position during
differentiation, although it would be interesting to follow the clusters of genes involved
in 'sternness' on chromosome 17, to see if they are rearranged within the nucleus. It is
suggested that CTs themselves have a 'polar' organisation, whereby gene-rich regions
are in the centre of the nucleus and gene-poor regions and centromeres are located
towards the nuclear periphery (Ferguson and Ward, 1992; Amrichova et al., 2003). This
arrangement is not fully established in hES cells, as I have shown that centromeres are
located within the centre of the nucleus. Therefore, it would be interesting to follow the
early differentiation of hES cells to find out when this reorganisation occurs, and how it
relates to the association of proteins such as Lamin A/C at the nuclear periphery.
Similarly, I have shown that the radial organisation of CTs is already present in hES
cells, so it would be interesting to look at cells prior to the mid-blastocyst stage and find
out when this arrangement is first apparent, and how the genome becomes organised
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following fertilization i.e. what comes first, transcription or organisation? In the mouse a
recent paper has reported that the organisation of chromocentres is completed at the
blastocyst stage, corresponding with the onset of differentiation (Martin et al., 2006). It
would be interesting to see if this organisation occurs on a comparative time scale in
human development, as I have shown that hES cells have yet to establish this spatial
distribution of centromeres.
It is possible that the distribution of centromeres in hES cells is related to their rapid cell
cycle time. This would be addressed by repeating the analysis on cells isolated at
different times during the cell cycle, and might provide further understanding of their
spatial arrangement. Another question to be addressed is where are these genes
relocating? Studies have shown the specific genes locate to PML bodies (Shiels et al.,
2001; Wang et al., 2004b) SC-35 nuclear speckles (Brown et al., 2006) and transcription
factories (Osborne et al., 2004) when active, and centromeric heterochromatin when
repressed (Brown et al., 1997), although currently the factors which determines whether
or not a gene leaves its CT to associate with one of these regions are still unclear. Over
the next few years, as more regions are identified that locate to nuclear organelles and
the epigenome is progressively mapped, markers that identify these genomic regions
should become more apparent. It would also be useful to control the movement of genes
within the nucleus. Currently this is not possible on a single gene basis, but as Tsuji-
Takayama et al., (2004) have shown that demethylating the genome with 5-azacytidine
switches pluripotent genes back on, it would be intriguing to see if re-expression of Oct4
cause the gene to relocate back outside of its CT in human cells.
Recently, the idea that genes are maintained in an open state in ES cells, has been
supported by the discovery of H3-K27 within lineage specific genes, which prevents
their expression via polycomb mediated repression (Bernstein et al., 2006a; Boyer et al.,
2006). However, confirmation of this theory would be provided by a combined sucrose
sedimentation / genomic microarray approach, as used by Gilbert et al., (2004) to
demonstrate the distribution of open and closed chromatin across the human genome in a
196
LCL. Polycomb proteins are also located at pericentromeric heterochromatin (Saurin et
al., 1998). This is especially relevant in Suv39h~" mice, whereby loss of pericentric H3-
K9me3 is compensated by H3-K27me3 and H3-K9me suggesting cross talk between
constitutive and facultative heterochromatin to rescue the repressed state (Peters et al.,
2003). Therefore, these proteins might be responsible for the clustering of centromeres
during differentiation.
The nuclear reprogramming capacity of oocytes was first demonstrated in mammals
nearly ten years ago (Wilmut et al., 1997). Since then nuclear transfer has been shown to
generate mice from post-mitotic cells, such as neurons, demonstrating that even
terminally differentiated cell retain the potential for pluripotency (Eggan et al., 2004).
Recently, hES cells were shown to be capable of nuclear reprogramming in somatic cell
fusion (Cowan et al., 2005). However, with the announcement this year from the
Yamanaka Lab in Kyoto, that a combination of only Oct4 and three other transcription
factors can reprogram an adult fibroblast back into an ES cell (Zwaka personal
communication) the stem cell field is looking for better ways to define these cells.
Surface markers and gene expression profiles will not be enough to predict the
behaviour of ES cells in vivo. Therefore, a comprehensive epigenetic map of pluripotent
stem cells is needed ifwe are ever going to follow a direct lineage.
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Summary
Nuclear organisation is thought to be important in
regulating gene expression. Here we investigate whether
human embryonic stem cells (hES) have a particular
nuclear organisation, which could be important for
maintaining their pluripotent state. We found that whereas
the nuclei of hES cells have a general gene-density-related
radial organisation of chromosomes, as is seen in
differentiated cells, there are also distinctive localisations
for chromosome regions and gene loci with a role in
pluripotency. Chromosome 12p, a region of the human
genome that contains clustered pluripotency genes
including NANOG, has a more central nuclear localisation
in ES cells than in differentiated cells. On chromosome 6p
we find no overall change in nuclear chromosome position,
but instead we detect a relocalisation of the 0CT4 locus, to
a position outside its chromosome territory. There is also a
smaller proportion of centromeres located close to the
nuclear periphery in hES cells compared to differentiated
cells. We conclude that hES cell nuclei have a distinct
nuclear architecture, especially at loci involved in
maintaining pluripotency. Understanding this level of hES
cell biology provides a framework within which other
large-scale chromatin changes that may accompany
differentiation can be considered.
Key words: Centromere, Chromosome territory, Embryonic stem
cell, NANOG, Nucleus, OCT4
Introduction
The human genome is spatially organised within the nuclei of
differentiated cells. There is a radial arrangement of
chromosome territories (CTs): gene-rich chromosomes such as
chromosome 19 (HSA19) concentrate in the centre of the
nucleus and more gene-poor chromosomes (e.g. chromosome
18) localise toward the nuclear periphery (Croft et al., 1999;
Boyle et al., 2001; Cremer et al., 2001; Cremer et al., 2003).
Centromeres are also generally found at the nuclear periphery,
or around nucleoli (Carvalho et al., 2001; Weierich et al., 2003;
Gilchrist et al., 2004), whereas telomeres are mainly found in
the nuclear interior (Weierich et al., 2003). Gene clusters, and
individual chromosomal domains also have distinctive
localisations within respect to their CTs (Volpi et al., 2000;
Williams et al., 2002; Mahy et al., 2002a).
In model organisms it is clear that nuclear organisation can
regulate gene expression (Spector, 2003). Data are consistent
with nuclear organisation also being a determinant of gene
expression for the human genome. Therefore, there may be
differences in the nuclear organisation of different cell types.
Indeed, in some human cell types (amniocytes and fibroblasts)
with flat/ellipsoid-shaped nuclei, HSA18 can be found toward
the nuclear centre rather than at the nuclear periphery, as is
typical in cells with more spherical nuclei (lymphocytes,
keratinocytes, colon and cervix epithelial cells) (Cremer et al.,
2001; Cremer et al., 2003). In the mouse, differences in the
spatial and radial distribution of chromosomes have been
documented in different tissues of the animal (Parada et al.,
2004) as well as during the differentiation of T cells (Kim et
al., 2004). However, to date no significant change in radial
position of a human chromosome within the nucleus has been
documented during differentiation, although there may be
changes in chromosome associations (Kuroda et al., 2004).
Within CTs themselves, the position of gene clusters is
altered in different differentiated human cell types (Volpi et al.,
2000; Williams et al., 2002). This aspect of nuclear
organisation has not been studied in human stem cells, but in
the mouse, movement of specific genes out of CTs has been
seen upon the differentiation of ES cells (Chambeyron and
Bickmore, 2004). Human centromeres are localised close to
either the nuclear periphery or the nucleolus (Carvalho et al.,
2001; Weierich et al., 2003). However, changes of centromere
distribution in relation to cell cycle, physiological or
differentiation state have been reported (reviewed by Gilchrist
et al., 2004). In addition, lineage-specific centromere
associations into chromocentres have been reported during
lymphoid and myeloid differentiation, with an overall increase
in centromere clustering towards later stages of differentiation
(Beil et al., 2002; Alcobia et al., 2003).
If nuclear organisation regulates gene expression, then it
may have a key role in restricting it, as cells become more
committed to a differentiation pathway. Therefore it is
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important to determine how the genome is organised in the
nucleus of pluripotent cells, and particularly in stem cells
(Fisher and Merkenschlager, 2002). The organisation of human
chromosomes and centromeres has been studied in
haemopoietic progenitor cells (Cremer et al., 2003) and in
CD34+ stem cells from umbilical cord blood (Alcobia et al.,
2003). However, there have been no studies of nuclear
organisation in hES cells.
Human ES cells have been derived from the inner cell mass
of blastocysts, and as well as being able to self-renew, they
have the ability to differentiate into all three embryonic germ
layers when injected into severe combined immunodeficient
mice (Thomson et al., 1998). It is anticipated that hES cells
will be an important tool for understanding early human
development, with the hope that they may also have therapeutic
potential. Although they share many features with mouse ES
(mES) cells, including the expression of common genes
important for pluripotency, there are also key differences
between mES and hES cells (Pera and Trounson, 2004; Ginis
et al., 2004). Moreover, there are fundamental differences in
the organisation of chromosomes between the human and
mouse genomes. Therefore, mES cells cannot serve as a
suitable model for studying the nuclear organisation of human
stem cells and an investigation of hES cell nuclei is required.
Here we compared the nuclear organisation of differentiated
human cells with hES cells. We show that hES cells have a
radial organisation of chromosomes in the nucleus that relates
to gene density and that is typical of many differentiated cell
types. However, we find differences in the localisation of
chromosomes and gene loci with known roles in pluripotency.
We also describe differences in centromere position in hES cell
nuclei.
Materials and Methods
Human ES cell culture and analysis
Human ES cell lines HI (46XY), H7 and H9 (46XX) (Thomson et
al., 1998) were grown as previously described, with minor
modification (Xu et al., 2001). Briefly, the cells were cultured on
Matrigel-coated culture dishes with mouse embryonic fibroblast
conditioned medium supplemented with 8 ng/ml basic fibroblast
growth factor. Cells were routinely split 1:3 with collagenase. H7 cells
were passage (p)55. HI cells were used at p42-65 and H9 cells were
at p39-55.
The cells were analysed by flow cytometry for the hES cell surface
antigens SSEA4 and Tra-1-60 using a FACScan (BD Biosciences).
Briefly, hES cells were harvested by trypsin/EDTA and washed with
phosphate-buffered saline (PBS). After treatment with 10% goat
serum to block non-specific binding, the cells were incubated with
monoclonal antibodies against SSEA4 (1:5, DSHB, IA) or Tra-1-60
(1:12, Chemicon) on ice for 30 minutes. The cells were then treated
with goat anti-mouse IgG3-FITC or goat anti-mouse IgM-PE (both at
1:100, Southern Biotechnologies). Finally, 104 cells were acquired for
each sample and analysed with CELLQUEST software.
Human (46XY) 1HD primary fibroblasts and FATO LCLs (46XY)
were grown as described previously (Croft et al., 1999).
Fluorescence in situ hybridisation
Chromosome paints were labelled with biotin-16-dUTP by nick
translation or by PCR amplification (Croft et al., 1999) or obtained
commercially (Cambio). BACs were labelled by nick translation with
digoxigenin-ll-dUTP. 200 ng paint and 70 ng BAC were used per
slide, with 6 p,g human Cotl DNA (GIBCO BRL) as competitor.
For 2D analysis, cells were swollen in 75 mM KC1 before fixation
in 3:1 methanokacetic acid. Hybridisation was as described previously
(Croft et ah, 1999) but with the denaturing time reduced to 1.15
minutes for hES cells. For 3D analysis, hES cells were trypsinised and
washed twice in PBS before permeabilisation in CSK buffer (100 mM
NaCl, 300 mM sucrose, 3 mM MgCb, 10 mM PIPES, pH 6.8, 0.5%
Triton X-100) for 5 minutes on ice. After washing in PBS, cells were
fixed with 4% paraformaldehyde/PBS for 10 minutes, washed again
in PBS and cytospun onto slides at 11 g (Shandon, Cytospin3) for 5
minutes. Slides were then subjected to freeze-thaw in 20%
glycerol/PBS and FISH was carried out as described previously (Croft
et al., 1999). To check the preservation of nuclear structure after
cytospinning, we compared the nuclear organisation of centromeres
in primary fibroblasts grown on slides to that of primary fibroblasts
cytospun onto slides.
After hybridisation, biotinylated probes were detected using
fluorochrome-conjugated avidin (FITC or Texas Red) (Vector
Laboratories) followed by biotinylated anti-avidin (Vector
Laboratories) and a final layer of fluorochrome-conjugated avidin.
Digoxigenin-labelled probes were detected with sequential layers of
FITC-conjugated antidigoxigenin (BCL) and FITC-conjugated anti-
sheep antibody (Vector Laboratories). Slides were counterstained with
0.5 p,g/ml DAPI. Telomere FISH was carried out using a telomere
PNA FISH Kit (DAKO).
Immunofluorescence
Centromeres were detected by immunofluorescence using either a
CENP-C antibody (gift of W. Earnshaw, Wellcome Trust Centre for
Cell Biology, University of Edinburgh, UK) and FITC-conjugated
anti-rabbit secondary antibody, or CREST serum and a Texas Red
anti-human secondary antibody. PML bodies were detected using
5S10 monoclonal antibody and Texas Red anti-mouse secondary
antibody. Nucleoli were detected using a Ki67 antibody and FITC-
conjugated anti-rabbit secondary antibody. All secondary antibodies
were supplied by Jackson ImmunoResearch Laboratories.
Image capture and image analysis
2D slides were examined using a Zeiss Axioplan fluorescence
microscope fitted with a triple band-pass filter (Chroma #83000).
Grey-scale images were captured with a cooled CCD camera
(Princeton Instruments Pentamax) and analysed using custom IPLab
scripts. For 3D analysis, a focus motor was used to collect images at
0.25 p.m intervals in the z-plane using a Xillig CCD camera. 3D image
stacks were analysed using IPLab and deconvolved using Hazebuster
(Vaytek).
The radial distribution of CTs was determined in 2D specimens by
an erosion script, as previously described (Croft et al., 1999). The
radial distribution of specific gene loci was assessed manually across
the five erosion shells from the edge (shell 1) to the centre (shell 5) of
the nucleus. These distributions were normalised to the proportion of
the total DAPI signal present in each shell. 3D chromosome position
was determined as previously described (Bridger et al., 2000).
Analysis of probe position relative to the surface of CTs, and
interphase separation (d) were as previously described (Mahy et al.,
2002a; Mahy et al., 2002b; Chambeyron and Bickmore, 2004).
Differences in the nuclear position of CTs and gene loci were tested
for statistical significance using a Mann-Whitney U test in Minitab
13. This is a nonparametric test of the hypothesis that two groups
come from the same distribution, without assuming that the data are
normally distributed.
3D analysis of centromeres and telomeres in the z-plane was
performed using a custom IPLab script. Briefly, the script defines the
outline of the DAPI nucleus in each frame of the z-stack, calculates
the highest level of intensity for each fluorescent spot and locates
which frame the spot is positioned in.
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Results
HSA18 and 19 have a radial distribution in the nuclei of
human ES cells
The radial distribution of CTs in the nucleus, related to their
gene density, was first described for HSA18 and 19 (Croft et
al., 1999). These chromosomes are of approximately the same
size (76 and 63 Mb, respectively) but HSA 18 is very gene-
poor, harbouring an estimated 449 genes, whereas HSA19 is
very gene-rich with 1528 genes (http://www.ensembl.org/
Homo_sapiens/). HSA18 is found towards the nuclear
periphery in a variety of differentiated cells and HSA19 is in
the centre of the nucleus (Croft et al., 1999; Cremer et al.,
2003). This radial distribution is conserved amongst primates
(Tanabe et al., 2002) and it is also applicable to other human
chromosomes (Cremer et al., 2001; Boyle et al., 2001).
We investigated the radial position of HSA18 and HSA19 in
the nuclei of HI (XY) and H9 (XX) hES cells. The cells were
cultured on Matrigel and the expression of cell-surface antigens
SSEA-4 and Tra-1-60 cells was analysed by flow cytometry. Of
the HI cells, 70% were SSEA-4 positive and 55% were positive
for Tra-I-60, indicating that most of the cells in the culture were
undifferentiated (Draper et al., 2002; Carpenter et al., 2004).
Chromosome position was first established using fluorescence
in situ hybridisation (FISH) with chromosome paints for
HSA18 and 19 in 2D preparations (Fig. 1A). Although this
flattens nuclear morphology, it does not alter the measured
radial distribution of chromosomes (Croft et al., 1999), and it
allows for rapid and automated analysis of large numbers of
nuclei. The radial position of each CT was established from the
distribution ofhybridisation signal, relative to that of total DNA,
in five erosion shells (Croft et al., 1999; Boyle et al., 2001). In
both cell lines, HSA19 has a more central nuclear location than
HSA18 CP=S0.001), and data for HI cells is shown in Fig. IB.
This was confirmed by 3D analysis of HI cells (Fig. 1C).
HSA18 is significantly closer to the nuclear periphery than
HSA19 in the x and y-axes (P^O.OOl), though differences
through the z-axis were not significant (P=0.68).
An altered nuclear distribution of 12p in human ES cells
The data in Fig. 1 suggest that CTs in hES cell nuclei have a
gene-density-related radial organisation similar to that seen in
many differentiated human cell types. (Cremer et al., 2001;
Cremer et al., 2003). To determine whether there might be
changes in the nuclear distribution of specific CTs in hES cells,
we examined the radial position of the CTs that carry genes with
a known role in maintaining the undifferentiated state. OCT4
(POU5F1) is located within a cluster of non-class I genes
embedded within the MHC class I region on HSA6p21.33.
OCT4 expression is essential to maintain the undifferentiated
phenotype of hES cells (Matin et al., 2004). NANOG (12pl3.31)
expression is also required to maintain the undifferentiated state
of hES cells (Zaehres et al., 2005). We hybridised chromosome
paints for 6p and 12p, together with BACs for OCT4 and
NANOG, to nuclei from hES cells and lymphoblastoid cells
(LCLs) (Fig. 2A). The radial position of the CTs was
established using the same erosion analysis as used in Fig. 1.
We have previously reported that human chromosomes 6 and
12 have nuclear distributions in LCLs and fibroblasts that are
intermediate between those of HSA18 and HSA19, i.e. they are
located neither at the nuclear periphery, nor in the nuclear centre
(Boyle et al., 2001). This was confirmed here for 6p and 12p in
LCLs (Fig. 2B). There was no significant difference in the radial
position of 6p between LCLs and hES cells. However, 12p was
located significantly closer to the nuclear centre (shell 5) in hES
cells compared to LCLs (P=0.04) (Fig. 2B).
Nuclear organisation of pluripotency genes in ES and
differentiated cells
IfCT radial position differs between ES cells and differentiated
cell types, then it might be expected that the radial position of
specific gene loci on these chromosomes follow that of their
host chromosome. Consistent with this, NANOG (12p), but not
OCT4 (6p) was located closer to the nuclear centre in hES
compared with LCLs (Fig. 2C).
Fig. 1. The radial distribution of
HSA18 and 19 in hES cells.
(A) hES cell nuclei,
counterstained with DAPI (blue)
and hybridised with chromosome
paints for HSA18 or 19. (B)
Distribution of HSA18 and 19
hybridisation signals within the
nucleus of HI ES cells analysed
by erosion of 2D images into five
concentric shells from the edge
(1) to the centre (5) of the
nucleus. The mean (±s.e.m.)
proportion of hybridisation
signal, normalised to the amount
of DAPI signal, is shown for each
shell (n=50). (C) Analysis of
HSA18 and 19 hybridisation
signals within 3D-preserved hES
cell nuclei. Graphs are the
distributions of the centres of the
HSA18 and 19 territories, along
the fractional radius of each
nucleus, along the x, y and z-axes
(«=20). Bar, 5 prn.
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Fig. 2. Radial distribution of 6p, 12p, OCT4 and NANOG in ES
cells. (A) Interphase hybridisation of BAC probes containing OCT4
or NANOG (red), and chromosome paints for either 6p or 12p
(green), within the nuclei of human ES cells counterstained with
DAPI (blue). (B) Distribution of HSA6p and 12p hybridisation
signals within the nucleus of ES cells, by erosion of 2D images into
5 concentric shells from the edge (1) to the centre (5) of the
nucleus. The mean (±s.e.m.) proportion of hybridisation signal,
normalised to the amount of DAPI signal, is shown for each shell
(n=50). C) Distribution of hybridisation signals from OCT4 or
/VAAOG-containing BACs within the nucleus of ES cells, by
erosion of 2D images into five concentric shells from the edge (1)
to the centre (5) of the nucleus. The proportion of hybridisation
signals, normalised to the amount of DAPI signal, is shown for
each shell (n=50). Bar, 5 p,m.
As well as having a radial organisation within the nucleus,
CTs also have a distinctive architecture themselves. In
differentiated cells, gene-rich domains and regions of
coordinately regulated gene expression, loop out from CTs
(Volpi et al., 2000; Mahy et al., 2002a). One of the gene-rich
domains of the human genome that we have previously shown
to loop out from its CT in LCLs is the distal part of llpl5.5
(Mahy et al., 2002a). We found that loci from 11 p 15.5
(positions 0.25-2.1 Mb, NCBI build 35, http://
www.ensembl.org/Homo_sapiens) are also located outside the
1 lp territory in hES cell nuclei, even though this region of the
genome does not contain any genes with a known role in
maintaining pluripotency (Table 1). In contrast, RCN, which is
expressed in both LCLs (Mahy et al., 2002b) and hES cells
(Ramalho-Santos et al., 2002), but which is located in a low
gene-density region at 11 pi3 (32Mb), remains inside the CT
(Table 1). Therefore, CT architecture is well developed in hES
cells, and is organised in a similar manner to differentiated
cells, with regions of generally high gene density located out
side of CTs.
To determine whether a specific CT architecture could be
detected at pluripotency genes expressed in ES cells, we
analysed the intra-CT position of NANOG and OCT4. We
measured the distances between hybridisation signals for BACs
for the specific loci, and the visible edge of the hybridisation
signal for the corresponding CT (Mahy et al., 2002). We found
that NANOG is located well within the 12p CT in both LCL
and ES cells (Table 1, Fig. 3A).
However, the intra-CT behaviour of NANOG contrasts with
that of OCT4, which is a non-class I gene, embedded within
the MHC Class I region (Fig. 3A). Classical class I region
genes are expressed constitutively in human LCLs and
fibroblasts. Unlike mES cells, hES cells also express class I
genes (Tian et al., 1997; Drukker et al., 2002; Draper et al.,
2002; Carpenter et al., 2004). The Class I and Class III regions
have been found outside CTs in LCLs (Volpi et al., 2000). We
confirmed this using BACs that flank OCT4 and that contain
either another non-class I gene (FLOT1), or the most
centromeric genes of the class I region (MICB). We found that
these regions were located, on average, outside the 6p CT in
hES cells (Table 1 and Fig. 3A). However, the mean position
of the intervening OCT4 locus differed between ES and LCL
cells. On average, OCT4 was just inside the CT in LCLs, but
outside the CT in ES cells (Table 1 and Fig. 3A). This
difference was small, but statistically significant (P=0.041).
Analysing the distribution of distances revealed that this
Table 1. Intra-CT position of loci in hES cells and LCLs
Cytogenetic Genomic position Position relative to CT edge
Locus position (Mb) Probe name LCL (p.m) ES (|xm)
IF1TM3 1 lp15.5 0.2 D11S483 -1.4±0.3 -0.70±1.13
INS 1 Ip 15.5 2.1 CINS/IGF2 -0.6±0.2 -0.55±0.15
RCN 1 lp 13 32 cHl 1148 0.6±0.2 0.26±0.04
NANOG 12p 13.31 7.8 RP11-358117 0.23±0.06 0.32+0.04
FLOTI 6p21.33 30.8 RP11-324F19 -0.07±0.07 -0.11 ±0.08
OCT4 6p21.33 31.2 RP11-1058J10 0.03±0.06 -0.15±0.09
MICB 6p21.33 31.6 RP11-184F16 -0.25±0.09 -0.31 ±0.16
The cytogenetic position and genome position (from NCBI build 35, http://www.ensembl.org/Homo_sapiens) of each locus is indicated, together with the
name of the cosmid or BAC probe used in FISH. Mean (±s.e.m.) position, in pin, of specific loci relative to the edge of CTs in nuclei from hES cells and from
LCLs. Negative values indicate positions outside the visible limits of the CT. LCL data for 1 lp 15.5 loci is taken from Mahy et al., 2002a.
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Fig. 3. Intrachromosome territory organisation of NANOG and
OCT4. (A) Position (mean±s.e.m.) in |xm, relative to the inside, edge
or outside CTs, for loci including NANOG and OCT4, as well as loci
flanking OCT4, in the nuclei of hES cells (□) and LCLs (■)
(rc=100). Negative values indicate localisation outside the CT. The
map of the genomic regions around OCT4 and NANOG (according to
NCBI build 35) is shown below. Genes present in the BACs used are
highlighted in bold. (B) Histogram of the distribution of FISH
signals from a BAC containing OCT4, relative to the edge of the
chromosome 6p CT, in nuclei from hES cells (open bars) and LCLs
(filled bars). Negative distance indicates localisation outside the
visible limits of the CT (n=100).
change in mean intra-CT position represented, not a change in
the overall percentage of OCT4 loci found well (>0.2 p,m)
outside the CT (36% for both LCLs and ES cells), but a
reduction in the number of loci found deep within the CT (>0.6
|xm), and a consequent increase in the OCT4 loci positioned at
the CT edge (Fig. 3B).
During the differentiation of mouse ES cells, the movement
of loci relative to the surface of CTs is generally accompanied
by cytologically detectable changes in chromatin condensation
(Chambeyron and Bickmore, 2004). To investigate this further,
we measured the interphase distance (d) between OCT4 and the
flanking BAC clones. In all cases, the distribution of d values
conformed to that expected of a random-walk model of
chromatin structure (s.d.=0.52-0.6; median/mean -1.0) (Sachs
et al., 1995; Chambeyron and Bickmore, 2004). There was no
significant difference in the mean-squared interphase distance
(<d2>) between OCT4 and MICB BACS (genomic distance, 350
kb) for hES cells and LCLs (<r/2>=0.5±0.06 and 0.41 ±0.04 p,m2
respectively, P=0.41). However, there was a significantly larger
interphase separation between OCT4 and FLOT1 (genomic
distance, 400 kb) in LCLs (<d2>=0.33±0.04 p-m2) compared to
hES cells (0.24±0.03 |xm2), P=0.04. In both LCLs and hES cells
the large sizes of the d2 values measured around OCT4, are
consistent with the presence of a generally open chromatin fibre
structure, rather than a compact one (Gilbert et al., 2004).
These data suggest that both the intra-CT architecture and
the long-range chromatin configuration around the OCT4 locus
differ between hES cells and a differentiated cell type that does
not express this marker of pluripotency.
Localisation and clustering of centromeres in human ES
cells
We detected distinctive nuclear organisation of chromosome
arms and specific gene loci in hES cells. To investigate other
non-genic regions we compared the position and number of
centromere clusters in hES cells with that in two diploid
differentiated cell types: LCLs and primary fibroblasts.
Centromeres were detected in paraformaldehyde-fixed cells
using antibodies that recognise CENP-C or CREST serum.
There were no significant differences in the extent of
centromere clustering between hES cells and these two
differentiated cell types. The average number of centromere
signals scored per cell was 34, 36 and 38 for ES, LCL and
proliferating fibroblasts, respectively («=20). Centromere
position was analysed with respect to the nuclear periphery, or
to the nucleolus (detected with antibody that recognises pKi67)
(Fig. 4A). A significantly lower proportion of centromeres was
associated with the nuclear periphery of hES cells in
comparison with LCLs (P<0.04) or fibroblasts (PcO.OOl) (Fig.
4B). Similar proportions of centromeres were associated with
nucleoli in hES cells and fibroblasts (P>0.39). In hES cells a
significantly higher proportion of centromeres were not
associated with either the nuclear periphery or the nucleolus
than either differentiated cell type (P<0.004). These
differences were confirmed by examination of centromere
distribution through the z-axis of nuclei (Fig. 4C). Centromeres
have a normal distribution along the z-axis of ES cell nuclei,
in contrast with a bimodal distribution towards the top and
bottom surface of the nucleus of fibroblasts.
Telomeres are dispersed throughout the nucleoplasm of
differentiated cells (Weierich et al., 2003). Most primary
diploid somatic cells, including fibroblasts, do not have active
telomerase activity, and so are subject to progressive telomere
shortening. Germ cells and stem cells in contrast have active
telomerase, and robust telomerase activity is detected in hES
cells (Thomson et al., 1998). We found that telomeres had a
near-normal distribution in the centre of the nucleus of both
hES cells and LCLs, though this is skewed towards the bottom
of the nucleus in fibroblasts (Fig. 4D).
Lastly, we also analysed the nuclear distribution of PML
bodies. The function of these nuclear bodies remains unknown,
though they have been implicated in transcriptional regulation,
apoptosis, and DNA damage and stress sensing (Dellaire and
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A the radial organisation of CTs, is already established in hES
cells. Gene-poor chromosome 18 is located toward the nuclear
periphery of ES cells, whereas gene-rich HSA19 is more
internal (Fig. 1). HSA18 is seen towards the nuclear periphery
of a variety of differentiated cell types including lymphocytes
(Croft et al., 1999), keratinocytes, and leukaemic and cancer
cell lines (Cremer et al., 2003). However, a peripheral
localisation of HSA18 was not seen in the very flat nuclei of
amniotic fluid cells and quiescent fibroblasts (Bridger et al.,
2000; Cremer et al., 2001). The nuclei of HI ES cells are quite
spherical (average heightdength ratio=1.02±0.1), more similar
to the shape of lymphocyte nuclei (ratio=1.00±0.1), than to
those of fibroblasts (ratio=0.25±0.4). A differential localisation
of HSA18 and 19 was also reported for granulocyte-
macrophage colony-forming cells (GM-CFCs) and it has been
suggested that radial distribution is also present in the
pluripotent haematopoietic progenitor cells (Cremer et al.,
2003). As we show that this radial distribution is already
present in hES cells, we think it highly likely that a similar
nuclear organisation will be present in most, if not all, foetal
and adult stem cells.
Chromosome 12p is located in the centre of the nucleus
in ES cells
Differences in the radial distribution of mouse chromosomes
have been documented in different tissues and during T-cell
differentiation (Parada et al., 2004; Kim et al., 2004). However,
to date no significant change in radial position of a human
chromosome within the nucleus had been documented during
differentiation, although there may be changes in chromosome
associations (Kuroda et al., 2004).
Here we have detected a significantly more central nuclear
localisation for the short arm of human chromosome 12 in ES
cells. It is interesting to note that recurrent gains of
chromosome 12, including isol2p, have been found in human
ES cells (Draper et al., 2004). It has been suggested that
increased dosage of genes on chromosome 12 (and therefore
presumably increased gene expression levels) is
advantageous to the propagation of undifferentiated ES cells.
Although the functional significance of positioning in the
nuclear centre of mammalian cells is unknown, the presence
in this zone of the nucleus of the most gene-dense human
chromosomes (Boyle et al., 2001) suggests that it may confer
some transcriptional advantage. Chromosome 12p contains a
cluster of genes whose expression is linked to the
maintenance of pluripotency. NANOG expression is required
to maintain ES cells in an undifferentiated state (Zaehres et
al., 2005). It is located just proximal of two other genes,
STELLA and GDF3, which are also expressed in ES cells and
downregulated upon differentiation (Clark et al., 2004). A
BAC that covers this gene cluster also shows a more central
nuclear position in hES cells when compared with LCLs (Fig.
2C). Is it possible that it is the transcriptional activity of this
gene cluster that is driving the nuclear localisation of 12p in
hES cells?
Preferential association of inactive genes with the nuclear
periphery has been reported in differentiated cells, compared
with their position in expressing cell types (Zink et al., 2004).
However, we detect no association of either NANOG or OCT4
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Fig. 4. Centromere and telomere localisation in hES cells.
(A) Localisation of centromeres (CREST, red), and nucleoli (Ki67,
green) in single image frames, taken at 0.75 p,m intervals, through
the z-axis of hES cell nuclei counterstained with DAPI (blue). Note
the absence of centromeres from the nuclear periphery. (B) Mean
(±s.e.m.) proportion of centromeres per cell that are associated with
the nuclear periphery (left), the nucleolus (middle), or neither of
these nuclear compartments (right), in HI ES cells (open bars), LCLs
(filled bars) and fibroblasts (hatched bars) (n=20). The mean
(±s.e.m.) distribution of (C) centromeres and (D) telomeres through
the z-plane from the top (0) to the bottom (1) of nuclei from ES, LCL
and fibroblast cells (n=20). Bar, 5 p,m.
Bazett-Jones, 2004). Their nuclear distribution has not been
extensively studied, but many transcriptionally active genomic
regions, including parts of the major histocompatibility
complex (MHC) at 6p, are reported to be associated with them
(Wang et al., 2004). The average number ofPML bodies scored
in hES cells (11), is lower than that seen in LCLs (15) or
fibroblasts (27), but despite the differences in abundance of
PML bodies between cell types, their intranuclear distribution
towards the central mid-plane of the nucleus was the same in
all three cell types (data not shown).
Discussion
The radial distribution of chromosome territories is
present in hES cells
We found that a major organisational feature of human nuclei,
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A relocalisation of OCT4, with respect to its
chromosome territory, in hES cells
In contrast to the central nuclear localisation of 12p and
NANOG in human ES cells, we detected no significant
difference in the radial nuclear position of 6p or OCT4 between
ES and differentiated cells. Both gene and chromosome
territory remain in an intermediate nuclear position (Fig. 2).
However, we found that compared with LCLs, OCT4 is located
significantly closer to, or just beyond the CT edge in hES cells
(Fig. 3). In both cell types, the flanking Class I and Class III
MHC regions were located outside the 6p CT, consistent with
other results (Volpi et al., 2000). The local chromatin structure
of OCT4 has not been studied in hES cells but, in the mouse,
increased DNA methylation and histone deacetylation of the
Oct4 enhancer/promoter are seen in trophoblast cells compared
with ES cells (Hattori et al., 2004). The data we have presented
here would be consistent with a more long-range remodelling
of chromatin architecture around OCT4, which might also
contribute to its transcriptional regulation.
Therefore, for both of the best-studied genes involved in
pluripotency, we find a distinctive nuclear organisation in
human ES cells. In the case ofNANOG, the whole chromosome
arm is localised towards the nuclear centre, whereas for OCT4
there is a more localised reorganisation that allows the gene to
leave the confines of its chromosome territory.
Internal nuclear distribution of centromeres in hES cells
In most human cell types, the predominant reported
distribution of centromeres is toward the nuclear periphery
(reviewed by Gilchrist et al., 2004). In contrast, we have found
that centromeres seem to be found mainly within the nuclear
interior of hES cells (Fig. 4). Factors determining centromere
position in the nucleus are not clear. Under some conditions,
the levels of histone acetylation of centric heterochromatin can
alter centromere position in human and mouse somatic cells
(Taddei et al., 2001) and, in the mouse, histone hypoacetylation
at satellite repeats only occurs upon the induction of
differentiation of mES cells (Keohane et al., 1996). Histone
modifications in hES cells have yet to be examined.
Localisation of centromeres away from the nuclear periphery
may also reflect the rapid cell cycles of hES cells. In turn the
localisation of centromeres within the nucleus may influence
mechanisms of gene silencing (Fisher and Merkenschlager,
2002). Most interestingly, changes in the nuclear distribution
of centromeres have recently been correlated with the
maturation and developmental competency of mouse oocytes
(Zuccotti et al., 2005).
To our knowledge, this is the first study of nuclear
organisation in human ES cells. We have found that hES cell
nuclei have a distinct nuclear architecture, especially at loci
involved in maintaining pluripotency. Understanding how this
nuclear organisation is established and how it influences gene
expression might subsequently allow a better understanding of
pluripotency.
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August 2004, and who is much missed. A.E.W. was funded by a stem
cell studentship from the Medical Research Council, UK. W.A.B. is
a Centennial fellow of the James S. McDonnell foundation. The work
was supported in part by the EU FP6 Network of Excellence
Epigenome (LSHG-CT-2004-503433). We thank W. Earnshaw
(University of Edinburgh) for the gift of anti-CenpC antibody.
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